Medizin
Refine
Year of publication
Has Fulltext
- yes (599)
Is part of the Bibliography
- no (599)
Keywords
- inflammation (30)
- macrophage (13)
- glioblastoma (10)
- SARS-CoV-2 (9)
- cancer (9)
- prostate cancer (9)
- apoptosis (8)
- hypoxia (8)
- data science (7)
- macrophages (7)
- pain (7)
- COVID-19 (6)
- biomarker (6)
- differentiation (6)
- epilepsy (6)
- macrophage polarization (6)
- miRNA (6)
- microRNA (6)
- Cirrhosis (5)
- Magnetic resonance imaging (5)
- autophagy (5)
- breast cancer (5)
- children (5)
- curcumin (5)
- endothelial cells (5)
- environmental tobacco smoke (5)
- lipocalin-2 (5)
- multiple sclerosis (5)
- neurodegeneration (5)
- particulate matter (5)
- prevalence (5)
- proliferation (5)
- psoriasis (5)
- stroke (5)
- Acute myeloid leukemia (4)
- Aspergillus (4)
- B cells (4)
- Cancer treatment (4)
- Gene expression (4)
- Hemorrhage (4)
- Labor and delivery (4)
- Liver diseases (4)
- MSD (4)
- Musculoskeletal system (4)
- NKG2D (4)
- Pregnancy (4)
- ataxia telangiectasia (4)
- bipolar disorder (4)
- bladder cancer (4)
- child (4)
- cytokines (4)
- epidemiology (4)
- immunotherapy (4)
- infection (4)
- integrins (4)
- iron (4)
- mTOR (4)
- machine learning (4)
- mesenchymal stromal/stem cells (4)
- migration (4)
- obesity (4)
- osteoarthritis (4)
- outcome (4)
- polytrauma (4)
- quality of life (4)
- radical prostatectomy (4)
- renal cell carcinoma (4)
- sphingosine-1-phosphate (4)
- sulforaphane (4)
- thymus (4)
- tumor microenvironment (4)
- DNA methylation (3)
- Death rates (3)
- EEG microstates (3)
- Evaluation (3)
- Gender (3)
- General practice (3)
- Hepatocellular carcinoma (3)
- Inflammation (3)
- Kinematic analysis (3)
- Knees (3)
- Legs (3)
- Macrophages (3)
- Medical risk factors (3)
- Morbidity (3)
- Multimorbidity (3)
- Multivariate analysis (3)
- NK cells (3)
- NoxO1 (3)
- PCR (3)
- Pain (3)
- Polypharmacy (3)
- Reliability (3)
- acetaminophen (3)
- aging (3)
- angiogenesis (3)
- bevacizumab (3)
- blood (3)
- caspase-2 (3)
- ceramides (3)
- cirrhosis (3)
- colorectal cancer (3)
- complement (3)
- dental profession (3)
- dentate gyrus (3)
- dentist (3)
- drug resistance (3)
- electrolytic cleaning (3)
- entropy (3)
- exercise (3)
- flow cytometry (3)
- glioma (3)
- growth (3)
- immunity (3)
- information theory (3)
- innate immunity (3)
- invasion (3)
- invasive fungal disease (3)
- meningioma (3)
- metabolism (3)
- metastasis (3)
- mitochondria (3)
- monocytes (3)
- mortality (3)
- mutual information (3)
- natural killer cell (3)
- neuroblastoma (3)
- neuropathic pain (3)
- p21 (3)
- periimplantitis (3)
- physical activity (3)
- preeclampsia (3)
- primary care (3)
- proteomics (3)
- public health (3)
- questionnaire (3)
- reactive oxygen species (3)
- regeneration (3)
- systematic biopsy (3)
- transfusion (3)
- trauma (3)
- tumor progression (3)
- vitamin D (3)
- working memory (3)
- ADHD (2)
- ATM (2)
- ATP-citrate lyase (2)
- Angiogenesis (2)
- Angiography (2)
- Asphyxia (2)
- Ataxia telangiectasia (2)
- Atrial fibrillation (2)
- BCL6 (2)
- BPH (2)
- Biomarker (2)
- Birth weight (2)
- Blood (2)
- Borrelia (2)
- Brain metastasis (2)
- Breast cancer (2)
- Breast tumors (2)
- C-reactive protein (2)
- CC16 (2)
- CD44 (2)
- CDKN1A (2)
- CIK cells (2)
- CLP (2)
- COMP (2)
- CUELA (2)
- Cancer chemotherapy (2)
- Candida (2)
- Cell binding (2)
- Cell differentiation (2)
- Cesarean section (2)
- Chemotherapy (2)
- Citation analysis (2)
- Cohort studies (2)
- Cre-recombinase (2)
- Crohn's disease (2)
- Crohn’s disease (2)
- Cuela (2)
- Cytokines (2)
- Density equalizing mapping (2)
- Dentist (2)
- Depression (2)
- Diagnostic medicine (2)
- Ears (2)
- Elderly (2)
- Flow cytometry (2)
- G2A (2)
- GPCR (2)
- HDAC (2)
- HIV (2)
- Holmes tremor (2)
- IBD (2)
- Inflammatory bowel disease (2)
- Intensive care units (2)
- Ischemia (2)
- Jaw (2)
- LSCC (2)
- Lesions (2)
- MICA (2)
- Malaria (2)
- Markovianity (2)
- Medical education (2)
- Mental health and psychiatry (2)
- Messenger RNA (2)
- Methicillin-resistant Staphylococcus aureus (2)
- Mouse models (2)
- Musculoskeletal disorder (2)
- Myalgia (2)
- NADH dehydrogenase (2)
- NADPH oxidase (2)
- NAFLD (2)
- NASH (2)
- NK cells (2)
- Neonates (2)
- Neutropenia (2)
- Normal distribution (2)
- Nox1 (2)
- OXA-48 (2)
- Obstetrics and gynecology (2)
- Patients (2)
- Physicians (2)
- Portal hypertension (2)
- Portal veins (2)
- Postural control (2)
- Preterm birth (2)
- Prognosis (2)
- Protease inhibitor therapy (2)
- Psychology (2)
- Quality of life (2)
- Questionnaire (2)
- RNF4 (2)
- ROS (2)
- Regression analysis (2)
- Research architecture (2)
- Surgery (2)
- T cell (2)
- T cells (2)
- Torque (2)
- Transcription factors (2)
- Treg cell (2)
- Ulcerative colitis (2)
- Vitamin D (2)
- acetyl-CoA (2)
- additives (2)
- adhesion (2)
- adipose-derived mesenchymal stem cells (2)
- air flow (2)
- alcohol (2)
- anaemia (2)
- anal cancer (2)
- animal model (2)
- anticonvulsants (2)
- antiviral therapy (2)
- ascites (2)
- atherosclerosis (2)
- augmentation (2)
- bibliometrics (2)
- bibliometry (2)
- bio imaging (2)
- bioluminescence (2)
- biomarkers (2)
- biopsy (2)
- borrelia (2)
- calretinin (2)
- cancer stem cells (2)
- carbapenemases (2)
- cardiac surgery (2)
- cell cycle (2)
- cervical cancer (2)
- chemotherapy (2)
- chemotherapy resistance (2)
- cholesterol (2)
- classical Hodgkin lymphoma (2)
- coagulopathy (2)
- cochlear implant (2)
- colon cancer (2)
- colon carcinoma cells (2)
- colorectal carcinoma (2)
- complications (2)
- concordance (2)
- congenital diaphragmatic hernia (2)
- continuous performance test (2)
- corona virus (2)
- coronavirus (2)
- cyclosporin A (2)
- dance (2)
- dendritic cells (2)
- dental assistants (2)
- dental education (2)
- dental implant (2)
- dentists (2)
- depression (2)
- diet (2)
- disintegration (2)
- elderly (2)
- encoding (2)
- erastin (2)
- exosomes (2)
- extracellular vesicles (2)
- fMRI (2)
- female subjects (2)
- ferroptosis (2)
- fibroblasts (2)
- forensic entomology (2)
- functional genomics (2)
- fusion (2)
- fusion biopsy (2)
- gender (2)
- gene expression (2)
- gene regulation (2)
- genetics (2)
- histology (2)
- histone acetylation (2)
- human genomics (2)
- imaging (2)
- immune evasion (2)
- immunohistochemistry (2)
- inflammatory bowel disease (2)
- integrin (2)
- interleukin-4 (2)
- iron deficiency (2)
- iron metabolism (2)
- irradiation (2)
- knowledge discovery (2)
- layer-specificity (2)
- lipoxygenase (2)
- liver damage (2)
- liver fibrosis (2)
- liver transplantation (2)
- lung cancer (2)
- lyme disease (2)
- mTORC1 (2)
- maintenance (2)
- mass spectrometry (2)
- methylprednisolone (2)
- miR-181 (2)
- mouse (2)
- mucormycetes (2)
- multimorbidity (2)
- multinucleated giant cells (2)
- musculoskeletal (2)
- mycophenolic acid (2)
- natural killer cells (2)
- neurogenesis (2)
- next generation sequencing (NGS) (2)
- occupational health (2)
- olfaction (2)
- oxidative phosphorylation (2)
- oxidative stress (2)
- palatal tremor (2)
- patient (2)
- patients (2)
- perforant path transection (2)
- phagocytes (2)
- pharmacokinetics (2)
- plasmid (2)
- polypharmacy (2)
- primary cilium (2)
- primary immunodeficiency (2)
- proteome (2)
- qRT-PCR (2)
- qualitative research (2)
- quantitative MRI (2)
- re-osseointegration (2)
- regulatory T cell (2)
- renal cell cancer (2)
- renal tubular epithelial cells (2)
- resistance (2)
- respiratory chain (2)
- schizophrenia (2)
- second-hand smoke (2)
- secretion (2)
- seizure (2)
- selection (2)
- sex (2)
- signal transduction (2)
- simulation (2)
- sound-induced flash illusion (2)
- sphingosine 1-phosphate (2)
- sphingosine 1-phosphate receptor (2)
- spirochetes (2)
- standard value (2)
- starvation (2)
- stationarity (2)
- surgery (2)
- survivin (2)
- therapy (2)
- tissue engineering (2)
- total hip replacement (2)
- toxicity (2)
- tracking (2)
- trophoblast (2)
- trophoblasts (2)
- tumor growth (2)
- tumor-associated macrophages (2)
- uteroglobin (2)
- vaccination (2)
- (novel) brominated flame retardants ((N)BFR) (1)
- 1-propanol (1)
- 16 segment AHA model (1)
- 16p11.2 (1)
- 17-AAG (1)
- 2-deoxyglucose (2-DG) (1)
- 3D gait analysis (1)
- 5' UTR (1)
- A-FFIP (1)
- AB-serum (1)
- ABCB1 (1)
- ABCC1 (1)
- ACLF (1)
- ADGRE1 (1)
- ADHD differential diagnosis (1)
- AICAR (1)
- AKT signaling (1)
- ALD (1)
- AML – acute myeloid leukemia (1)
- AMPK (1)
- APRI (1)
- ASAP (1)
- ASD-specific (1)
- AU-rich element (1)
- Acute Myeloid Leukemia (1)
- Addison’s disease (1)
- Adenocarcinoma (1)
- Adenylyl cyclase (1)
- Adhesion (1)
- Adverse drug reaction (1)
- Ag-RDT (1)
- Aging (1)
- Akaike information criterion (AIC) (1)
- Alcohol (1)
- Allergic asthma (1)
- Amitriptyline (1)
- Amniotic fluid (1)
- Anal cancer (1)
- Anamneseerhebung (1)
- Anesthesia, Intravenous (1)
- Aneurysms (1)
- Animal wings (1)
- Anosmia (1)
- Anterior cruciate ligament reconstruction (1)
- Anticholinergic (1)
- Anticoagulant therapy (1)
- Anticoagulants [MeSH] (1)
- Anticoagulation (1)
- Antiplatelet therapy (1)
- Antiretroviral therapy (1)
- Antiviral therapy (1)
- Anxiety (1)
- Aortic stiffness (1)
- Apoptosis (1)
- Arms (1)
- Aromatase Inhibitors (1)
- Ascites (1)
- Aspergillus fumigatus (1)
- Aspergillus species (1)
- Ataxia-telangiectasia (1)
- Atherosclerosis (1)
- Atm (1)
- Attention-deficit / hyperactivity disorder (1)
- Attitude (1)
- Audio equipment (1)
- Audio signal processing (1)
- Audiology (1)
- Aurora A (1)
- Australia (1)
- Autism (1)
- Autism spectrum disorder (1)
- Automated Tube Potential Selection (1)
- Automatic Environmental Tobacco Smoke Emitter (1)
- Axons (1)
- B cell subpopulations (1)
- B-cell antigen receptor (1)
- B.1.1.7 (1)
- B.1.617.1 (1)
- B.1.617.2 (1)
- BIRC5 (1)
- BMNC (1)
- BNT2b2 (1)
- BPO (1)
- BRAF (1)
- BRUCE (1)
- Bayesian inference (1)
- Bee venom allergy (1)
- Benefit (1)
- Bibliometric analysis (1)
- Big five (1)
- Birth (1)
- Bleeding (1)
- Bleeding risk (1)
- Blood groups (1)
- Blood plasma (1)
- Bloodstream infections (1)
- Body limbs (1)
- Bone marrow (1)
- Borrelia miyamotoi (1)
- Bradycardia (1)
- Bright light therapy (1)
- Bronchial inflammation (1)
- Burden of illness (1)
- C. elegans (1)
- CAD/CAM (1)
- CD19 (1)
- CD271 (1)
- CD3/CD19 depletion (1)
- CD36 (1)
- CD41 (1)
- CD45RA naïve lymphocytes (1)
- CD62P (1)
- CD74 (1)
- CD8+ T lymphocytes (1)
- CD8+ tumor infiltrating lymphocytes (1)
- CDK2 (1)
- CEND-1 (1)
- CHA2DS2-VASc-score (1)
- CPE (1)
- CPT1A (1)
- CRISPR/Cas9 (1)
- CRM (1)
- CRM1 (1)
- CRP (1)
- CRPC (1)
- CSC marker (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- Caco-2 cells (1)
- Canada (1)
- Cancer (1)
- Cancer Staging (1)
- Cancer detection and diagnosis (1)
- Cancers and neoplasms (1)
- Cannabis (1)
- Carcinoma, Ductal, Breast (1)
- Cardiovascular epidemiology (1)
- Cardiovascular magnetic resonance (1)
- Caregiver burden (1)
- Case management (1)
- Case management [MeSH] (1)
- Cell distribution (1)
- Cell motility (1)
- Cell signalling (1)
- Cell staining (1)
- Cellular stress responses (1)
- Central nervous system (1)
- Cerebrospinal fluid (1)
- Chaperone proteins (1)
- Chemoradiotherapy (1)
- Child adiposity (1)
- Chondral Lesion (1)
- Chronic disease [MeSH] (1)
- Chronic hepatitis (1)
- Chronic intestinal failure (1)
- Chronic kidney disease (1)
- Citation (1)
- Clincial pharmacology (1)
- Co-morbidity (1)
- Cognitive impairment (1)
- Cognitive neurology (1)
- Colchicum (1)
- Cold hardiness (1)
- Cold tolerance (1)
- Colorectal cancer (1)
- Computed axial tomography (1)
- Computed tomography (1)
- Computed tomography imaging (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computer hardware (1)
- Computer software (1)
- Computers (1)
- Conservative treatment (1)
- Constrained posture (1)
- Coronary artery disease (1)
- Cost-effectiveness analysis (1)
- Critical care (1)
- Cryptococcus (1)
- CspA (1)
- CspZ (1)
- Culture positive (1)
- Cyp46a1 (1)
- Cytogenetics (1)
- Cytoplasm (1)
- Cytoplasmic staining (1)
- Cytoreductive nephrectomy (1)
- Cytoskeletal proteins (1)
- D-dimer (1)
- DBS (1)
- DC-NK cell interaction (1)
- DHA (1)
- DLPFC (1)
- DNA Damage (1)
- DNA damage (1)
- DNA damage response (1)
- DNA-binding proteins (1)
- DOMS (1)
- DST (1)
- Data processing (1)
- Data science (1)
- De-isolation (1)
- Deletion mutation (1)
- Dengue (1)
- Dengue fever (1)
- Density equalizing (1)
- Dental education (1)
- Dental implants (1)
- Dental phobia (1)
- Dental practice (1)
- Dental students (1)
- Dental training (1)
- Developmental and epileptic encephalopathy (1)
- Diabetes mellitus (1)
- Diagnostic accuracy (1)
- Diagnostic error (1)
- Diagnostic imaging (1)
- Diagnostic markers (1)
- Digestive system procedures (1)
- Digital workshops (1)
- Direct costs (1)
- Disabilities (1)
- Discs large (1)
- Distance to water (1)
- Distribution limits (1)
- Domestic animals (1)
- Double-blind placebo-controlled trial (1)
- Drug susceptibility testing (1)
- Drug therapy (1)
- Dual-Source CT (1)
- Dynamic MRI (1)
- D’Amico classification (1)
- ECMO (1)
- EGFR (1)
- EGFRvIII mutation (1)
- EMR1 (1)
- EPA (1)
- ERK3/MAPK6 (1)
- ERM (1)
- Early intervention (1)
- Economic analysis (1)
- Economic benchmarks (1)
- Education (1)
- Elevation (1)
- Ellipsoids (1)
- Emotional recognition (1)
- Emotions (1)
- EndMT (1)
- Endocrine cancer (1)
- Endometriosis (1)
- Endoplasmic reticulum (1)
- Endothelial cell (EC) (1)
- Endothelial cells (1)
- Endovascular aortic repair (1)
- England (1)
- Enterobacterales (1)
- Enterobacteriaceae (1)
- Enzyme regulation (1)
- Epidemiology (1)
- Epidermal growth factor receptor (1)
- Epidural abscess (1)
- Epidural block (1)
- Epilepsy (1)
- Epileptic seizures (1)
- Epsilon (1)
- Ergonomics (1)
- Erythropoiesis (1)
- Estrogen Receptor Modulators (1)
- Etiology (1)
- Eutheria (1)
- Evidence based medicine (1)
- Evidence-based dentistry (1)
- Evidence-based medicine (1)
- Exercise (1)
- Exercise challenge (1)
- Exercise-induced asthma (1)
- Exhaled nitric oxide (1)
- Extracorporeal membrane oxygenation (1)
- Exudates and transudates (1)
- F4/80 (1)
- FFLU (1)
- FFPE (1)
- FIB-4 (1)
- FOXO3 (1)
- FOXO3a (1)
- Factor H (1)
- Factor analysis (1)
- Feasibility studies (1)
- Feedback (1)
- Fevers (1)
- Filariosis (1)
- Finevo (1)
- Five-Konzept (1)
- Forced expiratory volume in 1 s (1)
- Forensics (1)
- Frail (1)
- Francisella tularensis (1)
- Francisella tularensis subspecies holarctica (1)
- Functional clustering (1)
- Functional electrical stimulation (1)
- Functional mitral regurgitation (1)
- Fusarium (1)
- GABA (1)
- GMP (1)
- GPR4 (1)
- GRK2 (1)
- GSK3α (1)
- GSK3β (1)
- Gait analysis (1)
- Galleria mellonella (1)
- Gastric cancer (1)
- Gastrointestinal (1)
- Gastrointestinal tract (1)
- Gender analysis (1)
- Gene prediction (1)
- General dental practice (1)
- Genetics (1)
- Genome annotation (1)
- Genu valgum (1)
- Geographically weighted regression (GWR) (1)
- German people (1)
- Germany (1)
- Gesprächsführung (1)
- Gestational diabetes (1)
- Gleason Score (1)
- Gleason score (1)
- Gleason upgrading (1)
- Glioblastoma (1)
- Global health (1)
- Glucose Transporter Type 1 (1)
- Goserelin (1)
- Gram negative bacteria (1)
- Guiding growth (1)
- GvHD (1)
- HBV (1)
- HBV reactivation (1)
- HCC (1)
- HCV treatment (1)
- HIFT (1)
- HLA class II (1)
- HLA peptidome (1)
- HNSCC (1)
- HOD (1)
- HODE (1)
- HOLEP (1)
- HPV (1)
- HSCT (1)
- HSV (1)
- HSV-1 (1)
- HSV-2 (1)
- HT22 neurons (1)
- HUVEC (1)
- Hashimoto’s thyroiditis (1)
- HbA1c (1)
- HeLa cells (1)
- Health care (1)
- Health economics (1)
- Health services research [MeSH] (1)
- Health‑related quality of life (1)
- Heart failure (1)
- Hedgehog (1)
- Hematopoietic stem cell transplantation (1)
- Hepatitis C virus (1)
- Hip (1)
- Histology (1)
- Hmox1 (1)
- HoLEP (1)
- Hodgkin lymphoma (1)
- Hospitals (1)
- Hsp90 inhibitor (1)
- HuR (1)
- Human (1)
- Human olfaction (1)
- Hydrocephalus (1)
- Hymenoptera venom immunotherapy (1)
- Hypertension (1)
- IFN-β (1)
- IHC (1)
- IKKε (1)
- IL-15 (1)
- IL-18BP (1)
- IL-1β (1)
- IL-21 (1)
- IL-27 cytokine (1)
- IL-33 (1)
- IL-6 (1)
- INR (1)
- IPS e.max system (1)
- IPSS (1)
- IRES translation (1)
- ISR (1)
- Image analysis (1)
- Immune cells (1)
- Immune suppression (1)
- Immunohistochemistry techniques (1)
- Immunology (1)
- Impella (1)
- Imrt (1)
- IncL (1)
- IncX (1)
- Incidence rate (1)
- Indirect costs (1)
- Induced sputum (1)
- Infarction (1)
- Infectious disease epidemiology (1)
- Inferior vena cava thrombus (1)
- Inflammatory diseases (1)
- Injury Severity Score (ISS) (1)
- International normalized ratio (1)
- Internet (1)
- Intersectoral care (1)
- Interspecific competition (1)
- Intervention development (1)
- Intestinal failure-associated liver disease (1)
- Intravenous injections (1)
- Ireb2 (1)
- Iron Overload (1)
- Iron chelation (1)
- Joint loading (1)
- Jumping (1)
- K-homology RNA-binding domain (1)
- KAP (1)
- KCNQ1 (1)
- KPS (1)
- KRAS (1)
- Kappa (1)
- Karyotypes (1)
- Keap1-Nrf2 (1)
- Ketogenic Diet (1)
- Ki-67 (1)
- Kidney transplant recipients (1)
- Kinematic posture analysis (1)
- Knowledge (1)
- Kommunikation (1)
- Kupffer cells (1)
- Kynurenine (1)
- LAMTOR2 (1)
- LC3 I/II (1)
- LCH (1)
- LC–MS/MS (1)
- LDL (1)
- LIR interaction, (1)
- LIVIN (1)
- LM11A 31 (1)
- LQTS (1)
- LSTA1 (1)
- Laboratory techniques and procedures (1)
- Lafora disease (1)
- Langerhans cell histiocytosis (1)
- Lecture (1)
- Left atrial appendage occlusion (1)
- Left hemisphere (1)
- Leg axis (1)
- Leigh syndrome (1)
- Lennox–Gastaut syndrome (1)
- Lernzuwachs (1)
- Light sheet fluorescence microscopy (1)
- Linear regression analysis (1)
- Liver fibrosis (1)
- Liver transplantation (1)
- Livestock (1)
- LncRNA - long noncoding RNA (1)
- Loa loa (1)
- Local climate (1)
- Long-/Post-COVID (1)
- Longchain polyunsaturated fatty acids (1)
- Lower limb deformities (1)
- Luciferase (1)
- Lyme disease (1)
- Lymphangioleiomyomatosis (1)
- Lymphoma (1)
- M. Intracellulare (1)
- M. avium (1)
- M. avium complex (1)
- M. chimaera (1)
- MAGGIC score (1)
- MAIT cell (1)
- MCAO (1)
- MCI (1)
- MEDIC (1)
- MEIS (1)
- MEIS2 (1)
- MMP14 (1)
- MMP2 (1)
- MRI (1)
- MRI patterns of gliomas (1)
- MRP4 (1)
- Machine learning (1)
- Machine learning algorithms (1)
- Machine-learning (1)
- Mammalian target of rapamycin (1)
- Mapping (1)
- Marker genes (1)
- Marsupials (1)
- Mastoiditis (1)
- Mechanisms of disease (1)
- Meckel’s diverticulum (1)
- Medical Physics: Diagnostic (1)
- Medical communication (1)
- Medical ethics (1)
- Medical research (1)
- Medical traineeship (1)
- Medication changes (1)
- Medicine and health sciences (1)
- Membrane staining (1)
- Meta-analysis (1)
- Metabolism, Inborn Errors (1)
- Metalloproteases (1)
- Metastasis (1)
- Metastatic renal cell carcinoma (1)
- Metastatic tumors (1)
- Methanol (1)
- Method validation (1)
- Methods (1)
- Michael acceptor (1)
- Micro-CT (1)
- Microalgae (1)
- Microfilaremia (1)
- Microglial cells (1)
- Microphones (1)
- Migrant health (1)
- MitraClip (1)
- Molecular medicine (1)
- Molecular neuroscience (1)
- Monocytes and macrophages (1)
- Monosaccharide Transport Proteins (1)
- Morphometry (1)
- Mortality (1)
- Mucomaix® matrix (1)
- Multi-modal feedback (1)
- Multidetector Computed Tomography (1)
- Multimedication (1)
- Multiplate (1)
- Multiple chronic conditions (1)
- Multiple-indication review (1)
- Musculoskeletal mechanics (1)
- Mycobacteria (1)
- Mycobacterium avium complex (1)
- Myocardial perfusion (1)
- Myocardial revascularization (1)
- Myocardial segmentation (1)
- Myocarditis (1)
- N2 (1)
- N501Y (1)
- NADPH oxidase 4 (1)
- NDBI (1)
- NF-ĸB (1)
- NF-κB pathway (1)
- NF-кB (1)
- NIRS (1)
- NK cell (1)
- NK receptors (1)
- NK-92 (1)
- NKT cell (1)
- NLRP3 inflammasomes (1)
- NS3 protease inhibitor (1)
- NSCLC (1)
- NTDs (1)
- NTM (1)
- Native T1 mapping (1)
- Necrosis (1)
- Negative staining (1)
- Neglected tropical diseases (1)
- Nek1 (1)
- Neoplasms (1)
- Neuroendocrine cancer (1)
- Neuroimaging (1)
- Neurons (1)
- Neuropathic pain (1)
- Neuropsychological testing (1)
- Neuropsychology (1)
- Next-generation sequencing (1)
- Niche differentiation (1)
- Nimotuzumab (1)
- Non-small cell lung cancer (1)
- Non-tuberculous mycobacteria (1)
- Non-urothelial (1)
- Nonpenetrating (1)
- Nontuberculous mycobacteria (1)
- Nordic questionnaire (1)
- Notch (1)
- Nrf2 (1)
- OGR1 (1)
- OGTT (1)
- OHIP-G14 (1)
- OHRQoL (1)
- OSA (1)
- OSCE (1)
- OXA-484 (1)
- Obesity (1)
- Older adults (1)
- Olfactory diagnostics (1)
- Open pulmonary tuberculosis (1)
- Opossums (1)
- Opportunistic infections (1)
- Opsoclonus-myoclonus syndrome (1)
- Optogenetics (1)
- Oral and maxillofacial surgery (1)
- Oral anticoagulation (1)
- Ordinary least squares (OLS) (1)
- Orthodontist (1)
- Orthopaedics (1)
- OspE (1)
- Osteoarthritis (1)
- Outpatients (1)
- Overwintering (1)
- PBX (1)
- PBX1 (1)
- PD-L1 (1)
- PEI (1)
- PF-06273340 (1)
- PINK1 (1)
- PKA (1)
- PKCε (1)
- PML (1)
- POCT (1)
- PSA (1)
- PTM (1)
- PYGL (1)
- Paediatric research (1)
- Pancreatic neuroendocrine tumor (1)
- Paraneoplastic neurological syndromes (1)
- Parenteral nutrition (1)
- Parkinson’s disease (1)
- Patellofemoral Joint (1)
- Patient and public Involvement (1)
- Patient education (1)
- Patient knowledge (1)
- Patient participation (1)
- Patient safety (1)
- Patient satisfaction (1)
- Patterns of care (1)
- Pediatric orthopedic (1)
- Peer-feedback (1)
- Per1−/−-mice (1)
- Percutaneous coronary intervention (1)
- Personality (1)
- Pgrmc1 (1)
- Pharm-fMRI (1)
- Pharmacometrics (1)
- Pharyngeal reflex (1)
- Phenotypic plasticity (1)
- Phospholipids (1)
- Photoreceptors (1)
- Phylogenetic analysis (1)
- Physical environment (1)
- Physiology (1)
- Plasmapheresis (1)
- Platelet-rich fibrin (1)
- Platelets (1)
- Point-of-care testing (1)
- Poly-Pore (1)
- PolySUMOylation (1)
- Positron emission tomography (1)
- Post-offence drinking (1)
- Post-traumatic stress disorder (1)
- Practice (1)
- Prediction (1)
- Prevalence (1)
- Primary care (1)
- Primary health care (1)
- Primary health care [MeSH] (1)
- Probability density (1)
- Probability distribution (1)
- Professional dance (1)
- Prostaglandin (1)
- Prostate cancer (1)
- Prosthetic rehabilitation (1)
- Protein translation (1)
- Proteomes (1)
- Prototypes (1)
- Psychological stress (1)
- Public and occupational health (1)
- Public health (1)
- Publication (1)
- Publication output (1)
- QbTest® (1)
- Quantitative features (1)
- Quantra (1)
- Quinolinate phosphoribosyltransferase (1)
- Quinolinic acid (1)
- RAS (1)
- RITA (1)
- RNA (1)
- RNA binding proteins (1)
- RNA chaperone (1)
- RNA extraction (1)
- RNA isolation (1)
- RNA sequencing (1)
- RNA therapeutics (1)
- RNA therapy (1)
- RNA-binding protein (1)
- RNAi and CRISPR screens (1)
- ROC analysis (1)
- Radiation exposure (1)
- Radiological assessment (1)
- Rainfall (1)
- Randomised trial (1)
- Rare Diseases (1)
- Reactive oxygen species (1)
- Regret (1)
- Regulatory networks (1)
- Renal vein thrombus (1)
- Research design (1)
- Resource competition (1)
- Respiratory Syncytial Virus (1)
- Respiratory infections (1)
- Restricted posture (1)
- Retina (1)
- Ribosomes (1)
- Risk assessment (1)
- Rural area (1)
- Rush protocol (1)
- S1P (1)
- S1P lyase (1)
- S1P1–5 (1)
- S1PR1 (1)
- SARS-COV-2 (1)
- SCA2 (1)
- SENP6 (1)
- SF-36 (1)
- SGPL1 knockout cell line (1)
- SH-SY5Y neuroblastoma cells (1)
- SKALE score (1)
- SLC6a3 (1)
- SLC7A11 (1)
- SMOC1 (1)
- SNORD95 (1)
- SSTI (1)
- ST2L (1)
- STAMPE2 (1)
- STAT3 (1)
- STIR (1)
- SUD (1)
- SUMO (1)
- SUMO chains (1)
- SW480 cells (1)
- Sarcopenia (1)
- Science structure (1)
- Scientists (1)
- Scientometric analysis (1)
- Scientometrics (1)
- Scientometry (1)
- Seattle heart failure model (1)
- Seizures (1)
- Sensory perception (1)
- Sequence alignment (1)
- Sequence motif analysis (1)
- Serum biomarker (1)
- Sholl analysis (1)
- Short bowel syndrome (1)
- Side effects (1)
- Simulated patients (1)
- Skeletal joints (1)
- Slc11a2 (1)
- Slc25a37 (1)
- Smart nebulizer (1)
- Social research (1)
- Social sciences (1)
- Software tool (1)
- Software tools (1)
- Specimen preparation and treatment (1)
- Speech signal processing (1)
- Spinal injuries (1)
- Spinocerebellar ataxia type 2 (1)
- Sport (1)
- Sports and exercise medicine (1)
- Sputum smear-negative (1)
- Squamous cell carcinoma (1)
- StUbL (1)
- Stakeholder participation (1)
- Static MRI (1)
- Statistical analysis (1)
- Statistical data (1)
- Stenotrophomonas maltophilia (1)
- Stereotactic radiosurgery (1)
- Strength training (1)
- Stress and resilience (1)
- Stroke (1)
- Sub-segmentation (1)
- Sub-zero exposure (1)
- Suicide (1)
- Sumatra (1)
- Superoxide (1)
- Surgical and invasive medical procedures (1)
- Surgical education (1)
- Surgical oncology (1)
- Survey (1)
- Surveys (1)
- Survivin (1)
- Synapses (1)
- Systematic reviews (1)
- T cell receptor (1)
- T cell response (1)
- T-cell development (1)
- T-cell receptor (1)
- T-cell receptor (TCR) (1)
- T-lymphocytes (1)
- TACE (1)
- TALE-homdomain protein (1)
- TAPSE (1)
- TB-therapy (1)
- TBK1 (1)
- TDAG8 (1)
- TGF-β1 (1)
- TGR(mREN2)27 (1)
- TIMP2 (1)
- TLR (1)
- TNF inhibitors (1)
- TNF-α (1)
- TP53 (1)
- TP53-induced glycolysis and apoptosis regulator (1)
- TRIM25 (1)
- TRIMs (1)
- TRPM8 (1)
- TSP-4 (1)
- TURP (1)
- Targeted therapy (1)
- Temporomandibular joint (1)
- Temporomandibular joint dysfunction (1)
- Tet-inducible system (1)
- Tfrc (1)
- Thoracic aortic aneurysm (1)
- Thrombosis (1)
- Thromboxane (1)
- Total hip arthroplasty (1)
- Toxicity (1)
- Transcription (1)
- Transcriptional control (1)
- Translation initiation (1)
- Translational research (1)
- Transportation (1)
- Trk (1)
- TrkC (1)
- Tubers (1)
- Tularemia (1)
- Tumor infiltrating lymphocytes (1)
- ULBP4 (1)
- UTUC (1)
- Ultra microscopy (1)
- Ultra-rush protocol (1)
- Ultrasonic nebulizer (1)
- Umbilical cord (1)
- Uncertainty (1)
- Undergraduate training (1)
- United States (1)
- Urethral cancer (1)
- VIM (1)
- Vacuoles (1)
- Validation (1)
- Validity (1)
- Variant histology (1)
- Vasculitis (1)
- Vasculogenesis (1)
- Veins (1)
- Vertebral body (1)
- Vespid venom allergy (1)
- Viral load (1)
- Virtual patients (1)
- Vitamin D deficiency (1)
- Vmem (1)
- Volumetric analysis (1)
- Warburg effect (1)
- Water chemistry (1)
- Western diet (1)
- White blood cells (1)
- Winter survival (1)
- Work shadowing (1)
- Workstation comparison (1)
- Wound healing (1)
- Wounds (1)
- X-ray computed tomography (1)
- XIAP (1)
- YM155 (1)
- Yellow fluorescent protein (1)
- Zoonosis (1)
- Zoopotentation (1)
- Zooprophylaxis (1)
- Zymosan-induced peritonitis (1)
- academic (1)
- accident (1)
- acetylation (1)
- acetylcholinesterase (1)
- acoustic radiation force impulse imaging (1)
- acquired drug resistance (1)
- actin dynamics (1)
- activities of daily life (1)
- acute infections (1)
- acute inflammation (1)
- acute kidney injury (1)
- acute lung injury (1)
- acute lung injury (ALI) (1)
- acute lymphoblastic leukemia (1)
- acute pain (1)
- acute respiratory distress syndrome (1)
- acute-on-chronic liver failure (1)
- acute-on-chronic liver failure (ACLF) (1)
- adenosine (1)
- adenosine receptors (1)
- adipocytes (1)
- adiponectin (1)
- adipose-derived mesenchymal stem/stromal cells (1)
- adipose-derived stem cells (1)
- adipose-derived stromal/stem cells (1)
- adjuvant chemotherapy (1)
- adoptive cancer immunotherapy (1)
- adoptive immunotherapy (1)
- adrenal insuffciency (1)
- adult neurogenesis (1)
- adverse reaction (1)
- affective disorder (1)
- affective disorders (1)
- age (1)
- aged (1)
- ageing (1)
- agent-based models (1)
- air pollution (1)
- airborne bacteria (1)
- albumin (1)
- alcohol use disorder (AUD) (1)
- alcoholic hepatitis (1)
- algorithm (1)
- all-ceramics (1)
- allergy (1)
- allogeneic stem cell transplantation (1)
- alpha-synuclein (1)
- alpharetroviral vector (1)
- amlexanox (1)
- amyotrophic lateral sclerosis (ALS) (1)
- analgesics (1)
- anaplastic large cell lymphoma (1)
- anemia (1)
- angioedema control test (1)
- angiography (1)
- anti-angiogenic therapy (1)
- anti-cancer therapy (1)
- anti-tumor activity (1)
- antiadhesive composites (1)
- antibacterial composites (1)
- antibiotic therapy (1)
- antibodies (1)
- antifibrotic therapy (1)
- antifungal activity (1)
- antifungal combination therapy (1)
- antifungal host response (1)
- antifungal therapy (1)
- antimicrobial stewardship (1)
- antireflux surgery (1)
- antiviral (1)
- antiviral drugs (1)
- apical constriction (1)
- apical junction (1)
- apical polarity (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- arachidonate 15-lipoxygenase (1)
- arachidonic acid (1)
- architecture (1)
- aromatics (1)
- articular cartilage (1)
- aspiration (1)
- aspirin (1)
- assembly (1)
- assembly factor (1)
- associative memory (1)
- asthma (1)
- astrocytes (1)
- astrocytoma (1)
- ataxia score (1)
- atopy (1)
- attachment (1)
- attention (1)
- attention deficit hyperactivity disorder (1)
- attention deficit/hyperactivity disorder (ADHD) (1)
- auditory (1)
- authorship (1)
- autism spectrum disorder (1)
- autoimmunity (1)
- automatic environmental tobacco smoke emitter (1)
- automatic scene classification (1)
- autopsy (1)
- back scan (1)
- bacterial translocation (1)
- bacterial viability (1)
- bacterium (1)
- ball (1)
- ballet (1)
- basal cell carcinoma (1)
- basilar artery occlusion (BAO) (1)
- benign soft tissue tumor (1)
- best medical treatment (1)
- beta-band activity (1)
- beta-lactamases (1)
- bilateral tDCS (1)
- binary search procedure (1)
- bioactive lipids (1)
- bioactivity (1)
- bioavailability (1)
- biofilm (1)
- biologics (1)
- biologization (1)
- biomolecular analysis (1)
- biopsy naïve (1)
- bladder neck stenosis (1)
- blended learning (1)
- blood concentrates (1)
- blood culture (1)
- blood loss (1)
- blood pressure (1)
- blood-brain barrier (1)
- blow fly (1)
- body mass index (1)
- body posture (1)
- body sway (1)
- body weight distribution (1)
- bone damage (1)
- bone healing (1)
- bone marrow mononuclear cells (1)
- bone tissue (1)
- bone-regeneration (1)
- bone–implant interface (1)
- booster (1)
- borrelia mayonii (1)
- brain imaging (1)
- brain infection (1)
- brain phosphorylome (1)
- brain shift (1)
- brain tumor (1)
- brainstem (1)
- burden of disease (1)
- butyrylcholinesterase (1)
- bypass (1)
- cAMP (1)
- cIAP1/2 (1)
- cadherin (1)
- calbindin (1)
- calcitriol (1)
- cancer and drug vulnerabilities (1)
- cancer cell metabolism (1)
- cancer immunobiology (1)
- cancer metastases (1)
- cancer specific survival (1)
- cancer-associated fibroblasts (1)
- cancer-specific survival (1)
- canonical (1)
- car indoor (1)
- carbapenem resistance (1)
- carbon oxides (COx) (1)
- carcinoma (1)
- cardiac differentiation (1)
- cardiac regeneration (1)
- cardiac reprogramming (1)
- cardiomyocyte apoptosis (1)
- cardiomyocyte proliferation (1)
- cardiothoracic surgery (1)
- cardiovascular disease (1)
- case reports (1)
- caspase 8 (1)
- caspase-8 (1)
- castration resistance (1)
- catheter removal (1)
- cdk (1)
- cell adhesion (1)
- cell and focal adhesion (1)
- cell culture (1)
- cell cycle arrest (1)
- cell cycling (1)
- cell death (1)
- cell fusion (1)
- cell growth (1)
- cell motility (1)
- cell proliferation (1)
- cell survival (1)
- cell survival mechanisms (1)
- cellular reaction (1)
- cellular response (1)
- cellular therapies (1)
- center of pressure (1)
- central nervous system (1)
- central spasticity (1)
- centrifugation (1)
- ceramide (1)
- cerebellum (1)
- cerebral imaging (1)
- cerebral radiation necrosis (1)
- certepetide (1)
- chaperone-mediated autophagy (1)
- chaperones (1)
- chelation therapy (1)
- chemokine (1)
- chemokine receptors (1)
- chemoprotection (1)
- chemoradiotherapy (1)
- chemoresistance (1)
- chemotaxis (1)
- chemotherapeutic drug resistance (1)
- chest injury (1)
- chest trauma (1)
- chimeric antigen receptor (1)
- chloroplasts (1)
- cholangiocarcinoma (1)
- cholinesterase (1)
- chronic granulomatous disease (1)
- chronic hepatitis C (1)
- chronic infections (1)
- chronic inflammation (1)
- cigarette smoke (1)
- cigarette strength (1)
- citation (1)
- classification (1)
- classification of bone defects (1)
- clear cell (1)
- clinical performance (1)
- clinical research (1)
- clinical trial (1)
- clopidogrel (1)
- cluster analysis (1)
- cluster-randomized controlled trial (1)
- cluttering (1)
- coagulation (1)
- cochlear implants (1)
- cognition (1)
- cognitive aids (1)
- cognitive deficits (1)
- cognitive functions (1)
- cognitively stimulating leisure activities (1)
- collaborative healthcare (1)
- collagen (1)
- collagen I (1)
- collagen-based biomaterial (1)
- collagen-based matrix (1)
- collective cell migration (1)
- colon (1)
- colorectal cancer (CRC) (1)
- combined immunodeficiency (1)
- comorbidity (1)
- complex systems (1)
- complexity theory (1)
- complexome profiling (1)
- computational functional genomics (1)
- computational knowledge-discovery (1)
- computational techniques (1)
- confinement (1)
- connective tissue (1)
- connectivity (1)
- contamination (1)
- contralateral delay activity (1)
- controlled nuclear import (1)
- cooling period (1)
- coronary (1)
- coronavirus disease 2019 (1)
- cortex, gray matter (1)
- cortical thickness (1)
- covalent drugs (1)
- crime scene (1)
- critical care (1)
- critical-size defect (1)
- criticality (1)
- cryopreservation (1)
- cuticular hydrocarbons (1)
- cyclin D1 (1)
- cyclin Y (1)
- cyclins (1)
- cyclophosphamide (1)
- cystic fibrosis (1)
- cytarabin (1)
- cytokine storm (1)
- cytokine, angiogenesis (1)
- cytotoxic lymphocytes (1)
- cytotoxicity (1)
- daily activity protocols (1)
- dance teacher (1)
- data repositories (1)
- death rates (1)
- death receptor (1)
- debris (1)
- declaration of tobacco ingredients (1)
- decompensated liver cirrhosis (1)
- deep sedation (1)
- deferred treatment (1)
- delayed treatment (1)
- delta (1)
- dementia (1)
- demineralized bone matrix (1)
- dendrite morphogenesis (1)
- density equalizing mapping (1)
- dental assistant (1)
- dental health professional (1)
- dentoalveolar surgery (1)
- desensitization (1)
- development (1)
- dexamethasone (1)
- diabetes (1)
- diabetes mellitus (1)
- diabetes therapy (1)
- diagnostics (1)
- diaphragm development (1)
- dietary assessment (1)
- differentiated thyroid carcinoma (1)
- diffusion tensor imaging (1)
- digital age determination (1)
- digital workflow fracture load material thickness (1)
- dihydrocannabidiol (1)
- dihydroceramides (1)
- dimethylfumarate (1)
- diphtheria toxin (1)
- direct-acting antivirals (1)
- discoidin domain-containing receptor (1)
- disease-free survival (1)
- disordered iron metabolism (1)
- dissemination (1)
- diuretics (1)
- dog study (1)
- dopamine transporter (1)
- doublecortin (1)
- downgrading (1)
- doxycycline (1)
- drug (1)
- drug screening (1)
- drug–drug interactions (1)
- drug–gene interactions (1)
- drug–g–gene interactions (1)
- dual antiplatelet therapy (1)
- dynamic causal modeling (1)
- dysphagia (1)
- eNPP2 (1)
- early continence (1)
- early detection (1)
- early loss (1)
- early onset (1)
- ecological momentary assessment (1)
- economic outcomes (1)
- ectopic pregnancy (1)
- efferocytosis (1)
- efficacy (1)
- effort (1)
- eicosanoids (1)
- electrode design (1)
- electron transfer (1)
- electrophilic fatty acids (1)
- electrophysiology (1)
- eligibility (1)
- elite athletes (1)
- eltrombopag (1)
- emergency care (1)
- emergent self-organizing maps (1)
- endocannabinoids (1)
- endoplasmic reticulum (1)
- endothelial cell (1)
- endothelial nitric-oxide synthase (1)
- endourology (1)
- endovascular treatment (1)
- enterobacter infections; pseudomonas aeruginosa; epidemiology (1)
- enterocytes (1)
- entomological evidence (1)
- epidemics (1)
- epidermis (1)
- epigenetics (1)
- epileptic encephalopathies (1)
- epithelial-to-mesenchymal transition (EMT) (1)
- essential tremor (1)
- ethiodized oil (1)
- ethnicity (1)
- euthymic (1)
- everolimus (1)
- everyday life (1)
- ex vivo expansion (1)
- ex-Gaussian analysis (1)
- exertion (1)
- experimental pain models (1)
- expertise (1)
- exponential model (1)
- external hip adduction moment (1)
- external knee adduction moment (1)
- external validation (1)
- extracellular matrix (1)
- fNIRS (1)
- face-name association task (1)
- factor H (1)
- falls (1)
- false memory (1)
- fatigue (1)
- feasibility (1)
- feeder cells (1)
- female health (1)
- ferritin (1)
- ferritinophagy (1)
- ferroportin (1)
- fibrin-glue-spray technique (1)
- fibrinolysis (1)
- fibrosis (1)
- fibrotest (1)
- fingolimod (1)
- first-line chemotherapy (1)
- fitness (1)
- fixed partial dentures (1)
- follow-up (1)
- forensics (1)
- fractional anisotropy (1)
- fractionation (1)
- fragile-X-associated tremor-ataxia syndrome (1)
- frequency of attacks (1)
- fresh frozen plasma (1)
- fronto-temporal lobar dementia (1)
- fronto-temporal-lobar-dementia (1)
- full-contour crown restorations (1)
- function (1)
- functional connectivity (1)
- functional magnetic resonance imaging (1)
- fundoplication (1)
- fungi (1)
- fungus (1)
- gadolinium enhancing lesion (1)
- galactomannan (1)
- gastroesophageal reflux (1)
- gender differences (1)
- gene expression analysis (1)
- gene signature (1)
- gene therapy (1)
- general anaesthesia (1)
- general practitioner (1)
- genetic diversity (1)
- genetic model (1)
- genetic predisposition (1)
- genomic instability (1)
- geriatric patients (1)
- glial activation (1)
- glioma microenvironment (1)
- glucose metabolism (1)
- glutathione peroxidase 4 (1)
- glycolysis (1)
- glycoproteins (1)
- graft-versus-host disease (1)
- graft-versus-tumor effect (1)
- granulomas (1)
- granulomatous inflammation (1)
- graph theory (1)
- ground reaction forces (1)
- growth inhibition (1)
- haploidentical (1)
- head and neck squamous cell carcinoma (1)
- head-and-neck cancer (1)
- health service utilisation (1)
- healthcare workers (1)
- heart failure (1)
- heat (1)
- heat stress (1)
- hedgehog signaling (1)
- hedgehog signaling pathway (1)
- hematopoiesis (1)
- hematopoietic cell transplantation (1)
- hematopoietic stem and progenitor cells (1)
- hematopoietic stem cell transplantation (1)
- hemiepiphysiodesis plate (1)
- hemodialysis (1)
- hemorrhagic transformation (1)
- hepatic steatosis (1)
- hepatic stellate cells (1)
- hepatitis B virus (1)
- hepatitis C virus (1)
- hepatitis E virus (1)
- hepatoblastoma (1)
- hepatocellular cancer (1)
- hepatocellular carcinoma (1)
- hereditary angioedema (1)
- heterogeneity (1)
- high molecular weight plasticizer (1)
- high throughput (1)
- high-dimensional data sets (1)
- high-throughput nucleotide sequencing (1)
- hippocampus (1)
- histological outcomes (1)
- histomorphometry (1)
- histone deacetylase (1)
- home visit (1)
- homeodomain protein (1)
- host cell interaction (1)
- host cell response (1)
- host-pathogen interaction (1)
- host-targeting antivirals (1)
- hostpathogen interaction (1)
- human Natural Killer cell (1)
- human antigen R (HuR) (1)
- human cytomegalovirus (1)
- human decellularized dermis (1)
- human subjects (1)
- humans (1)
- humectant agents (1)
- hybrid abutment (1)
- hydrogen peroxide (1)
- hyperglycemia (1)
- hyperlipidemia (1)
- hypoxia-induced cell death (1)
- hypoxia-inducible factor (1)
- iRGD peptide (1)
- idiopathic dystonia (1)
- image analysis (1)
- image-guided tissue acquisition (1)
- immune cells (1)
- immune checkpoint (1)
- immune defense (1)
- immune deficiency (1)
- immune host defense (1)
- immune infiltration (1)
- immune profiling (1)
- immune response (1)
- immunoglobulin superfamily (1)
- immunological research (1)
- immunosuppressive agent (1)
- immunosuppressive drug (1)
- implant-mediated growth guidance (1)
- in vitro models (1)
- in vivo dosimetry (1)
- in-cabin exposure (1)
- indoor air pollution (1)
- induced membrane (1)
- inducible gene expression (1)
- inducible nitric oxide synthase (1)
- inertial motion capture (1)
- infection control (1)
- infection model (1)
- infectivity (1)
- infiltration (1)
- inhibitor (1)
- inhibitor of apoptosis protein family (1)
- inhibitors (1)
- inosine (1)
- inositol signaling (1)
- insertion (1)
- insulin resistance (1)
- insurance data (1)
- integration (1)
- interferon (1)
- interferon type III (1)
- interleukin-1 (1)
- interleukin-18 (1)
- interleukin-22 (1)
- internal ribosomal entry site (IRES) (1)
- internet (1)
- interstitial multicatheter brachytherapy (1)
- intervention study (1)
- intestinal barrier (1)
- intoxication (1)
- intracerebral hemorrhage (1)
- intravenous iron therapy (1)
- intrinsic apoptosis (1)
- intrinsic drug resistance (1)
- invasive fungal infection (1)
- invasive growth (1)
- inverse stage migration (1)
- inflammation (1)
- ionomycin (1)
- iron chelation (1)
- iron chelator (1)
- iron chelators (1)
- iron deficiency anemia (1)
- iron homeostasis (1)
- iron overload versus deprivation (1)
- iron-trafficking (1)
- ischemic stroke (1)
- isocaloric ketogenic diet (1)
- jejunoileal atresia (1)
- joint contact forces (1)
- junctional adhesion molecule (1)
- juvenile myoclonic epilepsy (1)
- keratinocytes (1)
- kidney cancer (1)
- kidney neoplasm (1)
- kinematics (1)
- knee adduction moment (1)
- knee joint (1)
- knee osteoarthritis (1)
- laceration (1)
- leg axis malalignment (1)
- lentiviral vector (1)
- leukemia (1)
- leukocytes (1)
- leukopenia (1)
- levetiracetam (1)
- lichen extracts (1)
- light irradiation (1)
- linoleic acid metabolites (1)
- lipid mediator (1)
- lipid metabolism (1)
- lipids (1)
- lipids inflammatory pain (1)
- lipofuscin (1)
- lipopolyplex (1)
- lipoxin A4 (1)
- liquid PRF (1)
- liquid-PRF (1)
- live cell imaging (1)
- live/dead staining (1)
- liver (1)
- liver X receptor (1)
- liver cirrhosis (1)
- liver disease (1)
- liver injury (1)
- liver resection (1)
- liver steatosis (1)
- lncRNA (1)
- local antibiotics (1)
- local control (1)
- local recurrence (1)
- location (1)
- locator (1)
- long-term follow-up (1)
- long-term potentiation (1)
- long-term prophylaxis (1)
- long-term study (1)
- longevity (1)
- low speed centrifugation concept (1)
- low-dose imaging (1)
- lower limb deformities (1)
- lung (1)
- lung development (1)
- lung disease (1)
- lung squamous cell carcinoma (LUSC) (1)
- luteolin (1)
- lymphangiogenesis (1)
- lymphocyte (1)
- mGluR3 (1)
- mGluR5 (1)
- mHealth (1)
- mRNA stability (1)
- mRNA-1273 (1)
- mRNA1273 (1)
- mTOR inhibition (1)
- machine learning (ML) (1)
- machine-learning (1)
- magnetoencephalography (1)
- major depression (1)
- major depression (MD) (1)
- major depressive disorder (1)
- major depressive disorder (MDD) (1)
- malignancy (1)
- malignant glioma (1)
- mammary cancer (1)
- mammary carcinoma (1)
- markovianity (1)
- mast cells (1)
- maternal tobacco smoke (1)
- mathematical modeling (1)
- matrix metalloproteinase (1)
- matrix metalloproteinases (1)
- mean diffusivity (1)
- mechanism of action (1)
- medical error (1)
- medical risk factors (1)
- medication (1)
- medication management (1)
- medication review (1)
- medulloblastoma resection (1)
- melanoma (1)
- membrane potential (1)
- membrane-less organelles (1)
- membranous urethral stricture (1)
- memebrane (1)
- memory (1)
- menthol (1)
- merkel cell carcinoma (1)
- mesenchymal stem cell (1)
- mesenchymal stromal cell (1)
- mesenchymal stromal cells (1)
- meta-analysis (1)
- metabolic cancer therapy (1)
- metabolic liver disease (1)
- metabolic syndrome (1)
- metamorphosis (1)
- metastatic colorectal cancer (1)
- metastatic prostate cancer (1)
- metastatic urethral cancer (1)
- metformin (1)
- methacarn (1)
- methylation profiling (1)
- miR (1)
- miR-122 (1)
- miR-142-3p (1)
- miR-21 (1)
- miR-375 (1)
- mice (1)
- microbiome (1)
- microenvironment (1)
- microglia (1)
- microlesions (1)
- microsatellite instability (1)
- microtemporal processes (1)
- microtubular cytoskeleton (1)
- microwave ablation (1)
- middle-aged (1)
- migration and invasion (1)
- mind wandering (1)
- minimal invasive surgery (1)
- mitochondrial disease (1)
- mobile air quality study (1)
- mobile phone (1)
- modified FDI criteria (1)
- mold (1)
- molecular surveillance (1)
- monoclonal antibodies (1)
- monocyte chemotactic protein 1 (MCP-1) (1)
- monolithic restorations (1)
- monotype abutment (1)
- monsoon (1)
- morbidity (1)
- morphogenesis (1)
- morphometry (1)
- mortality analysis (1)
- motility (1)
- motor activity (MA) (1)
- motor functions (1)
- mouse model (1)
- movement disorders (1)
- mpMRI (1)
- mtor (1)
- mucormycete (1)
- mucosal inflammation (1)
- multi-scale models (1)
- multidrug resistance (1)
- multifocal (1)
- multiscale entropy (1)
- multisensory integration (1)
- multivariable analysis (1)
- multivoxel pattern analysis (1)
- musculoskeletal disorders (1)
- musculoskeletal inflammation (1)
- musculoskeletal modeling (1)
- musculoskeletal pain (1)
- musculoskeletal system (1)
- myelodysplastic syndrome (1)
- myeloid cells (1)
- natural cytotoxicity (1)
- natural killer T cells (1)
- natural selection (1)
- naturalistic sample (1)
- ncRNA (1)
- neonate (1)
- nephrectomy (1)
- nephroblastoma (1)
- nephron sparing surgery (1)
- nephroureterectomy (1)
- nerve-sparing (1)
- network (1)
- neurexin (1)
- neurocognition (1)
- neuroimaging (1)
- neuronal avalanches (1)
- neuronal maturation (1)
- neuropsychological impairment (1)
- neurotrophins (1)
- next generation sequencing (1)
- next-generation sequencing (1)
- nitroalkylation (1)
- nitrogen oxides (NOx) (1)
- nodular sclerosis (1)
- noise intervention measures (1)
- nomogram (1)
- non-aneurysmal SAH (1)
- non-canonical (1)
- non-classical adhesion molecule (1)
- non-coding RNA (1)
- non-invasive fibrosis assessment (1)
- non-linear dynamics (1)
- non-malignant hematological diseases (1)
- non-sensory bias (1)
- nonnucleoside polymerase inhibitor (1)
- nuclear receptor coactivator 4 (1)
- nucleolus (1)
- nucleoredoxin (1)
- nucleotide metabolism (1)
- nursery schools (1)
- nutrient deprivation (1)
- nutrient endocytosis (1)
- occupational factors (1)
- older people (1)
- olfactory testing (1)
- omega-3 fatty acids (1)
- oncogenes (1)
- oncogenic signaling (1)
- one health (1)
- open field behavior (1)
- open-source (1)
- oral and maxillofacial Surgery (1)
- oral health (1)
- oral health burden (1)
- ordinary differential equations (ODE) (1)
- organisation of health services (1)
- organoids (1)
- organophosphate flame retardants (OFR) (1)
- organotypic culture (1)
- orientation (1)
- orthodontist (1)
- osteogenic sarcoma cells (1)
- osteoporosis (1)
- ostium (1)
- ouabain (1)
- outside-in signaling (1)
- overall survival (1)
- overdenture (1)
- oxaliplatin (1)
- p-eIF2α (1)
- p14 (1)
- p21Cip1/CDKN1A (1)
- p47phox (1)
- p53 (1)
- p62 (1)
- p75 (1)
- paediatric (1)
- pain genetics (1)
- pain intensity (1)
- pain medication (1)
- particle size distribution (1)
- particulate matter (PM) (1)
- passive smoke (1)
- pathogen (1)
- patient blood management (1)
- patient preference (1)
- patient safety (1)
- patients' experience (1)
- patient’s decree (1)
- pediatric (1)
- pediatric epilepsy (1)
- pediatric orthopedic (1)
- pentose phosphate pathway (1)
- perineurium (1)
- perio-prosthetic joint infection (1)
- peritoneal macrophages (1)
- peritumoral edema (1)
- peritumoral edema zone (1)
- peroxisome proliferator-activated receptor (1)
- phage display (1)
- phagocytosis (1)
- pharmacist (1)
- pharmacodynamics (1)
- pharmacoepigenetics (1)
- pharmacogenetics (1)
- pharmacogenomics (1)
- pharmacological data science (1)
- pharmacological plasticity (1)
- pharmacoresistance (1)
- phenoconversion (1)
- phenylephrine (1)
- phosphatases (1)
- pig (1)
- pilot study (1)
- pitch (1)
- pitch perception (1)
- placenta (1)
- planimetric measurement (1)
- plasma (1)
- plasminogen (1)
- platelet lysate (1)
- platelet-rich fibrin (1)
- platelet-rich-fibrin (1)
- platelets (1)
- point of care (1)
- point shear wave elastography (1)
- polarization (1)
- polo-like kinase 3 (1)
- poly(A)-tail (1)
- polyethylenimine (1)
- polymerase chain reaction (1)
- polyomavirus (MCPyV) (1)
- polyunsaturated fatty acid (1)
- porcine (1)
- portal hypertension (1)
- post-exercise hypotension (1)
- post-radiotherapy recurrence (1)
- post-transcriptional regulation (1)
- post-translational modifications (1)
- posterior circulation (1)
- posterior composite restoration (1)
- posterior fossa masses (1)
- posterior fossa tumor (1)
- postmonsoon (1)
- postnatal neurogenesis (1)
- postoperative complications (1)
- postoperative delirium (1)
- postoperative pain (1)
- posttranslational modification (1)
- postural control (1)
- posture (1)
- potassium channel (1)
- ppi1 (1)
- pre-emptive allogeneic hematopoietic stem cell transplantation (1)
- pre-professional (1)
- preconditioning (1)
- prediabetes (1)
- predictive coding (1)
- pretreatment (1)
- prevention (1)
- primary health care (1)
- primary prostate cancer (1)
- production (1)
- professional dance (1)
- prognosis (1)
- prognostic marker (1)
- progressive myoclonus epilepsy (1)
- prostaglandins (1)
- prostate neoplasm (1)
- proteasome (1)
- protein complexes (1)
- protein phosphorylation (1)
- protein–protein interaction (1)
- proton density (1)
- proton pump inhibitors (1)
- proton pumping (1)
- proton-sensing GPCR (1)
- proximal tubule cells (1)
- pseudomonas aeruginosa (1)
- psoriatic arthritis (1)
- psychological distress (1)
- pteridine (1)
- publication output (1)
- pulmonary hypertension (1)
- pulmonary hypoplasia (1)
- pulse-spreading harmonic complex (1)
- qPCR (1)
- qRT-PCR detection (1)
- qualitative study (1)
- quantitative magnetic resonance imaging (1)
- quantitative proteomics (1)
- quantitative radioactivity analysis (QRA) (1)
- quantitative whole-body autoradiography (QWBA) (1)
- quantum biology (1)
- quantum neurobiology (1)
- quiescence (1)
- race (1)
- radiation (1)
- radiation dosage (1)
- radiation dosimetry (1)
- radiation protection (1)
- radiation-induced (1)
- radical oxygen species (1)
- radical prostatecomy (1)
- radioimmunotherpay (1)
- radiosensitization (1)
- radiotherapy (1)
- radiotherapy resistance (1)
- radixin (1)
- rapamycin (1)
- rat (1)
- rat femur critical size defect (1)
- real-world data (1)
- recovery (1)
- recurrent hepatocellular carcinoma (1)
- red blood cell (1)
- red blood cells (1)
- reference values (1)
- regenerative medicine (1)
- regenerative therapy (1)
- regorafenib (1)
- regorafenib csf concentration (1)
- regression analysis (1)
- regulatory T helper cells (1)
- relaxometry (1)
- remodeling (1)
- renal failure (1)
- repeat biopsy (1)
- reperfusion injury (1)
- reproduction biology (1)
- resolution (1)
- resolution of inflammation (1)
- respiratory failure (1)
- rest period (1)
- resting‐state (1)
- restricted and repetitive behaviors (1)
- retinoic acid (1)
- reverberation (1)
- review (1)
- rheumatoid arthritis (1)
- ribavirin (1)
- risk factor (1)
- risk management (1)
- risk of falls (1)
- robotic-assisted radical prostatectomy (1)
- room simulation (1)
- rosetting T cells (1)
- rotational thromboelastometry (1)
- running (1)
- salvage mastectomy (1)
- salvage radical prostatectomy (1)
- sarcopenia (1)
- schizophrenia spectrum (1)
- sciatic nerve (1)
- scoping review (1)
- screening (1)
- screening routine (1)
- screening test (1)
- searchlight analysis (1)
- second-line (1)
- secondary cancer (1)
- secondary data analysis (1)
- secretome (1)
- segmental ureteral resection (1)
- segmentation (1)
- seizures (1)
- selectin (1)
- selective autophagy receptor (1)
- selfish genetic element (1)
- semiquinone (1)
- sensory organ development (1)
- sepsis (1)
- sequential decision-making (1)
- seroconversion (1)
- serum (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- severe congenital neutropenia (1)
- severely injured (1)
- shedding (1)
- short bowel (1)
- short linear motifs (SLiMs) (1)
- siRNA delivery (1)
- siRNA/RNAi (1)
- sickle cell anemia (1)
- signal transducer and activator of transcription-1 (1)
- signaling (1)
- silk fibroin (1)
- simulation training (1)
- single-sided deafness (1)
- sirtuin1 (1)
- size of cigarettes (1)
- skin diseases (1)
- small bowel (1)
- smartphone-app (1)
- smoking in pregnancy (1)
- socio-economic influences (1)
- soft tissue (1)
- soluble MICA (1)
- sonic hedgehog signaling (1)
- sorafenib (1)
- sound analyses (1)
- spatial (1)
- spatial learning (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- species differences (1)
- speech perception (1)
- sphinganine 1-phosphate (1)
- sphingolipid (1)
- sphingolipids (1)
- sphingosine 1-phoshate (1)
- sphingosine 1-phosphate antagonistst/inhibitors (1)
- sphingosine 1-phosphate metabolism (1)
- sphingosine 1-phosphate signaling (1)
- sphingosine kinase (1)
- spike mutation (1)
- spinal infection (1)
- spirochete (1)
- splicing (1)
- split-mouth (1)
- sport (1)
- spreading (1)
- stakeholder analysis (1)
- statin treatment (1)
- statistical parametric mapping (1)
- steatosis (1)
- stem cell niche (1)
- stem cell transplantation (1)
- stem cells (1)
- sterol regulatory element binding protein-2 (1)
- stoma (1)
- stress granules (1)
- stress period (1)
- stretching (1)
- structure (1)
- structured care program (1)
- stuttering (1)
- subcutaneous fat (1)
- subpopulation (1)
- subventricular zone (1)
- success rate (1)
- surgical oncology (1)
- survival (1)
- survival rate (1)
- swallowing (1)
- symmetry angle (1)
- symptoms (1)
- synaptic plasticity (1)
- synaptic signaling (1)
- synovial chondromatosis (1)
- synoviocytes (1)
- synuclein (1)
- systemic inflammation (1)
- t-distributed stochastic neighbor embedding (1)
- tandem mass spectrometry (1)
- targeted biopsy (1)
- tauopathies (1)
- tauopathy (1)
- teledentistry (1)
- telemedicine (1)
- temozolomide (1)
- temsirolimus (1)
- tension band plate (1)
- test protocol (1)
- testosterone (1)
- tetracycline (1)
- tetrahydrocannabinol (1)
- thalassemia (1)
- therapy monitoring (1)
- therapy resistance (1)
- thiazolidine and perhydrothiazine derivatives of aldophosphamide and I-aldophosphamide (1)
- three-stage Markov task (1)
- thrombectomy (1)
- thrombin (1)
- thrombolysis (1)
- thrombolysis (tPA) (1)
- thrombopenia (1)
- thrombopietin receptor agonist (1)
- thrombosis (1)
- thymic selection (1)
- tick (1)
- tissue mechanics (1)
- tobacco control (1)
- tobacco products (1)
- tobacco taxation (1)
- toc64 (1)
- toll-like receptor (1)
- topical agent (1)
- total knee arthroplasty (1)
- tractography (1)
- traffic emissions (1)
- trafficking (1)
- training program (1)
- transarterial chemoembolization (1)
- transcription factors (1)
- transcriptional profiling (1)
- transcriptome analysis (1)
- transfer entropy (1)
- transferrin (1)
- transgenic mice (1)
- transient elastography (1)
- transient receptor potential channels (1)
- transjugular intrahepatic portosystemic shunt (TIPS) (1)
- transketolase-like protein 1 (1)
- translational medical research (1)
- translational study (1)
- translocon (1)
- transmission (1)
- transrectal prostate biopsy (1)
- transverse axis (1)
- trauma registry (1)
- traumaticbraininjury(TBI) (1)
- treatment (1)
- triathlon (1)
- trophoblast organoids (1)
- trophoblastic cell lines (1)
- tuberous sclerosis complex (1)
- tumor adhesion (1)
- tumor immune evasion (1)
- tumor metabolism (1)
- tumor migration (1)
- tumor pain (1)
- tumor proliferation (1)
- tumor stroma (1)
- tumor-associated macrophages (TAM) (1)
- type B (1)
- type I interferon (1)
- tyrosine hydroxylase (1)
- tyrosine kinase inhibitors (1)
- tyrosine kinase receptor signaling (1)
- ubiquitin ligase (1)
- ulcerative colitis (1)
- ultrasonic cleaning (1)
- ultrasound (1)
- unconventional T cell (1)
- unilateral hip osteoarthritis (1)
- upgrading (1)
- upper tract urothelial carcinoma (1)
- ureteroscopy (1)
- urethal stricture (1)
- urethroplasty (1)
- urinary continence (1)
- urinary incontinence (1)
- usability (1)
- ustekinumab (1)
- validity (1)
- valproic acid (1)
- variability (1)
- vasoconstriction (1)
- vasodilation (1)
- vemurafenib (1)
- ventilation modes (1)
- ventralis intermedius nucleus (1)
- vertical transmission (1)
- vertigo (1)
- vestibular function (1)
- viability (1)
- viral tracing (1)
- virulence (1)
- virus (1)
- vismodegib (GDC-0449) (1)
- vitamin D deficiency (1)
- vitamin D metabolites (1)
- vitamin D receptor (1)
- vocational (1)
- volatile organic compounds (VOC) (1)
- volatile sedation (1)
- waiting time (1)
- walking (1)
- wavelet (1)
- wheezing (1)
- whole-genome sequencing (1)
- wild animals (1)
- within-person factors (1)
- workplace health promotion (1)
- wound healing (1)
- xenograft (1)
- zinc protoporphyrin (1)
- zirconia (1)
- ß-D-glucan (1)
- ß-amyloid (1)
- β-lactamases (1)
- γδT cell (1)
- fibrogenesis (1)
- fingolimod (1)
- flow cytometry (1)
Institute
Osteoarthritis (OA) is a slow-progressing joint disease, leading to the degradation and remodeling of the cartilage extracellular matrix (ECM). The usually quiescent chondrocytes become reactivated and accumulate in cell clusters, become hypertrophic, and intensively produce not only degrading enzymes, but also ECM proteins, like the cartilage oligomeric matrix protein (COMP) and thrombospondin-4 (TSP-4). To date, the functional roles of these newly synthesized proteins in articular cartilage are still elusive. Therefore, we analyzed the involvement of both proteins in OA specific processes in in vitro studies, using porcine chondrocytes, isolated from femoral condyles. The effect of COMP and TSP-4 on chondrocyte migration was investigated in transwell assays and their potential to modulate the chondrocyte phenotype, protein synthesis and matrix formation by immunofluorescence staining and immunoblot. Our results demonstrate that COMP could attract chondrocytes and may contribute to a repopulation of damaged cartilage areas, while TSP-4 did not affect this process. In contrast, both proteins similarly promoted the synthesis and matrix formation of collagen II, IX, XII and proteoglycans, but inhibited that of collagen I and X, resulting in a stabilized chondrocyte phenotype. These data suggest that COMP and TSP-4 activate mechanisms to protect and repair the ECM in articular cartilage.
Bacterial and fungal toll-like receptor activation elicits type I IFN responses in mast cells
(2021)
Next to their role in IgE-mediated allergic diseases and in promoting inflammation, mast cells also have antiinflammatory functions. They release pro- as well as antiinflammatory mediators, depending on the biological setting. Here we aimed to better understand the role of mast cells during the resolution phase of a local inflammation induced with the Toll-like receptor (TLR)-2 agonist zymosan. Multiple sequential immunohistology combined with a statistical neighborhood analysis showed that mast cells are located in a predominantly antiinflammatory microenvironment during resolution of inflammation and that mast cell-deficiency causes decreased efferocytosis in the resolution phase. Accordingly, FACS analysis showed decreased phagocytosis of zymosan and neutrophils by macrophages in mast cell-deficient mice. mRNA sequencing using zymosan-induced bone marrow-derived mast cells (BMMC) revealed a strong type I interferon (IFN) response, which is known to enhance phagocytosis by macrophages. Both, zymosan and lipopolysaccharides (LPS) induced IFN-β synthesis in BMMCs in similar amounts as in bone marrow derived macrophages. IFN-β was expressed by mast cells in paws from naïve mice and during zymosan-induced inflammation. As described for macrophages the release of type I IFNs from mast cells depended on TLR internalization and endosome acidification. In conclusion, mast cells are able to produce several mediators including IFN-β, which are alone or in combination with each other able to regulate the phagocytotic activity of macrophages during resolution of inflammation.
The interaction of macrophages with apoptotic cells is required for efficient resolution of inflammation. While apoptotic cell removal prevents inflammation due to secondary necrosis, it also alters the macrophage phenotype to hinder further inflammatory reactions. The interaction between apoptotic cells and macrophages is often studied by chemical or biological induction of apoptosis, which may introduce artifacts by affecting the macrophages as well and/or triggering unrelated signaling pathways. Here, we set up a pure cell death system in which NIH 3T3 cells expressing dimerizable Caspase-8 were co-cultured with peritoneal macrophages in a transwell system. Phenotype changes in macrophages induced by apoptotic cells were evaluated by RNA sequencing, which revealed an unexpectedly dominant impact on macrophage proliferation. This was confirmed in functional assays with primary peritoneal macrophages and IC-21 macrophages. Moreover, inhibition of apoptosis during Zymosan-induced peritonitis in mice decreased mRNA levels of cell cycle mediators in peritoneal macrophages. Proliferation of macrophages in response to apoptotic cells may be important to increase macrophage numbers in order to allow efficient clearance and resolution of inflammation.
Simple Summary:
Pharmacological activation of tumor suppressor p53 is a promising therapeutic strategy for a range of hematologic and solid cancers. Whether p53 activation augments or suppresses anti-tumor innate immunity is less understood. Here we show that treatment of differentiating human macrophages with a p53 activator idasanutlin suppresses their inflammatory responses to activators of toll-like receptors (TLR) -4 and -7/8. This is accompanied by reduced expression of TLR7, TLR8, as well as TLR4 co-receptor CD14. These data help evaluating the possibilities of combining p53-targeting and immunostimulatory anti-cancer therapies.
Abstract:
The transcription factor p53 has well-recognized roles in regulating cell cycle, DNA damage repair, cell death, and metabolism. It is an important tumor suppressor and pharmacological activation of p53 by interrupting its interaction with the ubiquitin E3 ligase mouse double minute 2 homolog (MDM2) is actively explored for anti-tumor therapies. In immune cells, p53 modulates inflammatory responses, but the impact of p53 on macrophages remains incompletely understood. In this study, we used the MDM2 antagonist idasanutlin (RG7388) to investigate the responses of primary human macrophages to pharmacological p53 activation. Idasanutlin induced a robust p53-dependent transcriptional signature in macrophages, including several pro-apoptotic genes. However, idasanutlin did not generally sensitize macrophages to apoptosis, except for an enhanced response to a Fas-stimulating antibody. In fully differentiated macrophages, idasanutlin did not affect pro-inflammatory gene expression induced by toll-like receptor 4 (TLR4), TLR3, and TLR7/8 agonists, but inhibited interleukin-4-induced macrophage polarization. However, when present during monocyte to macrophage differentiation, idasanutlin attenuated inflammatory responses towards activation of TLR4 and TLR7/8 by low doses of lipopolysaccharide or resiquimod (R848). This was accompanied by a reduced expression of CD14, TLR7, and TLR8 in macrophages differentiated in the presence of idasanutlin. Our data suggest anti-inflammatory effects of pharmacological p53 activation in differentiating human macrophages.
The tumor-microenvironment (TME) is an amalgamation of various factors derived from malignant cells and infiltrating host cells, including cells of the immune system. One of the important factors of the TME is microRNAs (miRs) that regulate target gene expression at a post transcriptional level. MiRs have been found to be dysregulated in tumor as well as in stromal cells and they emerged as important regulators of tumorigenesis. In fact, miRs regulate almost all hallmarks of cancer, thus making them attractive tools and targets for novel anti-tumoral treatment strategies. Tumor to stroma cell cross-propagation of miRs to regulate protumoral functions has been a salient feature of the TME. MiRs can either act as tumor suppressors or oncogenes (oncomiRs) and both miR mimics as well as miR inhibitors (antimiRs) have been used in preclinical trials to alter cancer and stromal cell phenotypes. Owing to their cascading ability to regulate upstream target genes and their chemical nature, which allows specific pharmacological targeting, miRs are attractive targets for anti-tumor therapy. In this review, we cover a recent update on our understanding of dysregulated miRs in the TME and provide an overview of how these miRs are involved in current cancer-therapeutic approaches from bench to bedside.
Background: The prevalence of metabolic liver diseases is increasing and approved pharmacological treatments are still missing. Many animal models of nonalcoholic fatty liver disease (NAFLD) show a full spectrum of fibrosis, inflammation and steatosis, which does not reflect the human situation since only up to one third of the patients develop fibrosis and nonalcoholic steatohepatitis (NASH). Methods: Seven week old C57Bl/J mice were treated with ethanol, Western diet (WD) or both. The animals’ liver phenotypes were determined through histology, immunohistochemistry, Western blotting, hepatic triglyceride content and gene expression levels. In a human cohort of 80 patients stratified by current alcohol misuse and body mass index, liver histology and gene expression analysis were performed. Results: WD diet and ethanol-treated animals showed severe steatosis, with high hepatic triglyceride content and upregulation of fatty acid synthesis. Mild fibrosis was revealed using Sirius-red stains and gene expression levels of collagen. Inflammation was detected using histology, immunohistochemistry and upregulation of proinflammatory genes. The human cohort of obese drinkers showed similar upregulation in genes related to steatosis, fibrosis and inflammation. Conclusions: We provide a novel murine model for early-stage fatty liver disease suitable for drug testing and investigation of pathophysiology.
(1) Background: Dance teachers (DT) are dependent on their functional body. Pain can hardly be avoided during the professional practice of dance. Pain can become so intense that it impairs, or even prevents, the professional practice. The aim of this study was to identify the determinants of pain intensity of the most severely affected body regions of DT in pain during the three-month period prior to the survey. (2) Methods: This cross-sectional study was conducted by an online survey. A total of 166 DT participated in the study; 143 of the DT were in pain during the three-month period and were included in the analysis. Using multiple linear regression, the determinants of pain intensity were identified from population parameters, occupational data, pain localisation, and temporal pain course. (3) Results: Regions of the lower extremity and head/trunk regions were most frequently indicated as the body regions with the most severe pain. The multiple regression model generated with the factors “functional impairment”, “biomechanical exposure”, and “pain at rest” explains a statistically significant, moderate proportion of the variance in pain intensity (R2 = 0.22, F (3, 106) = 10.04, p < 0.001). (4) Conclusions: Intensity of pain in DT seems to be related to the physical demands of professional practice.
Resorbable synthetic scaffolds are promising for different indications, espe- cially in the context of bone regeneration. However, they require additional biological components to enhance their osteogenic potential. In addition to different cell types, autologous blood-derived matrices offer many advantages to enhance the regenerative capacity of biomaterials. The present study aimed to analyze whether biologization of a PCL-mesh coated using differently centrifuged Platelet rich fibrin (PRF) matrices will have a positive influence on primary human osteoblasts activity in vitro. A polymeric resorbable scaffold (Osteomesh, OsteoporeTM (OP), Singapore) was combined with differently centrifuged PRF matrices to evaluate the additional influence of this biologization concept on bone regeneration in vitro. Peripheral blood of three healthy donors was used to gain PRF matrices centrifuged either at High (710× g, 8 min) or Low (44× g, 8 min) relative centrifugal force (RCF) according to the low speed centrifugation concept (LSCC). OP-PRF constructs were cultured with pOBs. POBs cultured on the uncoated OP served as a control. After three and seven days of cultivation, cell culture supernatants were collected to analyze the pOBs activity by determining the concentrations of VEGF, TGF-β1, PDGF, OPG, IL-8, and ALP- activity. Immunofluorescence staining was used to evaluate the Osteopontin expression of pOBs. After three days, the group of OP+PRFLow+pOBs showed significantly higher expression of IL-8, TGF-ß1, PDGF, and VEGF compared to the group of OP+PRFHigh+pOBs and OP+pOBs. Similar results were observed on day 7. Moreover, OP+PRFLow+pOBs exhibited significantly higher activity of ALP compared to OP+PRFHigh+pOBs and OP+pOBs. Immunofluorescence staining showed a higher number of pOBs adherent to OP+PRFLow+pOBs compared to the groups OP+PRFHigh+pOBs and OP+pOBs. To the best of our knowledge, this study is the first to investigate the osteoblasts activity when cultured on a PRF-coated PCL-mesh in vitro. The presented results suggest that PRFLow centrifuged according to LSCC exhibits autologous blood cells and growth factors, seem to have a significant effect on osteogenesis. Thereby, the combination of OP with PRFLow showed promising results to support bone regeneration. Further in vivo studies are required to verify the results and carry out potential results for clinical translation.
Iron deficiency (ID) is a common manifestation of inflammatory bowel disease (IBD), arising primarily due to chronic inflammation and/or blood loss. There is no gold standard for ID diagnosis, which is often complicated by concomitant inflammation. Zinc protoporphyrin (ZnPP) correlates with parameters of iron homeostasis and has been identified as a promising marker for ID, irrespective of inflammation. We investigated the diagnostic performance of ZnPP in ID, iron deficiency anemia, anemia of chronic disease and mixed anemia in a cross-sectional study in 130 patients with IBD. Different parameters were compared by receiver operator characteristic (ROC) analysis as detectors of iron-restricted erythropoiesis (IRE). IRE was detected in 91 patients (70.0%); fifty-nine (64.8%) had absolute ID and 23 (25.4%) functional ID. When inflammation was present, ZnPP was a more reliable sole biomarker of IRE than MCV, transferrin saturation (TSAT) or ferritin (AUC; 0.855 vs. 0.763, 0.834% and 0.772, respectively). The specificity of TSAT was significantly lower than ZnPP when inflammation was present (38% vs. 71%, respectively). We conclude that ZnPP is a reliable biomarker of functional ID in patients with IBD and more dependable than ferritin or TSAT, which are influenced by chronic inflammation. We propose that ZnPP may also have utility in patients with other chronic diseases.
Objective: To investigate temporal trends in prostate cancer (PCa) radical prostatectomy (RP) candidates.
Materials and Methods: Patients who underwent RP for PCa between January 2014 and December 2019 were identified form our institutional database. Trend analysis and logistic regression models assessed RP trends after stratification of PCa patients according to D'Amico classification and Gleason score. Patients with neoadjuvant androgen deprivation or radiotherapy prior to RP were excluded from the analysis.
Results: Overall, 528 PCa patients that underwent RP were identified. Temporal trend analysis revealed a significant decrease in low-risk PCa patients from 17 to 9% (EAPC: −14.6%, p < 0.05) and GS6 PCa patients from 30 to 14% (EAPC: −17.6%, p < 0.01). This remained significant even after multivariable adjustment [low-risk PCa: (OR): 0.85, p < 0.05 and GS6 PCa: (OR): 0.79, p < 0.001]. Furthermore, a trend toward a higher proportion of intermediate-risk PCa undergoing RP was recorded.
Conclusion: Our results confirm that inverse stage migration represents an ongoing phenomenon in a contemporary RP cohort in a European tertiary care PCa center. Our results demonstrate a significant decrease in the proportion of low-risk and GS6 PCa undergoing RP and a trend toward a higher proportion of intermediate-risk PCa patients undergoing RP. This indicates a more precise patient selection when it comes to selecting suitable candidates for definite surgical treatment with RP.
Objective: To investigate the value of standard [digital rectal examination (DRE), PSA] and advanced (mpMRI, prostate biopsy) clinical evaluation for prostate cancer (PCa) detection in contemporary patients with clinical bladder outlet obstruction (BOO) scheduled for Holmium laser enucleation of the prostate (HoLEP).
Material and Methods: We retrospectively analyzed 397 patients, who were referred to our tertiary care laser center for HoLEP due to BOO between 11/2017 and 07/2020. Of those, 83 (20.7%) underwent further advanced clinical PCa evaluation with mpMRI and/or prostate biopsy due to elevated PSA and/or lowered PSA ratio and/or suspicious DRE. Logistic regression and binary regression tree models were applied to identify PCa in BOO patients.
Results: An mpMRI was conducted in 56 (66%) of 83 patients and revealed PIRADS 4/5 lesions in 14 (25%) patients. Subsequently, a combined systematic randomized and MRI-fusion biopsy was performed in 19 (23%) patients and revealed in PCa detection in four patients (5%). A randomized prostate biopsy was performed in 31 (37%) patients and revealed in PCa detection in three patients (4%). All seven patients (9%) with PCa detection underwent radical prostatectomy with 29% exhibiting non-organ confined disease. Incidental PCa after HoLEP (n = 76) was found in nine patients (12%) with advanced clinical PCa evaluation preoperatively. In univariable logistic regression analyses, PSA, fPSA ratio, and PSA density failed to identify patients with PCa detection. Conversely, patients with a lower International Prostate Symptom Score (IPSS) and PIRADs 4/5 lesion in mpMRI were at higher risk for PCa detection. In multivariable adjusted analyses, PIRADS 4/5 lesions were confirmed as an independent risk factor (OR 9.91, p = 0.04), while IPSS did not reach significance (p = 0.052).
Conclusion: In advanced clinical PCa evaluation mpMRI should be considered in patients with elevated total PSA or low fPSA ratio scheduled for BOO treatment with HoLEP. Patients with low IPSS or PIRADS 4/5 lesions in mpMRI are at highest risk for PCa detection. In patients with a history of two or more sets of negative prostate biopsies, advanced clinical PCa evaluation might be omitted.
Objective: Research on visual working memory has shown that individual stimulus features are processed in both specialized sensory regions and higher cortical areas. Much less evidence exists for auditory working memory. Here, a main distinction has been proposed between the processing of spatial and non-spatial sound features. Our aim was to examine feature-specific activation patterns in auditory working memory.
Methods: We collected fMRI data while 28 healthy adults performed an auditory delayed match-to-sample task. Stimuli were abstract sounds characterized by both spatial and non-spatial information, i.e., interaural time delay and central frequency, respectively. In separate recording blocks, subjects had to memorize either the spatial or non-spatial feature, which had to be compared with a probe sound presented after a short delay. We performed both univariate and multivariate comparisons between spatial and non-spatial task blocks.
Results: Processing of spatial sound features elicited a higher activity in a small cluster in the superior parietal lobe than did sound pattern processing, whereas there was no significant activation difference for the opposite contrast. The multivariate analysis was applied using a whole-brain searchlight approach to identify feature-selective processing. The task-relevant auditory feature could be decoded from multiple brain regions including the auditory cortex, posterior temporal cortex, middle occipital gyrus, and extended parietal and frontal regions.
Conclusion: In summary, the lack of large univariate activation differences between spatial and non-spatial processing could be attributable to the identical stimulation in both tasks. In contrast, the whole-brain multivariate analysis identified feature-specific activation patterns in widespread cortical regions. This suggests that areas beyond the auditory dorsal and ventral streams contribute to working memory processing of auditory stimulus features.
Cephalization is a major innovation of animal evolution and implies a synchronization of nervous system, mouth, and foregut polarization to align alimentary tract and sensomotoric system for effective foraging. However, the underlying integration of morphogenetic programs is poorly understood. Here, we show that invagination of neuroectoderm through de novo polarization and apical constriction creates the mouth opening in the Caenorhabditis elegans embryo. Simultaneously, all 18 juxta-oral sensory organ dendritic tips become symmetrically positioned around the mouth: While the two bilaterally symmetric amphid sensilla endings are towed to the mouth opening, labial and cephalic sensilla become positioned independently. Dendrite towing is enabled by the pre-polarized sensory amphid pores intercalating into the leading edge of the anteriorly migrating epidermal sheet, while apical constriction-mediated cell–cell re-arrangements mediate positioning of all other sensory organs. These two processes can be separated by gradual inactivation of the 26S proteasome activator, RPN-6.1. Moreover, RPN- 6.1 also shows a dose-dependent requirement for maintenance of coordinated apical polarization of other organs with apical lumen, the pharynx, and the intestine. Thus, our data unveil integration of morphogenetic programs during the coordination of alimentary tract and sensory organ formation and suggest that this process requires tight control of ubiquitin-dependent protein degradation.
Congenital diaphragmatic hernia (CDH) is a major congenital malformation with high mortality. Outcome data on larger unselected patient groups in Germany are unavailable as there is no registry for CDH. Therefore, routine data from the largest German health insurance fund were analyzed for the years 2009–2013. Main outcome measures were incidence, survival and length of hospital stay. Follow-up was 12 months. 285 patients were included. The incidence of CDH was 2.73 per 10,000 live births. Overall mortality was 30.2%. A total of 72.1% of the fatalities occurred before surgery. Highest mortality (64%) was noted in patients who were admitted to specialized care later as the first day of life. Patients receiving surgical repair had a better prognosis (mortality: 10.8%). A total of 67 patients (23.5%) were treated with ECMO with a mortality of 41.8%. The median cumulative hospital stay among one-year survivors was 40 days and differed between ECMO- and non-ECMO-treated patients (91 vs. 32.5 days, p < 0.001). This is the largest German cohort study of CDH patients with a one-year follow-up. The ECMO subgroup showed a higher mortality. Another important finding is that delayed treatment in specialized care increases mortality. Prospective clinical registries are needed to elucidate the treatment outcomes in detail.
Locator® and ball attachments are well-established systems to attach overdentures to two inter-foraminal implants. This study aimed to evaluate differences between the two systems regarding prosthetic maintenance and patients' oral-health-related quality of life (OHRQoL). Dental records of patients with a mandibular implant-retained overdenture were retrospectively analyzed. Prosthetic maintenance measures involving the denture suprastructure and attachment matrix and patrix were analyzed. Furthermore, the Oral Health Impact Profile-G14 (OHIP-G14) was used to evaluate OHRQoL. Results were analyzed by means of Kaplan–Meier analysis and Student's t- and log-rank tests. The records of 122 patients were evaluated. Kaplan–Meier survival analysis revealed a significant difference between ball attachments (Group B; n patients = 47) and Locator® attachments (Group L; n patients = 75) regarding the occurrence of denture fractures (p < 0.001) and events affecting the matrix (p = 0.028) and patrix (p = 0.030). Group L had a significantly lower total OHIP-G14 score than Group B (p = 0.002). The most common maintenance events were matrix-related and denture relining for both attachment systems. Group B required more maintenance measures than Group L. Moreover, patients in Group L had better OHRQoL than patients in Group B.
Objectives This study wants to assess the cost-effectiveness of unmanned aerial vehicles (UAV) equipped with automated external defibrillators (AED) in out-of-hospital cardiac arrests (OHCA). Especially in rural areas with longer response times of emergency medical services (EMS) early lay defibrillation could lead to a significant higher survival in OHCA.
Participants 3296 emergency medical stations in Germany.
Setting Rural areas in Germany.
Primary and secondary outcome measures Three UAV networks providing 80%, 90% or 100% coverage for rural areas lacking timely access to EMS (ie, time-to-defibrillation: >10 min) were developed using a location allocation analysis. For each UAV network, primary outcome was the cost-effectiveness using the incremental cost-effectiveness ratio (ICER) calculated by the ratio of financial costs to additional life years gained compared with current EMS.
Results Current EMS with 3926 emergency stations was able to gain 1224 life years on annual average in the study area. The UAV network providing 100% coverage consisted of 1933 UAV with average annual costs of €43.5 million and 1845 additional life years gained on annual average (ICER: €23 568). The UAV network providing 90% coverage consisted of 1074 UAV with average annual costs of €24.2 million and 1661 additional life years gained on annual average (ICER: €14 548). The UAV network providing 80% coverage consisted of 798 UAV with average annual costs of €18.0 million and 1477 additional life years gained on annual average (ICER: €12 158).
Conclusion These results reveal the relevant life-saving potential of all modelled UAV networks. Furthermore, all analysed UAV networks could be deemed cost-effective. However, real-life applications are needed to validate the findings.
Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resources for real-time reverse-transcription polymerase chain reaction (rRT-PCR)-based testing have been exhausted. In order to meet the demands of testing and reduce transmission, SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) are being considered. These tests are fast, inexpensive, and simple to use, but whether they detect potentially infectious cases has not been well studied. We evaluated three lateral flow assays (RIDA®QUICK SARS-CoV-2 Antigen (R-Biopharm), SARS-CoV-2 Rapid Antigen Test (Roche)), and NADAL® COVID-19 Ag Test (Nal von Minden GmbH, Regensburg, Germany) and one microfluidic immunofluorescence assay (SARS-CoV-2 Ag Test (LumiraDx GmbH, Cologne, Germany)) using 100 clinical samples. Diagnostic rRT-PCR and cell culture testing as a marker for infectivity were performed in parallel. The overall Ag-RDT sensitivity for rRT-PCR-positive samples ranged from 24.3% to 50%. However, for samples with a viral load of more than 6 log10 RNA copies/mL (22/100), typically seen in infectious individuals, Ag-RDT positivity was between 81.8% and 100%. Only 51.6% (33/64) of the rRT-PCR-positive samples were infectious in cell culture. In contrast, three Ag-RDTs demonstrated a more significant correlation with cell culture infectivity (61.8–82.4%). Our findings suggest that large-scale SARS-CoV-2 Ag-RDT-based testing can be considered for detecting potentially infective individuals and reducing the virus spread.
KCNQ1 encodes the voltage-gated potassium (Kv) channel KCNQ1, also known as KvLQT1 or Kv7.1. Together with its ß-subunit KCNE1, also denoted as minK, this channel generates the slowly activating cardiac delayed rectifier current IKs, which is a key regulator of the heart rate dependent adaptation of the cardiac action potential duration (APD). Loss-of-function mutations in KCNQ1 cause congenital long QT1 (LQT1) syndrome, characterized by a delayed cardiac repolarization and a prolonged QT interval in the surface electrocardiogram. Autosomal dominant loss-of-function mutations in KCNQ1 result in long QT syndrome, called Romano–Ward Syndrome (RWS), while autosomal recessive mutations lead to Jervell and Lange-Nielsen syndrome (JLNS), associated with deafness. Here, we identified a homozygous KCNQ1 mutation, c.1892_1893insC (p.P631fs*20), in a patient with an isolated LQT syndrome (LQTS) without hearing loss. Nevertheless, the inheritance trait is autosomal recessive, with heterozygous family members being asymptomatic. The results of the electrophysiological characterization of the mutant, using voltage-clamp recordings in Xenopus laevis oocytes, are in agreement with an autosomal recessive disorder, since the IKs reduction was only observed in homomeric mutants, but not in heteromeric IKs channel complexes containing wild-type channel subunits. We found that KCNE1 rescues the KCNQ1 loss-of-function in mutant IKs channel complexes when they contain wild-type KCNQ1 subunits, as found in the heterozygous state. Action potential modellings confirmed that the recessive c.1892_1893insC LQT1 mutation only affects the APD of homozygous mutation carriers. Thus, our study provides the molecular mechanism for an atypical autosomal recessive LQT trait that lacks hearing impairment.
Studies over the past decade have revealed that metabolism profoundly influences immune responses. In particular, metabolism causes epigenetic regulation of gene expression, as a growing number of metabolic intermediates are substrates for histone post-translational modifications altering chromatin structure. One of these substrates is acetyl-coenzyme A (CoA), which donates an acetyl group for histone acetylation. Cytosolic acetyl-CoA is also a critical substrate for de novo synthesis of fatty acids and sterols necessary for rapid cellular growth. One of the main enzymes catalyzing cytosolic acetyl-CoA formation is ATP-citrate lyase (ACLY). In addition to its classical function in the provision of acetyl-CoA for de novo lipogenesis, ACLY contributes to epigenetic regulation through histone acetylation, which is increasingly appreciated. In this review we explore the current knowledge of ACLY and acetyl-CoA in mediating innate and adaptive immune responses. We focus on the role of ACLY in supporting de novo lipogenesis in immune cells as well as on its impact on epigenetic alterations. Moreover, we summarize alternative sources of acetyl-CoA and their contribution to metabolic and epigenetic regulation in cells of the immune system.
Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell diseases leading to an insufficient formation of functional blood cells. Disease-immanent factors as insufficient erythropoiesis and treatment-related factors as recurrent treatment with red blood cell transfusions frequently lead to systemic iron overload in MDS and AML patients. In addition, alterations of function and expression of proteins associated with iron metabolism might are increasingly recognized to be pathogenetic factors and potential vulnerabilities of these diseases. Iron is known to be involved in multiple intracellular and extracellular processes. It is essential for cell metabolism as well as for cell proliferation and closely linked to the formation of reactive oxygen species. Therefore, iron can influence the course of clonal myeloid disorders, the leukemic environment and the occurrence as well as the defense of infections. Imbalances of iron homeostasis may induce cell death of normal but also of malignant cells. New potential treatment strategies utilizing the importance of the iron homeostasis include iron chelation, modulation of proteins involved in iron metabolism, induction of leukemic cell death via ferroptosis and exploitation of iron proteins for the delivery of antileukemic drugs.
Here, we provide a summary of some of the latest findings about the function, the prognostic impact and potential treatment strategies of iron in patients with MDS and AML.
The ability to learn sequential contingencies of actions for predicting future outcomes is indispensable for flexible behavior in many daily decision-making contexts. It remains open whether such ability may be enhanced by transcranial direct current stimulation (tDCS). The present study combined tDCS with functional near-infrared spectroscopy (fNIRS) to investigate potential tDCS-induced effects on sequential decision-making and the neural mechanisms underlying such modulations. Offline tDCS and sham stimulation were applied over the left and right dorsolateral prefrontal cortex (dlPFC) in young male adults (N = 29, mean age = 23.4 years, SD = 3.2) in a double-blind between-subject design using a three-state Markov decision task. The results showed (i) an enhanced dlPFC hemodynamic response during the acquisition of sequential state transitions that is consistent with the findings from a previous functional magnetic resonance imaging (fMRI) study; (ii) a tDCS-induced increase of the hemodynamic response in the dlPFC, but without accompanying performance-enhancing effects at the behavioral level; and (iii) a greater tDCS-induced upregulation of hemodynamic responses in the delayed reward condition that seems to be associated with faster decision speed. Taken together, these findings provide empirical evidence for fNIRS as a suitable method for investigating hemodynamic correlates of sequential decision-making as well as functional brain correlates underlying tDCS-induced modulation. Future research with larger sample sizes for carrying out subgroup analysis is necessary in order to decipher interindividual differences in tDCS-induced effects on sequential decision-making process at the behavioral and brain levels.
Drug resistance is a commonly unavoidable consequence of cancer treatment that results in therapy failure and disease relapse. Intrinsic (pre-existing) or acquired resistance mechanisms can be drug-specific or be applicable to multiple drugs, resulting in multidrug resistance. The presence of drug resistance is, however, tightly coupled to changes in cellular homeostasis, which can lead to resistance-coupled vulnerabilities. Unbiased gene perturbations through RNAi and CRISPR technologies are invaluable tools to establish genotype-to-phenotype relationships at the genome scale. Moreover, their application to cancer cell lines can uncover new vulnerabilities that are associated with resistance mechanisms. Here, we discuss targeted and unbiased RNAi and CRISPR efforts in the discovery of drug resistance mechanisms by focusing on first-in-line chemotherapy and their enforced vulnerabilities, and we present a view forward on which measures should be taken to accelerate their clinical translation.
Background: To test the effect of variant histology relative to urothelial histology on stage at presentation, cancer specific mortality (CSM) and overall mortality (OM) after chemotherapy use, in urethral cancer.
Materials and Methods: Within the Surveillance, Epidemiology and End Results (2004–2016) database, we identified 1,907 primary variant histology urethral cancer patients. Kaplan-Meier plots, Cox regression analyses, cumulative incidence-plots, multivariable competing-risks regression models and propensity score matching for patient and tumor characteristics were used.
Results:Of 1,907 eligible urethral cancer patients, urothelial histology affected 1,009 (52.9%) vs. squamous cell carcinoma (SCC) 455 (23.6%) vs. adenocarcinoma 278 (14.6%) vs. other histology 165 (8.7%) patients. Urothelial histological patients exhibited lower stages at presentation than SCC, adenocarcinoma or other histology patients. In urothelial histology patients, five-year CSM was 23.5% vs. 34.4% in SCC (Hazard Ratio (HR) 1.57) vs. 40.7% in adenocarcinoma (HR 1.69) vs. 43.4% in other histology (HR 1.99, p<0.001). After matching in multivariate competing-risks regression models, variant histology exhibited 1.35-fold higher CSM than urothelial. Finally, in metastatic urethral cancer, lower OM was recorded after chemotherapy in general, including metastatic adenocarcinoma and other variant histology subtypes, except metastatic SCC.
Conclusion: Adenocarcinoma, SCC and other histology subtypes affect fewer patients than urothelial histology. Presence of variant histology results in higher CSM. Finally, chemotherapy for metastatic urethral cancer improves survival in adenocarcinoma and other variant histology subtypes, but not in SCC.
Simple Summary
Seizures are among the most common symptoms of meningioma patients even after surgery. This study sought to identify risk factors for early and late seizures in meningioma patients and to evaluate a modified version of a score to predict postoperative seizures on an independent cohort. The data underline that there are distinct factors identifying patients with a high risk of postoperative seizures following meningioma surgery which has been already shown before. We could further show that the high proportion of 43% of postoperative seizures occur as late seizures which are more dangerous because they may happen out of hospital. The modified STAMPE2 score could predict postoperative seizures when reaching very high scores but was not generally transferable to our independent cohort.
Abstract
Seizures are among the most common symptoms of meningioma. This retrospective study sought to identify risk factors for early and late seizures in meningioma patients and to evaluate a modified STAMPE2 score. In 556 patients who underwent meningioma surgery, we correlated different risk factors with the occurrence of postoperative seizures. A modified STAMPE2 score was applied. Risk factors for preoperative seizures were edema (p = 0.039) and temporal location (p = 0.038). For postoperative seizures preoperative tumor size (p < 0.001), sensomotory deficit (p = 0.004) and sphenoid wing location (p = 0.032) were independent risk factors. In terms of postoperative status epilepticus; sphenoid wing location (p = 0.022), tumor volume (p = 0.045) and preoperative seizures (p < 0.001) were independent risk factors. Postoperative seizures lead to a KPS deterioration and thus an impaired quality of life (p < 0.001). Late seizures occurred in 43% of patients with postoperative seizures. The small sub-cohort of patients (2.7%) with a STAMPE2 score of more than six points had a significantly increased risk for seizures (p < 0.001, total risk 70%). We concluded that besides distinct risk factors, high scores of the modified STAMPE2 score could estimate the risk of postoperative seizures. However, it seems not transferable to our cohort
Inflammation is a crucial part of immune responses towards invading pathogens or tissue damage. While inflammatory reactions are aimed at removing the triggering stimulus, it is important that these processes are terminated in a coordinate manner to prevent excessive tissue damage due to the highly reactive inflammatory environment. Initiation of inflammatory responses was proposed to be regulated predominantly at a transcriptional level, whereas post-transcriptional modes of regulation appear to be crucial for resolution of inflammation. The RNA-binding protein tristetraprolin (TTP) interacts with AU-rich elements in the 3′ untranslated region of mRNAs, recruits deadenylase complexes and thereby facilitates degradation of its targets. As TTP regulates the mRNA stability of numerous inflammatory mediators, it was put forward as a crucial post-transcriptional regulator of inflammation. Here, we summarize the current understanding of the function of TTP with a specific focus on its role in adding to resolution of inflammation.
The genetic background of pain is becoming increasingly well understood, which opens up possibilities for predicting the individual risk of persistent pain and the use of tailored therapies adapted to the variant pattern of the patient’s pain-relevant genes. The individual variant pattern of pain-relevant genes is accessible via next-generation sequencing, although the analysis of all “pain genes” would be expensive. Here, we report on the development of a cost-effective next generation sequencing-based pain-genotyping assay comprising the development of a customized AmpliSeq™ panel and bioinformatics approaches that condensate the genetic information of pain by identifying the most representative genes. The panel includes 29 key genes that have been shown to cover 70% of the biological functions exerted by a list of 540 so-called “pain genes” derived from transgenic mice experiments. These were supplemented by 43 additional genes that had been independently proposed as relevant for persistent pain. The functional genomics covered by the resulting 72 genes is particularly represented by mitogen-activated protein kinase of extracellular signal-regulated kinase and cytokine production and secretion. The present genotyping assay was established in 61 subjects of Caucasian ethnicity and investigates the functional role of the selected genes in the context of the known genetic architecture of pain without seeking functional associations for pain. The assay identified a total of 691 genetic variants, of which many have reports for a clinical relevance for pain or in another context. The assay is applicable for small to large-scale experimental setups at contemporary genotyping costs.
Long non-coding RNA aerrie controls DNA damage repair via YBX1 to maintain endothelial cell function
(2021)
Aging is accompanied by many physiological changes. These changes can progressively lead to many types of cardiovascular diseases. During this process blood vessels lose their ability to maintain vascular homeostasis, ultimately resulting in hypertension, stroke, or myocardial infarction. Increase in DNA damage is one of the hallmarks of aging and can be repaired by the DNA signaling and repair system. In our study we show that long non-coding RNA Aerrie (linc01013) contributes to the DNA signaling and repair mechanism. Silencing of Aerrie in endothelial cells impairs angiogenesis, migration, and barrier function. Aerrie associates with YBX1 and together they act as important factors in DNA damage signaling and repair. This study identifies Aerrie as a novel factor in genomic stability and as a binding partner of YBX1 in responding to DNA damage.
Ataxia-Telangiectasia (A-T), a pleiotropic chromosomal breakage syndrome, is caused by the loss of the kinase Ataxia-telangiectasia mutated (ATM). ATM is not only involved in the response to DNA damage, but also in sensing and counteracting oxidative stress. Since a disturbed redox balance has been implicated in the pathophysiology of A-T lung disease, we aimed to further explore the interplay between ATM and oxidative stress in lung cells. Using a kinetic trapping approach, we could demonstrate an interaction between the trapping mutant TRX1-CS and ATM upon oxidative stress. We could further show that combined inhibition of thioredoxin reductase (TrxR) and ATM kinase activity, using Auranofin and KU55933 respectively, induced an increase in cellular reactive oxygen species (ROS) levels and protein oxidation in lung cells. Furthermore, ATM inhibition sensitized lung cells to Auranofin-induced cell death that could be rescued by ROS scavengers. As a consequence, targeted reduction of ATM by TRX1 could serve as a regulator of oxidative ATM activation and contribute to the maintenance of the cellular redox homeostasis. These results highlight the importance of the redox-active function of ATM in preventing ROS accumulation and cell death in lung cells.
Iron deprivation activates mitophagy and extends lifespan in nematodes. In patients suffering from Parkinson’s disease (PD), PINK1-PRKN mutations via deficient mitophagy trigger iron accumulation and reduce lifespan. To evaluate molecular effects of iron chelator drugs as a potential PD therapy, we assessed fibroblasts by global proteome profiles and targeted transcript analyses. In mouse cells, iron shortage decreased protein abundance for iron-binding nucleotide metabolism enzymes (prominently XDH and ferritin homolog RRM2). It also decreased the expression of factors with a role for nucleotide surveillance, which associate with iron-sulfur-clusters (ISC), and are important for growth and survival. This widespread effect included prominently Nthl1-Ppat-Bdh2, but also mitochondrial Glrx5-Nfu1-Bola1, cytosolic Aco1-Abce1-Tyw5, and nuclear Dna2-Elp3-Pold1-Prim2. Incidentally, upregulated Pink1-Prkn levels explained mitophagy induction, the downregulated expression of Slc25a28 suggested it to function in iron export. The impact of PINK1 mutations in mouse and patient cells was pronounced only after iron overload, causing hyperreactive expression of ribosomal surveillance factor Abce1 and of ferritin, despite ferritin translation being repressed by IRP1. This misregulation might be explained by the deficiency of the ISC-biogenesis factor GLRX5. Our systematic survey suggests mitochondrial ISC-biogenesis and post-transcriptional iron regulation to be important in the decision, whether organisms undergo PD pathogenesis or healthy aging.
Functional circuit training (FCT) has been demonstrated to acutely enhance cognitive performance (CP). However, the moderators of this observation are unknown. This study aimed to elucidate the role of exercise intensity. According to an a priori sample size calculation, n = 24 healthy participants (26 ± 3 years, 13 females), in randomized order, performed a single 15-min bout of FCT with low (20–39% of the heart rate reserve/HRR), moderate (40–59% HRR) or high intensity (maximal effort). Immediately pre- and post-workout, CP was measured by use of the Digit Span test, Stroop test and Trail Making test. Non-parametric data analyses did not reveal significant differences between conditions (p > 0.05) although parameter-free 95% confidence intervals showed pre-post improvements in some outcomes at moderate and high intensity only. The effort level does not seem to be a major effect modifier regarding short-term increases in CP following HCT in young active adults.
Colorectal cancer (CRC) is one of the most frequently diagnosed tumor in humans and one of the most common causes of cancer-related death worldwide. The pathogenesis of CRC follows a multistage process which together with somatic gene mutations is mainly attributed to the dysregulation of signaling pathways critically involved in the maintenance of homeostasis of epithelial integrity in the intestine. A growing number of studies has highlighted the critical impact of members of the tripartite motif (TRIM) protein family on most types of human malignancies including CRC. In accordance, abundant expression of many TRIM proteins has been observed in CRC tissues and is frequently correlating with poor survival of patients. Notably, some TRIM members can act as tumor suppressors depending on the context and the type of cancer which has been assessed. Mechanistically, most cancer-related TRIMs have a critical impact on cell cycle control, apoptosis, epithelial–mesenchymal transition (EMT), metastasis, and inflammation mainly through directly interfering with diverse oncogenic signaling pathways. In addition, some recent publications have emphasized the emerging role of some TRIM members to act as transcription factors and RNA-stabilizing factors thus adding a further level of complexity to the pleiotropic biological activities of TRIM proteins. The current review focuses on oncogenic signaling processes targeted by different TRIMs and their particular role in the development of CRC. A better understanding of the crosstalk of TRIMs with these signaling pathways relevant for CRC development is an important prerequisite for the validation of TRIM proteins as novel biomarkers and as potential targets of future therapies for CRC.
Obstructive Sleep Apnea is emerging as a global health epidemic, particularly due to the obesity pandemic. However, comprehensive prevalence data are still lacking and global OSA research has not yet been structurally evaluated. Using the latest comprehensive age/gender-specific BMI and obesity data, a global landscape estimating the risk/burden of OSA was created. Results were presented in relation to an in-depth analysis of OSA research and countries’ socioeconomic/scientific background. While the USA, Canada, and Japan are the highest publishing countries on OSA, Iceland, Greece, and Israel appeared at the forefront when relating the scientific output to socioeconomic parameters. Conversely, China, India, and Russia showed relatively low performances in these relations. Analysis of the estimated population at risk (EPR) of OSA showed the USA, China, India, and Brazil as the leading countries. Although the EPR and OSA research correlated strongly, major regional discrepancies between the estimated demand and actual research performances were identified, mainly in, but not limited to, developing nations. Our study highlights regional challenges/imbalances in the global activity on OSA and allows targeted measures to mitigate the burden of undiagnosed/untreated OSA. Furthermore, the inclusion of disadvantaged countries in international collaborations could stimulate local research efforts and provide valuable insights into the regional epidemiology of OSA.
Reduced external knee adduction moments in the second half of stance after total hip replacement have been reported in hip osteoarthritis patients. This reduction is thought to shift the load from the medial to the lateral knee compartment and as such increase the risk for knee osteoarthritis. The knee adduction moment is a surrogate for the load distribution between the medial and lateral compartments of the knee and not a valid measure for the tibiofemoral contact forces which are the result of externally applied forces and muscle forces. The purpose of this study was to investigate whether the distribution of the tibiofemoral contact forces over the knee compartments in unilateral hip osteoarthritis patients 1 year after receiving a primary total hip replacement differs from healthy controls. Musculoskeletal modeling on gait was performed in OpenSim using the detailed knee model of Lerner et al. (2015) for 19 patients as well as for 15 healthy controls of similar age. Knee adduction moments were calculated by the inverse dynamics analysis, medial and lateral tibiofemoral contact forces with the joint reaction force analysis. Moments and contact forces of patients and controls were compared using Statistical Parametric Mapping two-sample t-tests. Knee adduction moments and medial tibiofemoral contact forces of both the ipsi- and contralateral leg were not significantly different compared to healthy controls. The contralateral leg showed 14% higher medial tibiofemoral contact forces compared to the ipsilateral (operated) leg during the second half of stance. During the first half of stance, the lateral tibiofemoral contact force of the contralateral leg was 39% lower and the ratio 32% lower compared to healthy controls. In contrast, during the second half of stance the forces were significantly higher (39 and 26%, respectively) compared to healthy controls. The higher ratio indicates a changed distribution whereas the increased lateral tibiofemoral contact forces indicate a higher lateral knee joint loading in the contralateral leg in OA patients after total hip replacement (THR). Musculoskeletal modeling using a detailed knee model can be useful to detect differences in the load distribution between the medial and lateral knee compartment which cannot be verified with the knee adduction moment.
Objective: Many patients with localized prostate cancer (PCa) do not immediately undergo radical prostatectomy (RP) after biopsy confirmation. The aim of this study was to investigate the influence of “time-from-biopsy-to- prostatectomy” on adverse pathological outcomes.
Materials and Methods: Between January 2014 and December 2019, 437 patients with intermediate- and high risk PCa who underwent RP were retrospectively identified within our prospective institutional database. For the aim of our study, we focused on patients with intermediate- (n = 285) and high-risk (n = 151) PCa using D'Amico risk stratification. Endpoints were adverse pathological outcomes and proportion of nerve-sparing procedures after RP stratified by “time-from-biopsy-to-prostatectomy”: ≤3 months vs. >3 and < 6 months. Medians and interquartile ranges (IQR) were reported for continuously coded variables. The chi-square test examined the statistical significance of the differences in proportions while the Kruskal-Wallis test was used to examine differences in medians. Multivariable (ordered) logistic regressions, analyzing the impact of time between diagnosis and prostatectomy, were separately run for all relevant outcome variables (ISUP specimen, margin status, pathological stage, pathological nodal status, LVI, perineural invasion, nerve-sparing).
Results: We observed no difference between patients undergoing RP ≤3 months vs. >3 and <6 months after diagnosis for the following oncological endpoints: pT-stage, ISUP grading, probability of a positive surgical margin, probability of lymph node invasion (LNI), lymphovascular invasion (LVI), and perineural invasion (pn) in patients with intermediate- and high-risk PCa. Likewise, the rates of nerve sparing procedures were 84.3 vs. 87.4% (p = 0.778) and 61.0% vs. 78.8% (p = 0.211), for intermediate- and high-risk PCa patients undergoing surgery after ≤3 months vs. >3 and <6 months, respectively. In multivariable adjusted analyses, a time to surgery >3 months did not significantly worsen any of the outcome variables in patients with intermediate- or high-risk PCa (all p > 0.05).
Conclusion: A “time-from-biopsy-to-prostatectomy” of >3 and <6 months is neither associated with adverse pathological outcomes nor poorer chances of nerve sparing RP in intermediate- and high-risk PCa patients.
MicroRNAs (miRNAs) have emerged as critical posttranscriptional regulators of the immune system, including function and development of regulatory T (Treg) cells. Although this critical role has been firmly demonstrated through genetic models, key mechanisms of miRNA function in vivo remain elusive. Here, we review the role of miRNAs in Treg cell development and function. In particular, we focus on the question what the study of miRNAs in this context reveals about miRNA biology in general, including context-dependent function and the role of individual targets vs. complex co-targeting networks. In addition, we highlight potential technical pitfalls and state-of-the-art approaches to improve the mechanistic understanding of miRNA biology in a physiological context.
Despite the success of immune checkpoint blockade in cancer, the number of patients that benefit from this revolutionary treatment option remains low. Therefore, efforts are being undertaken to sensitize tumors for immune checkpoint blockade, which includes combining immune checkpoint blocking agents such as anti-PD-1 antibodies with standard of care treatments. Here we report that a combination of chemotherapy (doxorubicin) and immune checkpoint blockade (anti-PD-1 antibodies) induces superior tumor control compared to chemotherapy and immune checkpoint blockade alone in the murine autochthonous polyoma middle T oncogene-driven (PyMT) mammary tumor model. Using whole transcriptome analysis, we identified a set of genes that were upregulated specifically upon chemoimmunotherapy. This gene signature and, more specifically, a condensed four-gene signature predicted favorable survival of human mammary carcinoma patients in the METABRIC cohort. Moreover, PyMT tumors treated with chemoimmunotherapy contained higher levels of cytotoxic lymphocytes, particularly natural killer cells (NK cells). Gene set enrichment analysis and bead-based ELISA measurements revealed increased IL-27 production and signaling in PyMT tumors upon chemoimmunotherapy. Moreover, IL-27 signaling improved NK cell cytotoxicity against PyMT cells in vitro. Taken together, our data support recent clinical observations indicating a benefit of chemoimmunotherapy compared to monotherapy in breast cancer and suggest potential underlying mechanisms.
Although cyclophosphamide (CP) has been used successfully in the clinic for over 50 years, it has so far not been possible to elucidate the mechanism of action and to use it for improvement. This was not possible because the basis of the mechanism of action of CP, which was found by lucky coincidence, is apoptosis, the discovery of which was honored with the Nobel Prize only in 2002. Another reason was that results from cell culture experiments were used to elucidate the mechanism of action, ignoring the fact that in vivo metabolism differs from in vitro conditions. In vitro, toxic acrolein is formed during the formation of the cytotoxic metabolite phosphoreamidemustard (PAM), whereas in vivo proapoptotic hydroxypropanal (HPA) is formed. The CP metabolites formed in sequence 4-hydroxycyclophosphamide (OHCP) are the main cause of toxicity, aldophosphamide (ALDO) is the pharmacologically active metabolite and HPA amplifies the cytotoxic apoptosis initiated by DNA alkylation by PAM. It is shown that toxicity is drastically reduced but anti-tumor activity strongly increased by the formation of ALDO bypassing OHCP. Furthermore, it is shown that the anti-tumor activity against advanced solid P388 tumors that grow on CD2F1 mice is increased by orders of magnitude if DNA damage caused by a modified PAM is poorly repairable. View Full-Text
Motivation: Calculating the magnitude of treatment effects or of differences between two groups is a common task in quantitative science. Standard effect size measures based on differences, such as the commonly used Cohen's, fail to capture the treatment-related effects on the data if the effects were not reflected by the central tendency. The present work aims at (i) developing a non-parametric alternative to Cohen’s d, which (ii) circumvents some of its numerical limitations and (iii) involves obvious changes in the data that do not affect the group means and are therefore not captured by Cohen’s d.
Results: We propose "Impact” as a novel non-parametric measure of effect size obtained as the sum of two separate components and includes (i) a difference-based effect size measure implemented as the change in the central tendency of the group-specific data normalized to pooled variability and (ii) a data distribution shape-based effect size measure implemented as the difference in probability density of the group-specific data. Results obtained on artificial and empirical data showed that “Impact”is superior to Cohen's d by its additional second component in detecting clearly visible effects not reflected in central tendencies. The proposed effect size measure is invariant to the scaling of the data, reflects changes in the central tendency in cases where differences in the shape of probability distributions between subgroups are negligible, but captures changes in probability distributions as effects and is numerically stable even if the variances of the data set or its subgroups disappear.
Conclusions: The proposed effect size measure shares the ability to observe such an effect with machine learning algorithms. Therefore, the proposed effect size measure is particularly well suited for data science and artificial intelligence-based knowledge discovery from big and heterogeneous data.
Background: The currently prevailing global threat of COVID-19 caused the publication numbers on coronaviruses to explode. The awareness of the scientific and public community is enormous. But what about the sense of all these undertakings and what can be learned about the future for a better understanding? These questions were answered with established bibliometric analyses of the time until the avalanche of publications unfolded.
Methods: Chronological, geographical aspects of publication output on coronavirus were also evaluated under the influence of epidemiological and socio-economic parameters.
Results: The trend in publication and citation numbers shows the strong influence of the past pandemics SARS and MERS with an untypical decline afterward. Research is becoming increasingly multidisciplinary over time. The USA and China, as the countries with the highest number of publications, are being displaced by other countries in the consideration of socio-economic and epidemiological aspects, which shows the effect of regional interest in corona research. A significant correlation was found between the number of SARS cases per country and related publications, while no correlation was found for MERS cases and articles.
Conclusions: The results underline the need for sustainable and forward-looking approaches that should not end with the containment of COVID-19.
Spinocerebellar ataxia type 2 (SCA2) is caused by polyglutamine expansion in Ataxin-2 (ATXN2). This factor binds RNA/proteins to modify metabolism after stress, and to control calcium (Ca2+) homeostasis after stimuli. Cerebellar ataxias and corticospinal motor neuron degeneration are determined by gain/loss in ATXN2 function, so we aimed to identify key molecules in this atrophic process, as potential disease progression markers. Our Atxn2-CAG100-Knock-In mouse faithfully models features observed in patients at pre-onset, early and terminal stages. Here, its cerebellar global RNA profiling revealed downregulation of signaling cascades to precede motor deficits. Validation work at mRNA/protein level defined alterations that were independent of constant physiological ATXN2 functions, but specific for RNA/aggregation toxicity, and progressive across the short lifespan. The earliest changes were detected at three months among Ca2+ channels/transporters (Itpr1, Ryr3, Atp2a2, Atp2a3, Trpc3), IP3 metabolism (Plcg1, Inpp5a, Itpka), and Ca2+-Calmodulin dependent kinases (Camk2a, Camk4). CaMKIV–Sam68 control over alternative splicing of Nrxn1, an adhesion component of glutamatergic synapses between granule and Purkinje neurons, was found to be affected. Systematic screening of pre/post-synapse components, with dendrite morphology assessment, suggested early impairment of CamKIIα abundance together with the weakening of parallel fiber connectivity. These data reveal molecular changes due to ATXN2 pathology, primarily impacting excitability and communication.
Lichen-forming fungi are symbiotic organisms that synthesize unique natural products with potential for new drug leads. Here, we explored the pharmacological activity of six lichen extracts (Evernia prunastri, Pseudevernia furfuracea, Umbilicaria pustulata, Umbilicaria crustulosa, Flavoparmelia caperata, Platismatia glauca) in the context of cancer and inflammation using a comprehensive set of 11 functional and biochemical in vitro screening assays. We assayed intracellular Ca2+ levels and cell migration. For cancer, we measured tumor cell proliferation, cell cycle distribution and apoptosis, as well as the angiogenesis-associated proliferation of endothelial cells (ECs). Targeting inflammation, we assayed leukocyte adhesion onto ECs, EC adhesion molecule expression, as well as nitric oxide production and prostaglandin (PG)E2 synthesis in leukocytes. Remarkably, none of the lichen extracts showed any detrimental influence on the viability of ECs. We showed for the first time that extracts of F. caperata induce Ca2+ signaling. Furthermore, extracts from E. prunastri, P. furfuracea, F. caperata, and P. glauca reduced cell migration. Interestingly, F. caperata extracts strongly decreased tumor cell survival. The proliferation of ECs was significantly reduced by E. prunastri, P. furfuracea, and F. caperata extracts. The extracts did not inhibit the activity of inflammatory processes in ECs. However, the pro-inflammatory activation of leukocytes was inhibited by extracts from E. prunastri, P. furfuracea, F. caperata, and P. glauca. After revealing the potential biological activities of lichen extracts by an array of screening tests, a correlation analysis was performed to evaluate particular roles of abundant lichen secondary metabolites, such as atranorin, physodic acid, and protocetraric acid as well as usnic acid in various combinations. Overall, some of the lichen extracts tested in this study exhibit significant pharmacological activity in the context of inflammation and/or cancer, indicating that the group lichen-forming fungi includes promising members for further testing.
Nitro fatty acids (NFAs) are endogenously generated lipid mediators deriving from reactions of unsaturated electrophilic fatty acids with reactive nitrogen species. Furthermore, Mediterranean diets can be a source of NFA. These highly electrophilic fatty acids can undergo Michael addition reaction with cysteine residues, leading to post-translational modifications (PTM) of selected regulatory proteins. Such modifications are capable of changing target protein function during cell signaling or in biosynthetic pathways. NFA target proteins include the peroxisome proliferator-activated receptor γ (PPAR-γ), the pro-inflammatory and tumorigenic nuclear factor-κB (NF-κB) signaling pathway, the pro-inflammatory 5-lipoxygenases (5-LO) biosynthesis pathway as well as soluble epoxide hydrolase (sEH), which is essentially involved in the regulation of vascular tone. In several animal models of inflammation and cancer, the therapeutic efficacy of well-tolerated NFA has been demonstrated. This has already led to clinical phase II studies investigating possible therapeutic effects of NFA in subjects with pulmonary arterial hypertension. Albeit Michael acceptors feature a broad spectrum of bioactivity, they have for a rather long time been avoided as drug candidates owing to their presumed unselective reactivity and toxicity. However, targeted covalent modification of regulatory proteins by Michael acceptors became recognized as a promising approach to drug discovery with the recent FDA approvals of the cancer therapeutics, afatanib (2013), ibrutinib (2013), and osimertinib (2015). Furthermore, the Michael acceptor, neratinib, a dual inhibitor of the human epidermal growth factor receptor 2 and epidermal growth factor receptor, was recently approved by the FDA (2017) and by the EMA (2018) for the treatment of breast cancer. Finally, a number of further Michael acceptor drug candidates are currently under clinical investigation for pharmacotherapy of inflammation and cancer. In this review, we focus on the pharmacology of NFA and other Michael acceptor drugs, summarizing their potential as an emerging class of future antiphlogistics and adjuvant in tumor therapeutics.
Post-exercise hypotension (PEH) is the phenomenon of lowered blood pressure after a single bout of exercise. Only a fraction of people develops PEH but its occurrence correlates well with long-term effects of sports on blood pressure. Therefore, PEH has been suggested as a suitable predictor for the effectivity of exercise as therapy in hypertension. Local vascular bioactive lipids might play a potential role in this context. We performed a cross-over clinical pilot study with 18 healthy volunteers to investigate the occurrence of PEH after a single short-term endurance exercise. Furthermore, we investigated the plasma lipid profile with focus on arachidonic acid (AA)-derived metabolites as potential biomarkers of PEH. A single bout of ergometer cycling induced a significant PEH in healthy volunteers with the expected high inter-individual variability. Targeted lipid spectrum analysis revealed significant upregulation of several lipids in the direct post-exercise phase. Among these changes, only 15- hydroxyeicosatetranoic acid (HETE) correlated significantly with the extent of PEH but in an AA-independent manner, suggesting that 15-HETE might act as specific PEH-marker. Our data indicate that specific lipid modulation might facilitate the identification of patients who will benefit from exercise activity in hypertension therapy. However, larger trials including hypertonic patients are necessary to verify the clinical value of this hypothesis.
The risk of increasing dengue (DEN) and chikungunya (CHIK) epidemics impacts 240 million people, health systems, and the economy in the Hindu Kush Himalayan (HKH) region. The aim of this systematic review is to monitor trends in the distribution and spread of DEN/CHIK over time and geographically for future reliable vector and disease control in the HKH region. We conducted a systematic review of the literature on the spatiotemporal distribution of DEN/CHIK in HKH published up to 23 January 2020, following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. In total, we found 61 articles that focused on the spatial and temporal distribution of 72,715 DEN and 2334 CHIK cases in the HKH region from 1951 to 2020. DEN incidence occurs in seven HKH countries, i.e., India, Nepal, Bhutan, Pakistan, Bangladesh, Afghanistan, and Myanmar, and CHIK occurs in four HKH countries, i.e., India, Nepal, Bhutan, and Myanmar, out of eight HKH countries. DEN is highly seasonal and starts with the onset of the monsoon (July in India and June in Nepal) and with the onset of spring (May in Bhutan) and peaks in the postmonsoon season (September to November). This current trend of increasing numbers of both diseases in many countries of the HKH region requires coordination of response efforts to prevent and control the future expansion of those vector-borne diseases to nonendemic areas, across national borders.
Background: While swallowing disorders are frequent sequela following posterior fossa tumor (PFT) surgery in children, data on dysphagia frequency, severity, and outcome in adults are lacking. The aim of this study was to investigate dysphagia before and after surgical removal of PFT. Additionally, we tried to identify clinical predictors for postsurgical swallowing disorders. Furthermore, this study explored the three-month outcome of dysphagic patients.
Methods: In a cohort of patients undergoing PFT surgery, dysphagia was prospectively assessed pre- and postoperatively using fiberoptic endoscopic evaluation of swallowing. Patients with severe dysphagia at discharge were re-evaluated after three months. Additionally, clinical and imaging data were collected to identify predictors for post-surgical dysphagia. Results: We included 26 patients of whom 15 had pre-operative swallowing disorders. After surgery, worsening of pre-existing dysphagia could be noticed in 7 patients whereas improvement was observed in 2 and full recovery in 3 subjects. New-onset dysphagia after surgery occurred in a minority of 3 cases. Postoperatively, 47% of dysphagic patients required nasogastric tube feeding. Re-evaluation after three months of follow-up revealed that all dysphagic patients had returned to full oral intake.
Conclusion: Dysphagia is a frequent finding in patients with PFT already before surgery. Surgical intervention can infer a deterioration of impaired swallowing function placing affected patients at temporary risk for aspiration. In contrast, surgery can also accomplish beneficial results resulting in both improvement and full recovery. Overall, our findings show the need of early dysphagia assessment to define the safest feeding route for the patient.
Background:Aedes aegypti is a potential vector for several arboviruses including dengue and Zika viruses. The species seems to be restricted to subtropical/tropical habitats and has difficulties in establishing permanent populations in southern Europe, probably due to constraints during the winter season. The aim of this study was to systematically analyze the cold tolerance (CT) of Ae. aegypti in its most cold-resistant life stage, the eggs.
Methods: The CT of Ae. aegypti eggs was compared with that of Ae. albopictus which is well established in large parts of Europe. By systematically studying the literature (meta-analysis), we recognized that CT has been rarely tested in Ae. aegypti eggs, but eggs can survive at zero and sub-zero temperatures for certain exposure periods. To overcome potential bias from experimental differences between studies, we then conducted species comparisons using a harmonized high-resolution CT measuring method. From subtropical populations of the same origin, the survival (hatching in %) and emergence of adults of both species were measured after zero and sub-zero temperature exposures for up to 9 days (3 °C, 0 °C and − 2 °C: ≤ 9 days; − 6 °C: ≤ 2 days).
Results: Our data show that Ae. aegypti eggs can survive low and sub-zero temperatures for a short time period similar to or even better than those of Ae. albopictus. Moreover, after short sub-zero exposures of eggs of both species, individuals still developed into viable adults (Ae. aegypti: 3 adults emerged after 6 days at − 2 °C, Ae. albopictus: 1 adult emerged after 1 day at − 6 °C).
Conclusions: Thus, both the literature and the present experimental data indicate that a cold winter may not be the preventing factor for the re-establishment of the dengue vector Ae. aegypti in southern Europe.
Psoriasis (PsO) is one of the common chronic inflammatory skin diseases. Approximately 3% of the European Caucasian population is affected. Psoriatic arthritis (PsA) is a chronic immune-mediated disease associated with PsO characterized by distinct musculoskeletal inflammation. Due to its heterogeneous clinical manifestations (e.g., oligo- or polyarthritis, enthesitis, dactylitis, and axial inflammation), early diagnosis of PsA is often difficult and delayed. Approximately 30% of PsO patients will develop PsA. The responsible triggers for the transition from PsO only to PsA are currently unclear, and the impacts of different factors (e.g., genetic, environmental) on disease development are currently discussed. There is a high medical need, recently unmet, to specifically detect those patients with an increased risk for the development of clinically evident PsA early to initiate sufficient treatment to inhibit disease progression and avoid structural damage and loss of function or even intercept disease development. Increased neoangiogenesis and enthesial inflammation are hypothesized to be early pathological findings in PsO patients with PsA development. Different disease states describe the transition from PsO to PsA. Two of those phases are of value for early detection of PsA at-risk patients to prevent later development of PsA as changes in biomarker profiles are detectable: the subclinical phase (soluble and imaging biomarkers detectable, no clinical symptoms) and the prodromal phase (imaging biomarkers detectable, unspecific musculoskeletal symptoms such as arthralgia and fatigue). To target the unmet need for early detection of this at-risk population and to identify the subgroup of patients who will transition from PsO to PsA, imaging plays an important role in characterizing patients precisely. Imaging techniques such as ultrasound (US), magnetic resonance imaging (MRI), and computerized tomography (CT) are advanced techniques to detect sensitively inflammatory changes or changes in bone structure. With the use of these techniques, anatomic structures involved in inflammatory processes can be identified. These techniques are complemented by fluorescence optical imaging as a sensitive method for detection of changes in vascularization, especially in longitudinal measures. Moreover, high-resolution peripheral quantitative CT (HR-pQCT) and dynamic contrast-enhanced MRI (DCE-MRI) may give the advantage to identify PsA-related early characteristics in PsO patients reflecting transition phases of the disease.
The coronavirus disease 2019 COVID-19 pandemic is rapidly spreading worldwide and is becoming a major public health crisis. Increasing evidence demonstrates a strong correlation between obesity and the COVID-19 disease. We have summarized recent studies and addressed the impact of obesity on COVID-19 in terms of hospitalization, severity, mortality, and patient outcome. We discuss the potential molecular mechanisms whereby obesity contributes to the pathogenesis of COVID-19. In addition to obesity-related deregulated immune response, chronic inflammation, endothelium imbalance, metabolic dysfunction, and its associated comorbidities, dysfunctional mesenchymal stem cells/adipose-derived mesenchymal stem cells may also play crucial roles in fueling systemic inflammation contributing to the cytokine storm and promoting pulmonary fibrosis causing lung functional failure, characteristic of severe COVID-19. Moreover, obesity may also compromise motile cilia on airway epithelial cells and impair functioning of the mucociliary escalators, reducing the clearance of severe acute respiratory syndrome coronavirus (SARS-CoV-2). Obese diseased adipose tissues overexpress the receptors and proteases for the SARS-CoV-2 entry, implicating its possible roles as virus reservoir and accelerator reinforcing violent systemic inflammation and immune response. Finally, anti-inflammatory cytokines like anti-interleukin 6 and administration of mesenchymal stromal/stem cells may serve as potential immune modulatory therapies for supportively combating COVID-19. Obesity is conversely related to the development of COVID-19 through numerous molecular mechanisms and individuals with obesity belong to the COVID-19-susceptible population requiring more protective measures.
Objective: Spinal epidural abscess (SEA) is a severe and life-threatening disease. Although commonly performed, the effect of timing in surgical treatment on patient outcome is still unclear. With this study, we aim to provide evidence for early surgical treatment in patients with SEA.
Methods: Patients treated for SEA in the authors' department between 2007 and 2016 were included for analysis and retrospectively analyzed for basic clinical parameters and outcome. Pre- and postoperative neurological status were assessed using the American Spinal Injury Association Impairment Scale (AIS). The self-reported quality of life (QOL) based on the Short-Form Health Survey 36 (SF-36) was assessed prospectively. Surgery was defined as "early", when performed within 12 hours after admission and "late" when performed thereafter. Conservative therapy was preferred and recommend in patients without neurological deficits and in patients denying surgical intervention.
Results: One hundred and twenty-three patients were included in this study. Forty-nine patients (39.8%) underwent early, 47 patients (38.2%) delayed surgery and 27 (21.9%) conservative therapy. No significant differences were observed regarding mean age, sex, diabetes, prior history of spinal infection, and bony destruction. Patients undergoing early surgery revealed a significant better clinical outcome before discharge than patients undergoing late surgery (p=0.001) and conservative therapy. QOL based on SF-36 were significantly better in the early surgery cohort in two of four physical items (physical functioning and bodily pain) and in one of four psychological items (role limitation) after a mean follow-up period of 58 months. Readmission to the hospital and failure of conservative therapy were observed more often in patients undergoing conservative therapy.
Conclusion: Our data on both clinical outcome and QOL provide evidence for early surgery within 12 hours after admission in patients with SEA.
Background: The treatment of severely injured patients, especially in older age, is complex, and based on strict guidelines. Methods: We conducted a retrospective study by analyzing our internal registry for mortality risk factors in deceased trauma patients. All patients that were admitted to the trauma bay of our level-1-trauma center from 2014 to 2018, and that died during the in-hospital treatment, were included. The aim of this study was to carry out a quality assurance concerning the initial care of severely injured patients. Results: In the 5-year period, 135 trauma patients died. The median (IQR) age was 69 (38–83) years, 71% were male, and the median (IQR) Injury Severity Score (ISS) was 25 (17–34) points. Overall, 41% of the patients suffered from severe traumatic brain injuries (TBI) (AIShead ≥ 4 points). For 12.7%, therapy was finally limited owing to an existing patient’s decree; in 64.9% with an uncertain prognosis, a ‘therapia minima’ was established in consensus with the relatives. Conclusion: Although the mortality rate was primarily related to the severity of the injury, a significant number of deaths were not exclusively due to medical reasons, but also to a self-determined limitation of therapy for severely injured geriatric patients. The conscientious documentation concerning the will of the patient is increasingly important in supporting medical decisions.
Background: The epidermal growth factor receptor (EGFR) signaling pathway is genetically activated in approximately 50% of glioblastomas (GBs). Its inhibition has been explored clinically but produced disappointing results, potentially due to metabolic effects that protect GB cells against nutrient deprivation and hypoxia. Here, we hypothesized that EGFR activation could disable metabolic adaptation and define a GB cell population sensitive to starvation.
Methods: Using genetically engineered GB cells to model different types of EGFR activation, we analyzed changes in metabolism and cell survival under conditions of the tumor microenvironment.
Results: We found that expression of mutant EGFRvIII as well as EGF stimulation of EGFR-overexpressing cells impaired physiological adaptation to starvation and rendered cells sensitive to hypoxia-induced cell death. This was preceded by adenosine triphosphate (ATP) depletion and an increase in glycolysis. Furthermore, EGFRvIII mutant cells had higher levels of mitochondrial superoxides potentially due to decreased metabolic flux into the serine synthesis pathway which was associated with a decrease in the NADPH/NADP+ ratio.
Conclusions: The finding that EGFR activation renders GB cells susceptible to starvation could help to identify a subgroup of patients more likely to benefit from starvation-inducing therapies.
Background: Unwanted anticholinergic effects are both underestimated and frequently overlooked. Failure to identify adverse drug reactions (ADRs) can lead to prescribing cascades and the unnecessary use of over-thecounter products. The objective of this systematic review and meta-analysis is to explore and quantify the frequency and severity of ADRs associated with amitriptyline vs. placebo in randomized controlled trials (RCTs) involving adults with any indication, as well as healthy individuals. Methods: A systematic search in six electronic databases, forward/backward searches, manual searches, and searches for Food and Drug Administration (FDA) and European Medicines Agency (EMA) approval studies, will be performed. Placebo-controlled RCTs evaluating amitriptyline in any dosage, regardless of indication and without restrictions on the time and language of publication, will be included, as will healthy individuals. Studies of topical amitriptyline, combination therapies, or including <100 participants, will be excluded. Two investigators will screen the studies independently, assess methodological quality, and extract data on design, population, intervention, and outcomes ((non-)anticholinergic ADRs, e.g., symptoms, test results, and adverse drug events (ADEs) such as falls). The primary outcome will be the frequency of anticholinergic ADRs as a binary outcome (absolute number of patients with/without anticholinergic ADRs) in amitriptyline vs. placebo groups. Anticholinergic ADRs will be defined by an experienced clinical pharmacologist, based on literature and data from Martindale: The Complete Drug Reference. Secondary outcomes will be frequency and severity of (non-)anticholinergic ADRs and ADEs. The information will be synthesized in meta-analyses and narratives. We intend to assess heterogeneity using metaregression (for indication, outcome, and time points) and I2 statistics. Binary outcomes will be expressed as odds ratios, and continuous outcomes as standardized mean differences. Effect measures will be provided using 95% confidence intervals. We plan sensitivity analyses to assess methodological quality, outcome reporting etc., and subgroup analyses on age, dosage, and duration of treatment. Discussion: We will quantify the frequency of anticholinergic and other ADRs/ADEs in adults taking amitriptyline for any indication by comparing rates for amitriptyline vs. placebo, hence, preventing bias from disease symptoms and nocebo effects. As no standardized instrument exists to measure it, our overall estimate of anticholinergic ADRs may have limitations.
Background: Essential Tremor (ET) is a progressive neurological disorder characterized by postural and kinetic tremor most commonly affecting the hands and arms. Medically intractable ET can be treated by deep brain stimulation (DBS) of the ventral intermediate nucleus of thalamus (VIM). We investigated whether the location of the effective contact (most tremor suppression with at least side effects) in VIM-DBS for ET changes over time, indicating a distinct mechanism of loss of efficacy that goes beyond progression of tremor severity, or a mere reduction of DBS efficacy.
Methods: We performed programming sessions in 10 patients who underwent bilateral vim-DBS surgery between 2009 and 2017 at our department. In addition to the intraoperative (T1) and first clinical programming session (T2) a third programming session (T3) was performed to assess the effect- and side effect threshold (minimum voltage at which a tremor suppression or side effects occurred). Additionally, we compared the choice of the effective contact between T1 and T2 which might be affected by a surgical induced “brain shift.”
Discussion: Over a time span of about 4 years VIM-DBS in ET showed continuous efficacy in tremor suppression during stim-ON compared to stim-OFF. Compared to immediate postoperative programming sessions in ET-patients with DBS, long-term evaluationshowednorelevantchangeinthechoiceofcontactwithrespecttosideeffects andefficacy.InthemajorityofthecasestheactivecontactatT2didnotcorrespondtothe most effective intraoperative stimulation site T1, which might be explained by a brain-shift due to cerebral spinal fluid loss after neurosurgical procedure.
This case series assessed a commercial airline flight from Tel Aviv, Israel, to Frankfurt, Germany, that occurred on March 9th, 2020. Among 102 passengers on a Boeing 737-900 aircraft were 24 members of a tourist group. Starting 7 days earlier, the group had contact with a hotel manager who later received a diagnosis of coronavirus disease 2019 (COVID-19). No member of the group had received a diagnosis of COVID-19 before the flight, and no measures to prevent transmission (eg, wearing of masks) had been applied. The flight duration was 4 hours 40 minutes.
MicroRNA miR-181 - a rheostat for TCR signaling in thymic selection and peripheral T-Cell function
(2020)
The selection of T cells during intra-thymic d evelopment is crucial to obtain a functional and simultaneously not self-reactive peripheral T cell repertoire. However, selection is a complex process dependent on T cell receptor (TCR) thresholds that remain incompletely understood. In peripheral T cells, activation, clonal expansion, and contraction of the active T cell pool, as well as other processes depend on TCR signal strength. Members of the microRNA (miRNA) miR-181 family have been shown to be dynamically regulated during T cell development as well as dependent on the activation stage of T cells. Indeed, it has been shown that expression of miR-181a leads to the downregulation of multiple phosphatases, implicating miR-181a as ‘‘rheostat’’ of TCR signaling. Consistently, genetic models have revealed an essential role of miR-181a/b-1 for the generation of unconventional T cells as well as a function in tuning TCR sensitivity in peripheral T cells during aging. Here, we review these broad roles of miR-181 family members in T cell function via modulating TCR signal strength.
With obesity having doubled in the last decade, hypertension is on the rise. In one-third of hypertensive patients the metabolic syndrome is present. This might be one factor for the increasing number of prescriptions for angiotensin receptor blockers and calcium-channel blockers besides a more favorable risk-to-benefit ratio. The aim of the present study was to evaluate a therapeutic drug monitoring (TDM) method for assessment of adherence based on cut-offs in inpatients and to compare it to an established urine drug screening in outpatients. A method for quantification of calcium-channel blockers and angiotensin receptor blockers using high-performance liquid chromatography-tandem mass spectrometric analysis (LC-MS/MS) was developed and validated. The method was applied to serum samples of 32 patients under supervised medication to establish cut-off values for adherence assessment based on dose-related concentrations (DRC, calculated from pharmacokinetic data). Furthermore, corresponding urine and blood samples of 42 outpatients without supervised medication were analysed and the results compared with regard to adherence assessment. All serum concentrations measured for amlodipine (n = 40), lercanidipine (n = 14), candesartan (n = 10), telmisartan (n = 4) and valsartan (n = 10) in inpatients were above the patient specific lower DRC confirming adherence. Of 42 outpatients the identification of analytes in urine as well as the quantification in serum exhibited differing results. According to urinalysis, adherence was demonstrated in only 87.0% of prescriptions, compared to 91.3% for serum analyses. Differences were observed for amlodipine, lercanidipine and candesartan which can be explained by a higher specificity of the serum analysis approach due to pharmacokinetics. The present study confirms that assessing adherence based on serum drug concentrations with individually calculated lower DRCs is more accurate than using qualitative urine analysis. In particular, drugs with low bioavailability, low renal excretion or high metabolism rate such as lercanidipine and candesartan may lead to underestimation of adherence via urine analysis.
Emerging evidence suggests a complex relationship between sphingosine 1-phosphate (S1P) signaling and stroke. Here, we show the kinetics of S1P in the acute phase of ischemic stroke and highlight accompanying changes in immune cells and S1P receptors (S1PR). Using a C57BL/6 mouse model of middle cerebral artery occlusion (MCAO), we assessed S1P concentrations in the brain, plasma, and spleen. We found a steep S1P gradient from the spleen towards the brain. Results obtained by qPCR suggested that cells expressing the S1PR type 1 (S1P1+) were the predominant population deserting the spleen. Here, we report the cerebral recruitment of T helper (TH) and regulatory T (TREG) cells to the ipsilateral hemisphere, which was associated with differential regulation of cerebral S1PR expression patterns in the brain after MCAO. This study provides insight that the S1P-S1PR axis facilitates splenic T cell egress and is linked to the cerebral recruitment of S1PR+ TH and TREG cells. Further insights by which means the S1P-S1PR-axis orchestrates neuronal positioning may offer new therapeutic perspectives after ischemic stroke.
Background: Many patients suffering from exercise-induced asthma (EIA) have normal lung function at rest and show symptoms and a decline in FEV1 when they do sports or during exercise-challenge. It has been described that long-chain polyunsaturated fatty acids (LCPUFA) could exert a protective effect on EIA.
Methods: In this study the protective effect of supplementation with a special combination of n-3 and n-6 LCPUFA (sc-LCPUFA) (total 1.19 g/ day) were investigated in an EIA cold air provocation model. Primary outcome measure: Decrease in FEV1 after exercise challenge and secondary outcome measure: anti-inflammatory effects monitored by exhaled NO (eNO) before and after sc-LCPUFA supplementation versus placebo.
Results: Ninety-nine patients with exercise-induced symptoms aged 10 to 45 were screened by a standardized exercise challenge in a cold air chamber at 4 °C. Seventy-three patients fulfilled the inclusion criteria of a FEV1 decrease > 15% and were treated double-blind placebo-controlled for 4 weeks either with sc-LCPUFA or placebo. Thirty-two patients in each group completed the study. Mean FEV1 decrease after cold air exercise challenge and eNO were unchanged after 4 weeks sc-LCPUFA supplementation.
Conclusion: Supplementation with sc-LCPUFA at a dose of 1.19 g/d did not have any broncho-protective and anti-inflammatory effects on EIA.
Trial registration: Clinical trial registration number: NCT02410096. Registered 7 February 2015 at Clinicaltrial.gov
SARS-CoV-2 is the causative agent of COVID-19. Severe COVID-19 disease has been associated with disseminated intravascular coagulation and thrombosis, but the mechanisms underlying COVID-19-related coagulopathy remain unknown. The risk of severe COVID-19 disease is higher in males than in females and increases with age. To identify gene products that may contribute to COVID-19-related coagulopathy, we analyzed the expression of genes associated with the Gene Ontology (GO) term “blood coagulation” in the Genotype-Tissue Expression (GTEx) database and identified four procoagulants, whose expression is higher in males and increases with age (ADAMTS13, F11, HGFAC, KLKB1), and two anticoagulants, whose expression is higher in females and decreases with age (C1QTNF1, SERPINA5). However, the expression of none of these genes was regulated in a proteomics dataset of SARS-CoV-2-infected cells and none of the proteins have been identified as a binding partner of SARS-CoV-2 proteins. Hence, they may rather generally predispose individuals to thrombosis without directly contributing to COVID-19-related coagulopathy. In contrast, the expression of the procoagulant transferrin (not associated to the GO term “blood coagulation”) was higher in males, increased with age, and was upregulated upon SARS-CoV-2 infection. Hence, transferrin warrants further examination in ongoing clinic-pathological investigations.
miR-142-3p expression is predictive for severe traumatic brain injury (TBI) in trauma patients
(2020)
Background: Predictive biomarkers in biofluids are the most commonly used diagnostic method, but established markers in trauma diagnostics lack accuracy. This study investigates promisingmicroRNAs(miRNA)releasedfromaffectedtissueafterseveretraumathathavepredictive values for the effects of the injury.
Methods: A retrospective analysis of prospectively collected data and blood samples of n = 33 trauma patients (ISS≥16) is provided. Levels of miR-9-5p, -124-3p, -142-3p, -219a-5p, -338-3pand-423-3p inseverelyinjuredpatients (PT)withouttraumatic braininjury (TBI) or with severe TBI (PT + TBI) and patients with isolated TBI (isTBI) were measured within 6 h after trauma.
Results: The highest miR-423-3p expression was detected in patients with severe isTBI, followed by patients with PT + TBI, and lowest levels were found in PT patients without TBI (2−∆∆Ct,p = 0.009). ApositivecorrelationbetweenmiR-423-3plevelandincreasingAIShead (p = 0.001) and risk of mortality (RISC II, p = 0.062) in trauma patients (n = 33) was found. ROC analysis of miR-423-3p levels revealed them as statistically significant to predict the severity of brain injury in trauma patients (p = 0.006). miR-124-3p was only found in patients with severe TBI, miR-338-3p was shown in all trauma groups. miR-9-5p, miR-142-3p and miR-219a-5p could not be detected in any of the four groups. Conclusion: miR-423-3p expression is significantly elevated after isolated traumatic braininjuryandpredictableforsevereTBIinthefirsthoursaftertrauma. miR-423-3pcouldrepresent a promising new biomarker to identify severe isolated TBI.
A message from the human placenta: structural and immunomodulatory defense against SARS-CoV-2
(2020)
The outbreak of the coronavirus disease 2019 (COVID-19) pandemic has caused a global public health crisis. Viral infections may predispose pregnant women to a higher rate of pregnancy complications, including preterm births, miscarriage and stillbirth. Despite reports of neonatal COVID-19, definitive proof of vertical transmission is still lacking. In this review, we summarize studies regarding the potential evidence for transplacental transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), characterize the expression of its receptors and proteases, describe the placental pathology and analyze virus-host interactions at the maternal-fetal interface. We focus on the syncytium, the barrier between mother and fetus, and describe in detail its physical andstructuraldefenseagainstviralinfections. Wefurtherdiscussthepotentialmolecularmechanisms, whereby the placenta serves as a defense front against pathogens by regulating the interferon type III signaling, microRNA-triggered autophagy and the nuclear factor-κB pathway. Based on these data, we conclude that vertical transmission may occur but rare, ascribed to the potent physical barrier, the fine-regulatedplacentalimmunedefenseandmodulationstrategies. Particularly,immunomodulatory mechanismsemployedbytheplacentamaymitigateviolentimmuneresponse,maybesoftencytokine storm tightly associated with severely ill COVID-19 patients, possibly minimizing cell and tissue damages, and potentially reducing SARS-CoV-2 transmission.
Chronic treatment with the mTOR inhibitor, everolimus, fails long-term in preventing tumor growth and dissemination in cancer patients. Thus, patients experiencing treatment resistance seek complementary measures, hoping to improve therapeutic efficacy. This study investigated metastatic characteristics of bladder carcinoma cells exposed to everolimus combined with the isothiocyanate sulforaphane (SFN), which has been shown to exert cancer inhibiting properties. RT112, UMUC3, or TCCSUP bladder carcinoma cells were exposed short- (24 h) or long-term (8 weeks) to everolimus (0.5 nM) or SFN (2.5 µM), alone or in combination. Adhesion and chemotaxis along with profiling details of CD44 receptor variants (v) and integrin α and β subtypes were evaluated. The functional impact of CD44 and integrins was explored by blocking studies and siRNA knock-down. Long-term exposure to everolimus enhanced chemotactic activity, whereas long-term exposure to SFN or the SFN-everolimus combination diminished chemotaxis. CD44v4 and v7 increased on RT112 cells following exposure to SFN or SFN-everolimus. Up-regulation of the integrins α6, αV, and β1 and down-regulation of β4 that was present with everolimus alone could be prevented by combining SFN and everolimus. Down-regulation of αV, β1, and β4 reduced chemotactic activity, whereas knock-down of CD44 correlated with enhanced chemotaxis. SFN could, therefore, inhibit resistance-related tumor dissemination during everolimus-based bladder cancer treatment.
Purpose: Sarcopenia, defined as a loss of muscle mass and quality, has been associated with impaired oncological outcome and treatment toxicities in several malignancies. However, its role in anal squamous cell carcinoma (ASCC) remains less well explored.
Methods/Materials: Planning CT scans were used to measure cross-sectional skeletal muscle area (SMA) to calculate the skeletal muscle index (SMI). The association of sarcopenia with clinical and treatment-related parameters, and toxicity was assessed in 114 patients with ASCC that underwent standard 5-Fluorouracil/Mitomycin C chemoradiotherapy (CRT). The prognostic impact of sarcopenia on local relapse-free survival (LRFS), disease-free survival (DFS), and overall survival was examined using a Cox regression analysis.
Results: 29 (25.4%) patients had sarcopenia. Patients with sarcopenia had lower baseline hemoglobin levels (p = 0.002), worse Karnofsky Performance Status (p = 0.001) lower BMI (p < 0.001), and a significantly lower body surface area (p = 0.03), and lower incidence of involved lymph nodes (p = 0.03). Regarding acute toxicity, sarcopenia was associated with a significantly higher incidence of ≥grade 3leukopenia (OR: 3.5; 95% CI: 1.6–7.5, p = 0.007) and ≥grade 3 thrombopenia (OR: 5.1; 95% CI: 1.3–21, p = 0.018) after CRT. Despite higher hematologic toxicity in sarcopenic patients, total treatment time was similar between patients with and without sarcopenia (median 44 vs 45 days, p = 0.95). There was no significant prognostic impact of sarcopenia on either LRFS, DFS, or OS.
Conclusion: This is the largest study to assess the impact of sarcopenia on toxicity and oncological outcome in patients with ASCC. Increased clinician awareness of higher hematological toxicity risk is needed for sarcopenic patients with ASCC undergoing CRT to facilitate closer monitoring of side effects and earlier introduction of supportive measures. Further prospective studies are needed to elucidate the prognostic role and impact of sarcopenia on CRT-related toxicity in ASCC.
Depletion of yeast/fly Ataxin-2 rescues TDP-43 overexpression toxicity. In mouse models of Amyotrophic Lateral Sclerosis via TDP-43 overexpression, depletion of its ortholog ATXN2 mitigated motor neuron degeneration and extended lifespan from 25 days to >300 days. There is another ortholog in mammals, named ATXN2L (Ataxin-2-like), which is almost uncharacterized but also functions in RNA surveillance at stress granules. We generated mice with Crispr/Cas9-mediated deletion of Atxn2l exons 5-8, studying homozygotes prenatally and heterozygotes during aging. Our novel findings indicate that ATXN2L absence triggers mid-gestational embryonic lethality, affecting female animals more strongly. Weight and development stages of homozygous mutants were reduced. Placenta phenotypes were not apparent, but brain histology showed lamination defects and apoptosis. Aged heterozygotes showed no locomotor deficits or weight loss over 12 months. Null mutants in vivo displayed compensatory efforts to maximize Atxn2l expression, which were prevented upon nutrient abundance in vitro. Mouse embryonal fibroblast cells revealed more multinucleated giant cells upon ATXN2L deficiency. In addition, in human neural cells, transcript levels of ATXN2L were induced upon starvation and glucose and amino acids exposure, but this induction was partially prevented by serum or low cholesterol administration. Neither ATXN2L depletion triggered dysregulation of ATXN2, nor a converse effect was observed. Overall, this essential role of ATXN2L for embryogenesis raises questions about its role in neurodegenerative diseases and neuroprotective therapies.
Manufacturing processes of custom implant abutments may contaminate their surfaces with micro wear deposits and generic pollutants. Such particulate debris, if not removed, might be detrimental and provoke inflammatory reactions in peri-implant tissues. Although regulatory guidelines for adequate cleaning, disinfection, or sterilization exist, there does not appear to be a consistent application and data on the amount and extent of such contaminants is lacking. The aim of the present in vitro study was to evaluate the quality and quantity of processing-related surface contamination of computer-aided design/computer-aided manufacturing (CAD/CAM) abutments in the state of delivery and after ultrasonic cleaning. A total of 28 CAD/CAM monotype and hybrid abutments were cleaned and disinfected applying a three-stage ultrasonic protocol (Finevo protocol). Before and after cleaning, the chemical composition and the contamination of the abutments were assessed using scanning electron microscopy (SEM), dispersive X-ray spectroscopy(EDX),andcomputer-aidedplanimetricmeasurement(CAPM).Inthedeliverycondition, monotype abutments showed a significantly higher amount of debris compared to hybrid abutments (4.86±6.10% vs. 0.03 ± 0.03%, p < 0.001). The polishing process applied in the laboratory after bonding the hybrid abutment components reduces the surface roughness and thus contributes substantially to their purity. The extent of contamination caused by computer-aided manufacturing of custom abutments can be substantially minimized using a three-stage ultrasonic protocol.
Alcoholism is one of the leading and increasingly prevalent reasons of liver associated morbidity and mortality worldwide. Alcoholic hepatitis (AH) constitutes a severe disease with currently no satisfying treatment options. Lipoxin A4 (LXA4), a 15-lipoxygenase (ALOX15)-dependent lipid mediator involved in resolution of inflammation, showed promising pre-clinical results in the therapy of several inflammatory diseases. Since inflammation is a main driver of disease progression in alcoholic hepatitis, we investigated the impact of endogenous ALOX15-dependent lipid mediators and exogenously applied LXA4 on AH development. A mouse model for alcoholic steatohepatitis (NIAAA model) was tested in Alox12/15+/+ and Alox12/15−/− mice, with or without supplementation of LXA4. Absence of Alox12/15 aggravated parameters of liver disease, increased hepatic immune cell infiltration in AH, and elevated systemic neutrophils as a marker for systemic inflammation. Interestingly, i.p. injections of LXA4 significantly lowered transaminase levels only in Alox12/15−/− mice and reduced hepatic immune cell infiltration as well as systemic inflammatory cytokine expression in both genotypes, even though steatosis progressed. Thus, while LXA4 injection attenuated selected parameters of disease progression in Alox12/15−/− mice, its beneficial impact on immunity was also apparent in Alox12/15+/+ mice. In conclusion, pro-resolving lipid mediators may be beneficial to reduce inflammation in alcoholic hepatitis.
Autism spectrum disorders (ASD) are highly heritable and are characterized by deficits in social communication and restricted and repetitive behaviors. Twin studies on phenotypic subdomains suggest a differing underlying genetic etiology. Studying genetic variation explaining phenotypic variance will help to identify specific underlying pathomechanisms. We investigated the effect of common variation on ASD subdomains in two cohorts including >2500 individuals. Based on the Autism Diagnostic Interview-Revised (ADI-R), we identified and confirmed six subdomains with a SNP-based genetic heritability h2SNP = 0.2–0.4. The subdomains nonverbal communication (NVC), social interaction (SI), and peer interaction (PI) shared genetic risk factors, while the subdomains of repetitive sensory-motor behavior (RB) and restricted interests (RI) were genetically independent of each other. The polygenic risk score (PRS) for ASD as categorical diagnosis explained 2.3–3.3% of the variance of SI, joint attention (JA), and PI, 4.5% for RI, 1.2% of RB, but only 0.7% of NVC. We report eight genome-wide significant hits—partially replicating previous findings—and 292 known and novel candidate genes. The underlying biological mechanisms were related to neuronal transmission and development. At the SNP and gene level, all subdomains showed overlap, with the exception of RB. However, no overlap was observed at the functional level. In summary, the ADI-R algorithm-derived subdomains related to social communication show a shared genetic etiology in contrast to restricted and repetitive behaviors. The ASD-specific PRS overlapped only partially, suggesting an additional role of specific common variation in shaping the phenotypic expression of ASD subdomains.
Introduction End-of-life care is an essential task performed by most healthcare providers and often involves decision-making about how and where patients want to receive care. To provide decision support to healthcare professionals and patients in this difficult situation, we will systematically review a knowledge cluster of the end-of-life care preferences of older patients with multimorbidity that we previously identified using an evidence map.
Methods and analysis We will systematically search for studies reporting end-of-life care preferences of older patients (mean age ≥60) with multimorbidity (≥2 chronic conditions) in MEDLINE, CINAHL, PsycINFO, Social Sciences Citation Index, Social Sciences Citation Index Expanded, PSYNDEX and The Cochrane Library from inception to September 2019. We will include all primary studies that use quantitative, qualitative and mixed methodologies, irrespective of publication date and language.
Two independent reviewers will assess eligibility, extract data and describe evidence in terms of study/population characteristics, preference assessment method and end-of-life care elements that matter to patients (eg, life-sustaining treatments). Risk of bias/applicability of results will be independently assessed by two reviewers using the Mixed-Methods Appraisal Tool. Using a convergent integrated approach on qualitative/quantitative studies, we will synthesise information narratively and, wherever possible, quantitatively.
Ethics and dissemination Due to the nature of the proposed systematic review, ethics approval is not required. Results from our research will be disseminated at relevant (inter-)national conferences and via publication in peer-reviewed journals. Synthesising evidence on end-of-life care preferences of older patients with multimorbidity will improve shared decision-making and satisfaction in this final period of life.
Recent studies suggested an important contribution of sphingosine-1-phospate (S1P) signaling via its specific receptors (S1PRs) in the production of pro-inflammatory mediators such as Interleukin (IL)-1β in cancer and inflammation. In an inflammation-driven cancer setting, we previously reported that myeloid S1PR1 signaling induces IL-1β production by enhancing NLRP3 (NOD-, LRR- and Pyrin Domain-Containing Protein 3) inflammasome activity. However, the autocrine role of S1P and enzymes acting on the S1P rheostat in myeloid cells are unknown. Using human and mouse macrophages with pharmacological or genetic intervention we explored the relative contribution of sphingosine kinases (SPHKs) in NLRP3 inflammasome activity regulation. We noticed redundancy in SPHK1 and SPHK2 activities towards macrophage NLRP3 inflammasome transcriptional induction and IL-1β secretion. However, pharmacological blockade of both kinases in unison completely abrogated NLRP3 inflammasome induction and IL-1β secretion. Interestingly, human and mouse macrophages demonstrate varied responses towards SPHKs inhibition and IL-1β secretion. Clinical datasets of renal cell carcinoma and psoriasis patients showed a positive correlation between enzymes affecting the S1P rheostat with NLRP3 inflammasome components expression, which corroborates our finding. Our data provide a better understanding on the role of SPHKs and de novo synthesized S1P in macrophage NLRP3 inflammasome activation
Pulmonary failure is the main cause of morbidity and mortality in the human chromosomal instability syndrome Ataxia-telangiectasia (A-T). Major phenotypes include recurrent respiratory tract infections and bronchiectasis, aspiration, respiratory muscle abnormalities, interstitial lung disease, and pulmonary fibrosis. At present, no effective pulmonary therapy for A-T exists. Cell therapy using adipose-derived mesenchymal stromal/stem cells (ASCs) might be a promising approach for tissue regeneration. The aim of the present project was to investigate whether ASCs migrate into the injured lung parenchyma of Atm-deficient mice as an indication of incipient tissue damage during A-T. Therefore, ASCs isolated from luciferase transgenic mice (mASCs) were intravenously transplanted into Atm-deficient and wild-type mice. Retention kinetics of the cells were monitored using in vivo bioluminescence imaging (BLI) and completed by subsequent verification using quantitative real-time polymerase chain reaction (qRT-PCR). The in vivo imaging and the qPCR results demonstrated migration accompanied by a significantly longer retention time of transplanted mASCs in the lung parenchyma of Atm-deficient mice compared to wild type mice. In conclusion, our study suggests incipient damage in the lung parenchyma of Atm-deficient mice. In addition, our data further demonstrate that a combination of luciferase-based PCR together with BLI is a pivotal tool for tracking mASCs after transplantation in models of inflammatory lung diseases such as A-T.
Progressive bladder cancer growth is associated with abnormal activation of the mammalian target of the rapamycin (mTOR) pathway, but treatment with an mTOR inhibitor has not been as effective as expected. Rather, resistance develops under chronic drug use, prompting many patients to lower their relapse risk by turning to natural, plant-derived products. The present study was designed to evaluate whether the natural compound, sulforaphane (SFN), combined with the mTOR inhibitor everolimus, could block the growth and proliferation of bladder cancer cells in the short- and long-term. The bladder cancer cell lines RT112, UMUC3, and TCCSUP were exposed short- (24 h) or long-term (8 weeks) to everolimus (0.5 nM) or SFN (2.5 µM) alone or in combination. Cell growth, proliferation, apoptosis, cell cycle progression, and cell cycle regulating proteins were evaluated. siRNA blockade was used to investigate the functional impact of the proteins. Short-term application of SFN and/or everolimus resulted in significant tumor growth suppression, with additive inhibition on clonogenic tumor growth. Long-term everolimus treatment resulted in resistance development characterized by continued growth, and was associated with elevated Akt-mTOR signaling and cyclin-dependent kinase (CDK)1 phosphorylation and down-regulation of p19 and p27. In contrast, SFN alone or SFN+everolimus reduced cell growth and proliferation. Akt and Rictor signaling remained low, and p19 and p27 expressions were high under combined drug treatment. Long-term exposure to SFN+everolimus also induced acetylation of the H3 and H4 histones. Phosphorylation of CDK1 was diminished, whereby down-regulation of CDK1 and its binding partner, Cyclin B, inhibited tumor growth. In conclusion, the addition of SFN to the long-term everolimus application inhibits resistance development in bladder cancer cells in vitro. Therefore, sulforaphane may hold potential for treating bladder carcinoma in patients with resistance to an mTOR inhibitor.
Treatment of large bone defects is one of the great challenges in contemporary orthopedic and traumatic surgery. Grafts are necessary to support bone healing. A well-established allograft is demineralized bone matrix (DBM) prepared from donated human bone tissue. In this study, a fibrous demineralized bone matrix (f-DBM) with a high surface-to-volume ratio has been analyzed for toxicity and immunogenicity. f-DBM was transplanted to a 5-mm, plate-stabilized, femoral critical-size-bone-defect in Sprague-Dawley (SD)-rats. Healthy animals were used as controls. After two months histology, hematological analyses, immunogenicity as well as serum biochemistry were performed. Evaluation of free radical release and hematological and biochemical analyses showed no significant differences between the control group and recipients of f-DBM. Histologically, there was no evidence of damage to liver and kidney and good bone healing was observed in the f-DBM group. Reactivity against human HLA class I and class II antigens was detected with mostly low fluorescence values both in the serum of untreated and treated animals, reflecting rather a background reaction. Taken together, these results provide evidence for no systemic toxicity and the first proof of no basic immunogenic reaction to bone allograft and no sensitization of the recipient.
Although the therapeutic armamentarium for bladder cancer has considerably widened in the last few years, severe side effects and the development of resistance hamper long-term treatment success. Thus, patients turn to natural plant products as alternative or complementary therapeutic options. One of these is curcumin, the principal component of Curcuma longa that has shown chemopreventive effects in experimental cancer models. Clinical and preclinical studies point to its role as a chemosensitizer, and it has been shown to protect organs from toxicity induced by chemotherapy. These properties indicate that curcumin could hold promise as a candidate for additive cancer treatment. This review evaluates the relevance of curcumin as an integral part of therapy for bladder cancer.
Christoph Sarrazin,1 Francesco Castelli,2 Pietro Andreone,3 Maria Buti,4 Massimo Colombo,5 Stanislas Pol,6 Filipe Calinas,7 Massimo Puoti,8 Antonio Olveira,9 Mitchell Shiffman,10 Jerry O Stern,11 George Kukolj,12 Michael Roehrle,13 Stella Aslanyan,11 Qiqi Deng,11 Richard Vinisko,11 Federico J Mensa,11 David R Nelson,14 on behalf of the HCVerso1 and 2 study groups 1Department of Internal Medicine 1, JW Goethe University Hospital, Frankfurt, Germany; 2Department of Infectious and Tropical Diseases, University of Brescia, Brescia, 3Department of Medical and Surgical Sciences, Università di Bologna and Azienda Ospedaliero-Universitaria, Policlinico Sant‘Orsola-Malpighi, Bologna, Italy; 4Department of Internal Medicine, Hospital Universitari Vall d’Hebron and CIBERehd del Instituto Carlos III, Barcelona, Spain; 5Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy; 6University Paris Descartes, Department of Hepatology, Hospital Cochin, APHP and INSERM UMS-20, Institut Pasteur, Paris, France; 7Department of Gastroenterology, Centro Hospitalar de Lisboa Central, Lisbon, Portugal; 8Department of Infectious Diseases, AO Ospedale Niguarda Cà Granda, Milan, Italy; 9Liver Unit, Hospital Universitario La Paz, CIBERehd, Madrid, Spain; 10Liver Institute of Virginia, Bon Secours Health System, Richmond, VA, USA; 11Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 12Boehringer Ingelheim Ltd/Ltée, Burlington, ON, Canada; 13Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; 14Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA Abstract:
The interferon-free combination of once-daily faldaprevir 120 mg, twice-daily deleobuvir 600 mg, and weight-based ribavirin was evaluated in two Phase III studies (HCVerso1, HCVerso2) in hepatitis C virus genotype-1b-infected, treatment-naïve patients, including those ineligible for peginterferon (HCVerso2). Patients without cirrhosis were randomized to 16 weeks (Arm 1; n=208 HCVerso1, n=213 HCVerso2) or 24 weeks (Arm 2; n=211 in both studies) of faldaprevir + deleobuvir + ribavirin. Patients with compensated cirrhosis received open-label faldaprevir + deleobuvir + ribavirin for 24 weeks (Arm 3; n=51, n=72). Primary endpoints were comparisons of adjusted sustained virologic response (SVR) rates with historical rates: 71% (HCVerso1) and 68% (HCVerso2). Adjusted SVR12 rates were significantly greater than historical controls for Arms 1 and 2 in HCVerso2 (76%, 95% confidence interval [CI] 71–81, P=0.002; 81%, 95% CI 76–86, P<0.0001) and Arm 2 in HCVerso1 (81%, 95% CI 77–86, P<0.0001), but not for Arm 1 of HCVerso1 (72%, 95% CI 66–77, P=0.3989). Unadjusted SVR12 rates in Arms 1, 2, and 3 were 71.6%, 82.5%, and 72.5%, respectively, in HCVerso1 and 75.6%, 82.0%, and 73.6%, respectively, in HCVerso2. Virologic breakthrough and relapse occurred in 24-week arms in 8%–9% and 1% of patients, respectively, and in 16-week arms in 7%–8% and 9%–11% of patients, respectively. The most common adverse events were nausea (46%–61%) and vomiting (29%–35%). Adverse events resulted in discontinuation of all medications in 6%–8% of patients. In treatment-naïve patients with hepatitis C virus genotype-1b infection, with or without cirrhosis, faldaprevir + deleobuvir + ribavirin treatment for 24 weeks resulted in adjusted SVR12 rates significantly higher than historical controls. Both studies were registered in ClinicalTrials.gov (NCT01732796, NCT01728324).
Genetic association studies have shown their usefulness in assessing the role of ion channels in human thermal pain perception. We used machine learning to construct a complex phenotype from pain thresholds to thermal stimuli and associate it with the genetic information derived from the next-generation sequencing (NGS) of 15 ion channel genes which are involved in thermal perception, including ASIC1, ASIC2, ASIC3, ASIC4, TRPA1, TRPC1, TRPM2, TRPM3, TRPM4, TRPM5, TRPM8, TRPV1, TRPV2, TRPV3, and TRPV4. Phenotypic information was complete in 82 subjects and NGS genotypes were available in 67 subjects. A network of artificial neurons, implemented as emergent self-organizing maps, discovered two clusters characterized by high or low pain thresholds for heat and cold pain. A total of 1071 variants were discovered in the 15 ion channel genes. After feature selection, 80 genetic variants were retained for an association analysis based on machine learning. The measured performance of machine learning-mediated phenotype assignment based on this genetic information resulted in an area under the receiver operating characteristic curve of 77.2%, justifying a phenotype classification based on the genetic information. A further item categorization finally resulted in 38 genetic variants that contributed most to the phenotype assignment. Most of them (10) belonged to the TRPV3 gene, followed by TRPM3 (6). Therefore, the analysis successfully identified the particular importance of TRPV3 and TRPM3 for an average pain phenotype defined by the sensitivity to moderate thermal stimuli.
NIMA (never-in-mitosis gene A)-related kinase 1 (Nek1) is shown to impact on different cellular pathways such as DNA repair, checkpoint activation, and apoptosis. Its role as a molecular target for radiation sensitization of malignant cells, however, remains elusive. Stably transduced doxycycline (Dox)-inducible Nek1 shRNA HeLa cervix and siRNA-transfected HCT-15 colorectal carcinoma cells were irradiated in vitro and 3D clonogenic radiation survival, residual DNA damage, cell cycle distribution, and apoptosis were analyzed. Nek1 knockdown (KD) sensitized both cell lines to ionizing radiation following a single dose irradiation and more pronounced in combination with a 6 h fractionation (3 × 2 Gy) regime. For preclinical analyses we focused on cervical cancer. Nek1 shRNA HeLa cells were grafted into NOD/SCID/IL-2Rγc−/− (NSG) mice and Nek1 KD was induced by Dox-infused drinking water resulting in a significant cytostatic effect if combined with a 6 h fractionation (3 × 2 Gy) regime. In addition, we correlated Nek1 expression in biopsies of patients with cervical cancer with histopathological parameters and clinical follow-up. Our results indicate that elevated levels of Nek1 were associated with an increased rate of local or distant failure, as well as with impaired cancer-specific and overall survival in univariate analyses and for most endpoints in multivariable analyses. Finally, findings from The Cancer Genome Atlas (TCGA) validation cohort confirmed a significant association of high Nek1 expression with a reduced disease-free survival. In conclusion, we consider Nek1 to represent a novel biomarker and potential therapeutic target for drug development in the context of optimized fractionation intervals.
Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especially,thedevelopmentoffibrosisandportalhypertensioninNAFLDpatientsrequirestreatment. Transgenic TGR(mREN2)27 rats overexpressing mouse renin spontaneously develop NAFLD with portal hypertension but without obesity. This study investigated the additional role of obesity in this model on the development of portal hypertension and fibrosis. Obesity was induced in twelve-week old TGR(mREN2)27 rats after receiving Western diet (WD) for two or four weeks. Liver fibrosis was assessed using standard techniques. Hepatic expression of transforming growth factor-β1 (TGF-β1), collagen type Iα1, α-smooth muscle actin, and the macrophage markers Emr1, as well as the chemoattractant Ccl2, interleukin-1β (IL1β) and tumor necrosis factor-α (TNFα) were analyzed. Assessment of portal and systemic hemodynamics was performed using the colored microsphere technique. Asexpected,WDinducedobesityandliverfibrosisasconfirmedbySiriusRedandOilRed O staining. The expression of the monocyte-macrophage markers, Emr1, Ccl2, IL1β and TNFα were increasedduringfeedingofWD,indicatinginfiltrationofmacrophagesintotheliver,eventhoughthis increase was statistically not significant for the EGF module-containing mucin-like receptor (Emr1) mRNA expression levels. Of note, portal pressure increased with the duration of WD compared to animals that received a normal chow. Besides obesity, WD feeding increased systemic vascular resistance reflecting systemic endothelial and splanchnic vascular dysfunction. We conclude that transgenic TGR(mREN2)27 rats are a suitable model to investigate NAFLD development with liver fibrosis and portal hypertension. Tendency towards elevated expression of Emr1 is associated with macrophage activity point to a significant role of macrophages in NAFLD pathogenesis, probably due to a shift of the renin–angiotensin system towards a higher activation of the classical pathway. The hepatic injury induced by WD in TGR(mREN2)27 rats is suitable to evaluate different stages of fibrosis and portal hypertension in NAFLD with obesity.
Background: The purpose of this pilot study was to create a valid and reliable set of assessment questions for examining Evidence-based Dentistry (EbD) knowledge. For this reason, we adapted and validated for dental students the Berlin Questionnaire (BQ), which assesses Evidence-based Medicine (EbM) abilities.
Methods: The Berlin Questionnaire was validated with medical residents. We adapted it for use in a dentistry setting. An expert panel reviewed the adapted BQ for content validity. A cross-sectional cohort representing four training levels (EbD-novice dental students, EbD-trained dental students, dentists, and EbM−/EbD-expert faculty) completed the questionnaire. A total of 140 participants comprised the validation set. Internal reliability, item difficulty and item discrimination were assessed. Construct validity was assessed by comparing the mean total scores of students to faculty and comparing proportions of students and faculty who passed each item.
Results: Among the 133 participants (52 EbD-novice dental students, 53 EbD-trained dental students, 12 dentists, and 16 EbM-/ EbD-expert faculty), a statistically significant (p < 0.001) difference was evident in the total score corresponding to the training level. The total score reliability and psychometric properties of items modified for discipline-specific content were acceptable. Cronbach’s alpha was 0.648.
Conclusion: The adapted Berlin Questionnaire is a reliable and valid instrument to assess competence in Evidence-based Dentistry in dental students. Future research will focus on refining the instrument further.
Background: Radiotherapy dose and target volume prescriptions for anal squamous cell carcinoma (ASCC) vary considerably in daily practice and guidelines, including those from NCCN, UK, Australasian, and ESMO. We conducted a pattern-of-care survey to assess the patient management in German speaking countries.
Methods: We developed an anonymous questionnaire comprising 18 questions on diagnosis and treatment of ASCC. The survey was sent to 361 DEGRO-associated institutions, including 41 university hospitals, 118 non-university institutions, and 202 private practices.
Results: We received a total of 101 (28%) surveys, including 20 (19.8%) from university, 36 (35.6%) from non-university clinics, and 45 (44.6%) from private practices. A total of 28 (27.8%) institutions reported to treat more than 5 patients with early-stage ASCC and 42 (41.6%) institutions treat more than 5 patients with locoregionally-advanced ASCC per year. Biopsy of suspicious inguinal nodes was advocated in only 12 (11.8%) centers. Screening for human immunodeficiency virus (HIV) is done in 28 (27.7%). Intensity modulated radiotherapy or similar techniques are used in 97%. The elective lymph node dose ranged from 30.6 Gy to 52.8 Gy, whereas 87% prescribed 50.4–55. 8 Gy (range: 30.6 to 59.4 Gy) to the involved lymph nodes. The dose to gross disease of cT1 or cT2 ASCC ranged from 50 to ≥60 Gy. For cT3 or cT4 tumors the target dose ranged from 54 Gy to more than 60 Gy, with 76 (75.2%) institutions prescribing 59.4 Gy. The preferred concurrent chemotherapy regimen was 5-FU/Mitomycin C, whereas 6 (6%) prescribed Capecitabine/Mitomycin C. HIV-positive patients are treated with full-dose CRT in 87 (86.1%) institutions. First assessment for clinical response is reported to be performed at 4–6 weeks after completion of CRT in 2 (2%) institutions, at 6–8 weeks in 20 (19.8%), and 79 (78%) institutions wait up to 5 months.
Conclusions: We observed marked differences in radiotherapy doses and treatment technique in patients with ASCC, and also variable approaches for patients with HIV. These data underline the need for an consensus treatment guideline for ASCC.
Objective: Phenotypic (Sensititre Myco, pDST) and genotypic drug susceptibility testing (GenoType NTM DR, gDST) in M. avium complex (MAC) have become available as standardized assays, but comparable data is needed. This study aimed to investigate the phenotypic and genotypic drug susceptibility patterns in MAC clinical isolates.
Methods: Overall, 98 isolates from 85 patients were included. pDST and gDST were performed on all isolates and results compared regarding specificity and sensitivity using pDST as a reference method. The impact of drug instability on pDST results was studied using a biological assay over 14 days. In addition, the evolution of antimicrobial resistance was investigated in sequential isolates of 13 patients.
Results: Macrolide resistance was rare, 1.2% (95% CI 0.7–7.3) of isolates in the base cohort. No aminoglycoside resistances were found, but 14.1% of the studied isolates (95% CI 7.8–23.8) showed intermediate susceptibility. The GenoType NTM DR identified two out of four macrolide-resistant isolates. Antibiotic stability was demonstrated to be poor in rifampicin, rifabutin, and doxycycylin.
Conclusions: pDST results in NTM for unstable antibiotics must be interpreted with care. A combination of pDST and gDST will be useful for the guidance of antimicrobial therapy in MAC-disease.
Molecular and cellular research modalities for the study of liver pathologies have been tremendously improved over the recent decades. Advanced technologies offer novel opportunities to establish cell isolation techniques with excellent purity, paving the path for 2D and 3D microscopy and high-throughput assays (e.g., bulk or single-cell RNA sequencing). The use of stem cell and organoid research will help to decipher the pathophysiology of liver diseases and the interaction between various parenchymal and non-parenchymal liver cells. Furthermore, sophisticated animal models of liver disease allow for the in vivo assessment of fibrogenesis, portal hypertension and hepatocellular carcinoma (HCC) and for the preclinical testing of therapeutic strategies. The purpose of this review is to portray in detail novel in vitro and in vivo methods for the study of liver cell biology that had been presented at the workshop of the 8th meeting of the European Club for Liver Cell Biology (ECLCB-8) in October of 2018 in Bonn, Germany.
Objective: To study the effect of total hip replacement (THR) on serum cartilage oligomeric matrix protein concentration (sCOMP) and its correlation with joint loading during gait in patients with unilateral hip osteoarthritis.
Design: In this prospective multimodal (clinical, biomechanical, biochemical) study blood samples from 15 patients were taken before and up to three times after THR (7 days, 3 months and 1 year), each after a resting period of at least 30 min, for analysis of sCOMP. Gait analysis was performed before and 1 year after THR to determine hip and knee joint moments.
Results: Seven days after THR, sCOMP decreased significantly compared to the preoperative measurement (p < 0.001). Three months and 1 year postoperatively, sCOMP reverted to concentrations in the range of the preoperative value. One year postoperatively, a linear correlation between sCOMP and the maximum hip flexion moment was indicated in the first half of the stance phase on the unaffected side (r = −0.736, p = 0.024). No further correlations could be determined.
Conclusions: Surprisingly, the removal of a joint affected by osteoarthritis did not have a sustained effect on sCOMP. Both before and after THR there was no scientifically substantiated correlation between sCOMP and joint moments from gait analysis. Consequently, the examination of sCOMP is not useful to detect altered joint loads that may influence degenerative changes of adjacent joints after THR.
The registration number in the German Registry of Clinical Trials is DRKS00015053.
Background: Experienced and anticipated regret influence physicians’ decision-making. In medicine, diagnostic decisions and diagnostic errors can have a severe impact on both patients and physicians. Little empirical research exists on regret experienced by physicians when they make diagnostic decisions in primary care that later prove inappropriate or incorrect. The aim of this study was to explore the experience of regret following diagnostic decisions in primary care.
Methods: In this qualitative study, we used an online questionnaire on a sample of German primary care physicians. We asked participants to report on cases in which the final diagnosis differed from their original opinion, and in which treatment was at the very least delayed, possibly resulting in harm to the patient. We asked about original and final diagnoses, illness trajectories, and the reactions of other physicians, patients and relatives. We used thematic analysis to assess the data, supported by MAXQDA 11 and Microsoft Excel 2016.
Results: 29 GPs described one case each (14 female/15 male patients, aged 1.5–80 years, response rate < 1%). In 26 of 29 cases, the final diagnosis was more serious than the original diagnosis. In two cases, the diagnoses were equally serious, and in one case less serious. Clinical trajectories and the reactions of patients and relatives differed widely. Although only one third of cases involved preventable harm to patients, the vast majority (27 of 29) of physicians expressed deep feelings of regret.
Conclusion: Even if harm to patients is unavoidable, regret following diagnostic decisions can be devastating for clinicians, making them ‘second victims’. Procedures and tools are needed to analyse cases involving undesirable diagnostic events, so that ‘true’ diagnostic errors, in which harm could have been prevented, can be distinguished from others. Further studies should also explore how physicians can be supported in dealing with such events in order to prevent them from practicing defensive medicine.
Background: Point of care devices for performing targeted coagulation substitution in patients who are bleeding have become increasingly important in recent years. New on the market is the Quantra. It is a device that uses sonorheometry, a sonic estimation of elasticity via resonance, which is a novel ultrasound-based technology that measures viscoelastic properties of whole blood. Several studies have already shown the comparability of the Quantra with devices already established on the market, such as the rotational thromboelastometry (ROTEM) device.
Objective: In contrast to existing studies, this study is the first prospective interventional study using this new system in a cardiac surgical patient cohort. We will investigate the noninferiority between an already existing coagulation algorithm based on the ROTEM/Multiplate system and a new algorithm based on the Quantra system for the treatment of coagulopathic cardiac surgical patients.
Methods: The study is divided into two phases. In an initial observation phase, whole blood samples of 20 patients obtained at three defined time points (prior to surgery, after completion of cardiopulmonary bypass, and on arrival in the intensive care unit) will be analyzed using both the ROTEM/Multiplate and Quantra systems. The obtained threshold values will be used to develop a novel algorithm for hemotherapy. In a second intervention phase, the new algorithm will be tested for noninferiority against an algorithm used routinely for years in our department.
Results: The main objective of the examination is the cumulative loss of blood within 24 hours after surgery. Statistical calculations based on the literature and in-house data suggest that the new algorithm is not inferior if the difference in cumulative blood loss is <150 mL/24 hours.
Conclusions: Because of the comparability of the Quantra sonorheometry system with the ROTEM measurement methods, the existing hemotherapy treatment algorithm can be adapted to the Quantra device with proof of noninferiority.
Trial Registration: ClinicalTrials.gov NCT03902275; https://clinicaltrials.gov/ct2/show/NCT03902275
International Registered Report Identifier (IRRID): DERR1-10.2196/17206
Background: Computerized virtual patients (VP) have spread into many areas of healthcare delivery and medical education. They provide various advantages like flexibility in pace and space of learning, a high degree of teaching reproducibility and a cost effectiveness. However, the educational benefit of VP as an additive or also as an alternative to traditional teaching formats remains unclear. Moreover, there are no randomized-controlled studies that investigated the use of VP in a dental curriculum. Therefore, this study investigates VP as an alternative to lecturer-led small-group teaching in a curricular, randomized and controlled setting.
Methods: Randomized and controlled cohort study. Four VP cases were created according to previously published design principles and compared with lecturer-led small group teaching (SGT) within the Oral and Maxillofacial Surgery clerkship for dental students at the Department for Cranio-, Oral and Maxillofacial Plastic Surgery, Goethe University, Frankfurt, Germany. Clinical competence was measured prior (T0), directly (T1) and 6 weeks (T2) after the intervention using theoretical tests and a self-assessment questionnaire. Furthermore, VP design was evaluated using a validated toolkit.
Results: Fifty-seven students (VP = 32; SGT = 25) agreed to participate in the study. No competence differences were found at T0 (p = 0.56). The VP group outperformed (p < .0001) the SGT group at T1. At T2 there was no difference between both groups (p = 0.55). Both interventions led to a significant growth in self-assessed competence. The VP group felt better prepared to diagnose and treat real patients and regarded VP cases as a rewarding learning experience.
Conclusions: VP cases are an effective alternative to lecture-led SGT in terms of learning efficacy in the short and long-term as well as self-assessed competence growth and student satisfaction. Furthermore, integrating VP cases within a curricular Oral and Maxillofacial Surgery Clerkship is feasible and leads to substantial growth of clinical competence in undergraduate dental students.
Background: Ataxia telangiectasia (A-T) is a rare autosomal-recessive multisystem disorder characterized by pronounced cerebellar ataxia, telangiectasia, cancer predisposition and altered body composition. In addition, evidence is rising for endocrine dysfunction.
Objectives: To determine the evolution of diabetes and its prevalence in a larger A-T cohort.
Methods: A retrospective analysis of the patient charts of 39 subjects from the Frankfurt A-T cohort was performed between August 2002 and 2018 concerning HbA1c and oral glucose tolerance (OGTT). The median follow-up period was 4 years (1–16 years). In addition, in 31 A-T patients aged 1 to 38 years HbA1c and fasting glucose were studied prospectively from 2018 to 2019.
Results: In the retrospective analysis, we could demonstrate a longitudinal increase of HbA1c. The prospective analysis showed a significant increase of HbA1c and fasting glucose with age (r = 0.79, p ≤ 0.0001). OGTT has a good sensitivity for insulin resistance screening, whereas HbA1c can be used to evaluate individual courses and therapy response. Seven out of 39 (17.9%) patients suffered from diabetes. Metformin did not always lead to sufficient diabetes control; one patient was treated successfully with repaglinide.
Conclusion: Diabetes is a common finding in older A-T patients and often starts in puberty. Our data clearly demonstrate the need for an annual diabetes screening in patients > 12 years.
Inhibitor-kappaB kinase epsilon (IKKε) and TANK-binding kinase 1 (TBK1) are non-canonical IκB kinases, both described as contributors to tumor growth and metastasis in different cancer types. Several hints indicate that they are also involved in the pathogenesis of melanoma; however, the impact of their inhibition as a potential therapeutic measure in this “difficult-to-treat” cancer type has not been investigated so far. We assessed IKKε and TBK1 expression in human malignant melanoma cells, primary tumors and the metastasis of melanoma patients. Both kinases were expressed in the primary tumor and in metastasis and showed a significant overexpression in tumor cells in comparison to melanocytes. The pharmacological inhibition of IKKε/TBK1 by the approved drug amlexanox reduced cell proliferation, migration and invasion. Amlexanox did not affect the cell cycle progression nor apoptosis induction but significantly suppressed autophagy in melanoma cells. The analysis of potential functional downstream targets revealed that NF-кB and ERK pathways might be involved in kinase-mediated effects. In an in vivo xenograft model in nude mice, amlexanox treatment significantly reduced tumor growth. In conclusion, amlexanox was able to suppress tumor progression potentially by the inhibition of autophagy as well as NF-кB and MAP kinase pathways and might therefore constitute a promising candidate for melanoma therapy.
The macrophage-inducible C-type lectin (mincle) is part of the innate immune system and acts as a pattern recognition receptor for pathogen-associated molecular patterns (PAMPS) and damage-associated molecular patterns (DAMPs). Ligand binding induces mincle activation which consequently interacts with the signaling adapter Fc receptor, SYK, and NF-kappa-B. There is also evidence that mincle expressed on macrophages promotes intestinal barrier integrity. However, little is known about the role of mincle in hepatic fibrosis, especially in more advanced disease stages. Mincle expression was measured in human liver samples from cirrhotic patients and donors collected at liver transplantation and in patients undergoing bariatric surgery. Human results were confirmed in rodent models of cirrhosis and acute-on-chronic liver failure (ACLF). In these models, the role of mincle was investigated in liver samples as well as in peripheral blood monocytes (PBMC), tissues from the kidney, spleen, small intestine, and heart. Additionally, mincle activation was stimulated in experimental non-alcoholic steatohepatitis (NASH) by treatment with mincle agonist trehalose-6,6-dibehenate (TDB). In human NASH, mincle is upregulated with increased collagen production. In ApoE deficient mice fed high-fat western diet (NASH model), mincle activation significantly increases hepatic collagen production. In human cirrhosis, mincle expression is also significantly upregulated. Furthermore, mincle expression is associated with the stage of chronic liver disease. This could be confirmed in rat models of cirrhosis and ACLF. ACLF was induced by LPS injection in cirrhotic rats. While mincle expression and downstream signaling via FC receptor gamma, SYK, and NF-kappa-B are upregulated in the liver, they are downregulated in PBMCs of these rats. Although mincle expressed on macrophages might be beneficial for intestinal barrier integrity, it seems to contribute to inflammation and fibrosis once the intestinal barrier becomes leaky in advanced stages of chronic liver disease.
The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.
Background/aims: Hepatocellular carcinoma (HCC) is a leading indication for liver transplantation (LT) worldwide. Early identification of patients at risk for HCC recurrence is of paramount importance since early treatment of recurrent HCC after LT may be associated with increased survival. We evaluated incidence of and predictors for HCC recurrence, with a focus on the course of AFP levels.
Methods: We performed a retrospective, single-center study of 99 HCC patients who underwent LT between January 28th, 1997 and May 11th, 2016. A multi-stage proportional hazards model with three stages was used to evaluate potential predictive markers, both by univariate and multivariable analysis, for influences on 1) recurrence after transplantation, 2) mortality without HCC recurrence, and 3) mortality after recurrence.
Results: 19/99 HCC patients showed recurrence after LT. Waiting time was not associated with overall HCC recurrence (HR = 1, p = 0.979). Similarly, waiting time did not affect mortality in LT recipients both with (HR = 0.97, p = 0.282) or without (HR = 0.99, p = 0.685) HCC recurrence. Log10-transformed AFP values at the time of LT (HR 1.75, p = 0.023) as well as after LT (HR 2.07, p = 0.037) were significantly associated with recurrence. Median survival in patients with a ratio (AFP at recurrence divided by AFP 3 months before recurrence) of 0.5 was greater than 70 months, as compared to a median of only 8 months in patients with a ratio of 5.
Conclusion: A rise in AFP levels rather than an absolute threshold could help to identify patients at short-term risk for HCC recurrence post LT, which may allow intensification of the surveillance strategy on an individualized basis.
Most living organisms possess varying degrees of regenerative capabilities but how these regenerative processes are controlled is still poorly understood. Naturally occurring bioelectric voltages (like Vmem) are thought to be playing instructive role in tissue regeneration, as well as embryonic development. The different distribution of ions on the either side of the cell membrane results in intra- and extra-cellular voltage differences, known as membrane potential or Vmem. The relationship between Vmem and cell physiology is conserved in a wide range of cell types and suggests that Vmem regulation is a fundamental control mechanism for regeneration related processes e.g., proliferation and differentiation. In the present study we measured Vmem in three different cell types (human osteogenic sarcoma cell line (OSC), rat bone marrow derived mesenchymal stem cells (BM-MSC), and rat dermal fibroblasts) and characterized the relationship between their Vmem and proliferation. In order to find out if Vmem controls proliferation, or visa-versa, we blocked and then unblocked Na+/K+-exchanging ATPase using ouabain and measured the proliferation. Our results demonstrate that Vmem can be pharmacologically manipulated to control proliferation in certain cell types like BM-MSC. Taken together, it is clear that control of bioelectrical properties in non-excitable cells could prove to be potentially a useful tool in regenerative medicine efforts.
In the context of workplace health promotion, physical activity programs have been shown to reduce musculoskeletal diseases and stress, and to improve the quality of life. The aim of this study was to examine the effects of using the “five-Business” stretch training device for office workers on their quality of life. A total of 313 office workers (173m/137f) participated voluntarily in this intervention–control study with an average age of 43.37 ± 11.24 (SD) years, 175.37 ± 9.35 cm in height and 75.76 ± 15.23 kg in weight, with an average BMI of 24.5 ± 3.81 kg/m2. The participants completed the stretch training twice a week for approximately 10 minutes for a duration of 12 weeks. The SF-36 questionnaire was used to evaluate the effectiveness of the intervention at baseline and after 12 weeks. Significantly improved outcomes in mental sum score (p = 0.008), physical functioning (p < 0.001), bodily pain (p = 0.01), vitality (p = 0.025), role limitations due to physical problems (p = 0.018) and mental health (p = 0.012) were shown after the stretching training. The results suggest that a 12-week stretching program for office desk workers is suitable to improve significantly their health-related quality of life.
Sphingosine 1-phosphate (S1P), derived from membrane sphingolipids, is a pleiotropic bioactive lipid mediator capable of evoking complex immune phenomena. Studies have highlighted its importance regarding intracellular signaling cascades as well as membrane-bound S1P receptor (S1PR) engagement in various clinical conditions. In neurological disorders, the S1P–S1PR axis is acknowledged in neurodegenerative, neuroinflammatory, and cerebrovascular disorders. Modulators of S1P signaling have enabled an immense insight into fundamental pathological pathways, which were pivotal in identifying and improving the treatment of human diseases. However, its intricate molecular signaling pathways initiated upon receptor ligation are still poorly elucidated. In this review, the authors highlight the current evidence for S1P signaling in neurodegenerative and neuroinflammatory disorders as well as stroke and present an array of drugs targeting the S1P signaling pathway, which are being tested in clinical trials. Further insights on how the S1P–S1PR axis orchestrates disease initiation, progression, and recovery may hold a remarkable potential regarding therapeutic options in these neurological disorders.
Background: Myocardial perfusion with cardiovascular magnetic resonance (CMR) imaging is an established diagnostic test for evaluation of myocardial ischaemia. For quantification purposes, the 16 segment American Heart Association (AHA) model poses limitations in terms of extracting relevant information on the extent/severity of ischaemia as perfusion deficits will not always fall within an individual segment, which reduces its diagnostic value, and makes an accurate assessment of outcome data or a result comparison across various studies difficult. We hypothesised that division of the myocardial segments into epi- and endocardial layers and a further circumferential subdivision, resulting in a total of 96 segments, would improve the accuracy of detecting myocardial hypoperfusion. Higher (sub-)subsegmental recording of perfusion abnormalities, which are defined relatively to the normal reference using the subsegment with the highest value, may improve the spatial encoding of myocardial blood flow, based on a single stress perfusion acquisition. Objective: A proof of concept comparison study of subsegmentation approaches based on transmural segments (16 AHA and 48 segments) vs. subdivision into epi- and endocardial (32) subsegments vs. further circumferential subdivision into 96 (sub-)subsegments for diagnostic accuracy against invasively defined obstructive coronary artery disease (CAD). Methods: Thirty patients with obstructive CAD and 20 healthy controls underwent perfusion stress CMR imaging at 3 T during maximal adenosine vasodilation and a dual bolus injection of 0.1mmol/kg gadobutrol. Using Fermi deconvolution for blood flow estimation, (sub-)subsegmental values were expressed relative to the (sub)subsegment with the highest flow. In addition, endo−/epicardial flow ratios were calculated based on 32 and 96 (sub-)subsegments. A receiver operating characteristics (ROC) curve analysis was performed to compare the diagnostic performance of discrimination between patients with CAD and healthy controls. Observer reproducibility was assessed using Bland-Altman approaches. Results: Subdivision into more and smaller segments revealed greater accuracy for #32, #48 and # 96 compared to the standard #16 approach (area under the curve (AUC): 0.937, 0.973 and 0.993 vs 0.820, p<0.05). The #96-based endo−/epicardial ratio was superior to the #32 endo−/epicardial ratio (AUC 0.979, vs. 0.932, p<0.05). Measurements for the #16 model showed marginally better reproducibility compared to #32, #48 and #96 (mean difference± standard deviation: 2.0±3.6 vs. 2.3±4.0 vs 2.5±4.4 vs. 4.1±5.6). Conclusions: Subsegmentation of the myocardium improves diagnostic accuracy and facilitates an objective cutoff-based description of hypoperfusion, and facilitates an objective description of hypoperfusion, including the extent and severity of myocardial ischaemia. Quantification based on a single (stress-only) pass reduces the overall amount of gadolinium contrast agent required and the length of the overall diagnostic study.
The permeability and inflammatory tissue reaction to Mucomaix® matrix (MM), a non- cross-linked collagen-based matrix was evaluated in both ex vivo and in vivo settings. Liquid platelet rich fibrin (PRF), a blood concentrate system, was used to assess its capacity to absorb human proteins and interact with blood cells ex vivo. In the in vivo aspect, 12 Wister rats had MM implanted subcutaneously, whereas another 12 rats (control) were sham-operated without biomaterial implantation. On days 3, 15 and 30, explantation was completed (four rats per time-point) to evaluate the tissue reactions to the matrix. Data collected were statistically analyzed using analysis of variance (ANOVA) and Tukey multiple comparisons tests (GraphPad Prism 8). The matrix absorbed the liquid PRF in the ex vivo study. Day 3 post-implantation revealed mild tissue inflammatory reaction with presence of mononuclear cells in the implantation site and on the biomaterial surface (mostly CD68-positive macrophages). The control group at this stage had more mononuclear cells than the test group. From day 15, multinucleated giant cells (MNGCs) were seen in the implantation site and the outer third of the matrix with marked increase on day 30 and spread to the matrix core. The presence of these CD68-positive MNGCs was associated with significant matrix vascularization. The matrix degraded significantly over the study period, but its core was still visible as of day 30 post-implantation. The high permeability and fast degradation properties of MM were highlighted.
Purpose: In the clinical routine, detection of focal cortical dysplasia (FCD) by visual inspection is challenging. Still, information about the presence and location of FCD is highly relevant for prognostication and treatment decisions. Therefore, this study aimed to develop, describe and test a method for the calculation of synthetic anatomies using multiparametric quantitative MRI (qMRI) data and surface-based analysis, which allows for an improved visualization of FCD.
Materials and Methods: Quantitative T1-, T2- and PD-maps and conventional clinical datasets of patients with FCD and epilepsy were acquired. Tissue segmentation and delineation of the border between white matter and cortex was performed. In order to detect blurring at this border, a surface-based calculation of the standard deviation of each quantitative parameter (T1, T2, and PD) was performed across the cortex and the neighboring white matter for each cortical vertex. The resulting standard deviations combined with measures of the cortical thickness were used to enhance the signal of conventional FLAIR-datasets. The resulting synthetically enhanced FLAIR-anatomies were compared with conventional MRI-data utilizing regions of interest based analysis techniques.
Results: The synthetically enhanced FLAIR-anatomies showed higher signal levels than conventional FLAIR-data at the FCD sites (p = 0.005). In addition, the enhanced FLAIR-anatomies exhibited higher signal levels at the FCD sites than in the corresponding contralateral regions (p = 0.005). However, false positive findings occurred, so careful comparison with conventional datasets is mandatory.
Conclusion: Synthetically enhanced FLAIR-anatomies resulting from surface-based multiparametric qMRI-analyses have the potential to improve the visualization of FCD and, accordingly, the treatment of the respective patients.
Temperature elevations constitute a major threat to plant performance. In recent years, much was learned about the general molecular mode of heat stress reaction of plants. The current research focuses on the integration of the knowledge into more global networks, including the reactions of cellular compartments. For instance, chloroplast function is central for plant growth and survival, and the performance of chloroplasts is tightly linked to the general status of the cell and vice versa. We examined the changes in photosynthesis, chloroplast morphology and proteomic composition posed in Arabidopsis thaliana chloroplasts after a single or repetitive heat stress treatment over a period of two weeks. We observed that the acclimation is potent in the case of repetitive application of heat stress, while a single stress results in lasting alterations. Moreover, the physiological capacity and its adjustment are dependent on the efficiency of the protein translocation process as judged from the analysis of mutants of the two receptor units of the chloroplast translocon, TOC64, and TOC33. In response to repetitive heat stress, plants without TOC33 accumulate Hsp70 proteins and plants without TOC64 have a higher content of proteins involved in thylakoid structure determination when compared to wild-type plants.
Children are commonly exposed to second-hand smoke (SHS) in the domestic environment or inside vehicles of smokers. Unfortunately, prenatal tobacco smoke (PTS) exposure is still common, too. SHS is hazardous to the health of smokers and non-smokers, but especially to that of children. SHS and PTS increase the risk for children to develop cancers and can trigger or worsen asthma and allergies, modulate the immune status, and is harmful to lung, heart and blood vessels. Smoking during pregnancy can cause pregnancy complications and poor birth outcomes as well as changes in the development of the foetus. Lately, some of the molecular and genetic mechanisms that cause adverse health effects in children have been identified. In this review, some of the current insights are discussed. In this regard, it has been found in children that SHS and PTS exposure is associated with changes in levels of enzymes, hormones, and expression of genes, micro RNAs, and proteins. PTS and SHS exposure are major elicitors of mechanisms of oxidative stress. Genetic predisposition can compound the health effects of PTS and SHS exposure. Epigenetic effects might influence in utero gene expression and disease susceptibility. Hence, the limitation of domestic and public exposure to SHS as well as PTS exposure has to be in the focus of policymakers and the public in order to save the health of children at an early age. Global substantial smoke-free policies, health communication campaigns, and behavioural interventions are useful and should be mandatory.
The Masquelet technique for the treatment of large bone defects is a two-stage procedure based on an induced membrane. We eliminate the first surgical step by using a decellularized dermal skin graft (Epiflex®) populated with bone marrow mononuclear cells (BMC), as a replacement for the induced membrane. The aim of this study was to demonstrate the feasibility of this technology and provide evidence of equivalent bone healing in comparison to the induced membrane-technique. Therefore, 112 male Sprague–Dawley rats were allocated in six groups and received a 10 mm femoral defect. Defects were treated with either the induced membrane or decellularized dermis, with or without the addition of BMC. Defects were then filled with a scaffold (β-TCP), with or without BMC. After a healing time of eight weeks, femurs were taken for histological, radiological and biomechanical analysis. Defects treated with Epiflex® showed increased mineralization and bone formation predominantly in the transplanted dermis surrounding the defect. No significant decrease of biomechanical properties was found. Vascularization of the defect could be enhanced by addition of BMC. Considering the dramatic reduction of a patient’s burden by the reduced surgical stress and shortened time of treatment, this technique could have a great impact on clinical practice.
The occupation of dental assistants (DAs) involves many health risks of the musculoskeletal system due to static and prolonged work, which can lead to musculoskeletal disorders (MSDs). The aim of the study was to investigate the prevalence of MSDs in DAs in Germany. Methods: For this purpose, an online questionnaire analyzed 406 (401 female participants and 5 male participants, 401w/5m) DAs. It was based on the Nordic Questionnaire (lifetime, 12-month, and seven-day MSDs’ prevalence separated into neck, shoulder, elbow, wrist, upper back, lower back, hip, knee, and ankle), and occupational and sociodemographic questions as well as questions about specific medical conditions. Results: 98.5% of the participants reported complaints of at least one body region in their lives, 97.5% reported at least one complaint in the last 12 months and 86.9% affirmed at least one complaint in the last seven days. For lifetime, 12-month and seven-day prevalence, the neck was the region that was most affected followed by the shoulder, the upper back and the lower back. Conclusion: The prevalence of MSDs among German (female) DAs was very high. The most affected area is the neck, followed by the shoulder, the lower back, and the upper back. It, therefore, seems necessary to devote more attention to ergonomics at the working practice of DAs as well in education and in dental work.